≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Renal cell carcinoma of kidney

Endpoint Browser PheWeb

C3_RENAL_CELL_CARCINOMA

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cancer registry: Topography ICD-O-3 — C64
  • Cancer registry: Morphology ICD-O-3 — 8312|831[6-9]
  • Cancer registry: Behaviour codes — 3

1 out of 7 registries used, show all original rules.

1341

4. Check minimum number of events

None

1341

5. Include endpoints

None

1341

6. Filter based on genotype QC (FinnGen only)

1305

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze
DF8

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 1305 498 807
Unadjusted period prevalence (%) 0.30 0.18 0.37
Median age at first event (years) 63.75 61.82 64.94

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1340
Matched controls
13400
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
307.7
1175
*
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
+∞
307.7
439
*
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
206.3
307.7
682
67
KAC10
NOMESCO Finland
Total nephrectomy with capsule
6628.7
307.7
459
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
307.7
1126
*
130
Kela drug reimbursment
Malignant tumour
+∞
307.7
376
*
JN4AD
NOMESCO Finland
Body CT examination
10.5
273.7
349
435
H02AB02
ATC
dexamethasone; systemic
26.6
227.0
160
68
8317/3-C64.9
ICD-O-3
Renal cell carcinoma, chromophobe type of kidney, NOS
+∞
211.2
197
*
JN4BD
NOMESCO Finland
Extensive body CT
10.6
204.9
247
281
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
539.1
192.6
187
*
JN4CD
NOMESCO Finland
Very extensive body CT
20.8
161.5
125
66
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
27.1
158.8
110
44
7125
FHL
Nephrectomy (extrrafascial)
1675.3
154.2
147
*
197
Kela drug reimbursment
Sunitinib
+∞
154.2
145
*
A03FA01
ATC
metoclopramide; systemic, rectal
5.6
152.2
355
813
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
68.0
151.5
83
13
C61
ICD-10 Finland
Malignant neoplasm of prostate
377.1
138.5
137
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
134.7
127
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
130.4
123
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
12.8
124.5
125
107
KAC00
NOMESCO Finland
Nephrectomy
443.6
123.9
122
*
L01XE04
ATC
[U] sunitinib
+∞
118.5
112
*
C64.80
ICD-10 Finland
Wilms tumour
+∞
118.5
112
*
KAD00
NOMESCO Finland
Partial nephrectomy
188.1
116.5
120
7
1890B
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,ADENOCARCINOMA]
+∞
112.1
106
*
KAD01
NOMESCO Finland
Percutaneous endoscopic partial nephrectomy
287.9
105.5
106
*
180
Kela drug reimbursment
Interferon alfa
+∞
104.6
99
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.4
99.7
302
835
WF049
NOMESCO Finland
Radiotherapy of metastasis
1008.7
97.3
94
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
94.9
90
*
1502
Kela drug reimbursment
Cabozantinib
+∞
84.3
80
*
B01AB10
ATC
tinzaparin; parenteral
4.7
83.6
219
537
3012
Kela drug reimbursment
Cabozantinib
+∞
83.2
79
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
848.5
82.4
80
*
KA1AE
NOMESCO Finland
Kidney ultrasound examination
9.4
81.2
100
114
U75
ICPC
Malignant neoplasm of kidney
+∞
78.9
75
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
75.7
72
*
116
Kela drug reimbursment
Prostate cancer
+∞
74.7
71
*
322
Kela drug reimbursment
Sunitinib
+∞
74.7
71
*
D30.0
ICD-10 Finland
Benign neoplasm: Kidney
19.8
73.1
57
30
Z51.5
ICD-10 Finland
Palliative care
5.0
72.4
168
371
XX3DW
NOMESCO Finland
Time consuming IT work
5.9
71.9
138
257
A04AA01
ATC
ondansetron; systemic, rectal
8.0
71.2
100
134
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
6.2
66.8
119
206
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
5.6
64.7
131
256
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
62.0
59
*
159
Kela drug reimbursment
Pazopanib
+∞
59.8
57
*
A04AA02
ATC
granisetron; systemic, transdermal
310.5
58.8
59
*
C648, ,
ICD-10 Finland
+∞
57.7
55
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
6.4
57.1
98
163
1890X
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,EI HIST VAHV]
+∞
56.7
54
*
N02AX02
ATC
tramadol; systemic, rectal
2.5
56.6
689
4026
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
72.0
54.6
62
9
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.4
54.4
222
735
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
549.3
53.9
53
*
L01EX07
ATC
cabozantinib; oral
+∞
53.5
51
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
6.9
53.2
85
131
158
Kela drug reimbursment
Everolimus
+∞
52.4
50
*
115
Kela drug reimbursment
Breast cancer
+∞
50.3
48
*
N02AA05
ATC
oxycodone; systemic
2.7
49.2
325
1408
B01AB05
ATC
enoxaparin; parenteral
2.4
48.5
476
2486
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
6.1
48.3
86
148
A11CC03
ATC
alfacalcidol; systemic
6.3
48.3
83
138
WZC00
NOMESCO Finland
Treatment plan or consultation
2.5
48.0
423
2102
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
47.6
359
1658
PJA12
NOMESCO Finland
Sentinel node biopsy
462.9
45.5
45
*
L01XE11
ATC
[U] pazopanib
+∞
45.0
43
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
227.3
43.2
44
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
119.0
43.0
46
*
TK800
NOMESCO Finland
Hemodialysis
7.0
42.3
66
99
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
12.0
42.2
43
37
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
41.9
40
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
41.9
40
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
409.4
40.3
40
*
L01XE26
ATC
[U] cabozantinib
+∞
39.8
38
*
WF002
NOMESCO Finland
Radical radiotherapy
66.4
39.3
45
7
L02AE02
ATC
leuprorelin; implant, parenteral
88.9
39.0
43
5
WZC30
NOMESCO Finland
Teaching
2.8
39.0
220
870
L03AA04, ,
ATC
+∞
38.7
37
*
L01EX01
ATC
sunitinib; oral
+∞
38.7
37
*
R31
ICD-10 Finland
Unspecified haematuria
2.8
38.2
226
915
TPH07
NOMESCO Finland
Cathetrisation of artery
2.8
37.7
209
818
WW500
NOMESCO Finland
Blood transfusion
6.2
37.4
65
109
L02BG04
ATC
letrozole; oral
72.1
37.1
42
6
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
36.6
35
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
4.9
36.6
84
182
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
7.5
35.8
52
72
NK6AN
NOMESCO Finland
Total body bone isotope imaging
68.6
35.2
40
6
B03XA02
ATC
darbepoetin alfa; parenteral
6.9
34.6
54
81
L03AB05
ATC
interferon alfa-2b; parenteral
+∞
34.5
33
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
34.5
33
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
7.2
34.1
51
73
JN3AD
NOMESCO Finland
Abdominal CT examination
2.7
33.8
203
826
Z49.0
ICD-10 Finland
Preparatory care for dialysis
9.6
33.7
40
43
168
Kela drug reimbursment
Axitinib
+∞
33.5
32
*
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
5.1
33.3
72
148
A12AA04
ATC
calcium carbonate; oral
6.9
33.3
52
78
L01BC06
ATC
capecitabine; oral
+∞
32.4
31
*
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
12.7
31.6
31
25
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
31.4
30
*
N18.8
ICD-10 Finland
Other chronic renal failure
4.5
31.2
78
181
UKC02
NOMESCO Finland
Cystoscopy
2.3
31.1
290
1442
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
71.7
31.0
35
5
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.1
30.6
54
92
N02AA01
ATC
morphine; systemic, rectal
6.4
30.6
51
82
18900
ICD-8 Finland
Malignant neoplasm of other and unspecified urinary organs, Kidney, except pelvis
+∞
30.3
29
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
30.3
29
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
309.1
29.9
30
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
6.8
29.9
47
71
U14
ICPC
Kidney symptom/complaint
5.8
29.8
55
98
ZXE20
NOMESCO Finland
More than three and less than five hours
2.5
29.4
214
953
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
4.0
29.3
85
221
L02BB03
ATC
bicalutamide; oral
+∞
29.3
28
*
198
Kela drug reimbursment
Sorafenib
+∞
29.3
28
*
Z49.1
ICD-10 Finland
Extracorporeal dialysis
7.3
28.5
42
59
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
39.9
28.1
35
9
Y77
ICPC
Malignant neoplasm prostate
102.3
27.8
30
*
V03AE01
ATC
polystyrene sulfonate; oral
6.3
27.7
47
77
L03AB04
ATC
interferon alfa-2a; parenteral
+∞
27.2
26
*
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
+∞
27.2
26
*
340
Kela drug reimbursment
Everolimus
+∞
27.2
26
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.8
26.9
148
573
N18.0
ICD-10 Finland
End-stage renal disease
7.0
26.8
41
60
KA3LT
NOMESCO Finland
Njurlesion coagulation
98.8
26.7
29
*
XKD00
NOMESCO Finland
Uroflowmetry
2.2
26.7
271
1388
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
26.1
477
3013
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
26.1
25
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
26.1
25
*
M04AA01
ATC
allopurinol; systemic
2.2
25.8
276
1442
2395A
ICD-9 Finland
Neoplasm of unspecified nature, Other genito-urinary organs
45.2
25.6
31
7
TPX10
NOMESCO Finland
Implantation of vascular injection port
5.6
25.4
49
91
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
25.2
672
4765
L01XE10
ATC
[U] everolimus
+∞
25.1
24
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
25.1
24
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
25.1
24
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
5.8
24.9
46
82
WF004
NOMESCO Finland
Palliative radiotherapy
254.7
24.7
25
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.9
24.7
124
456
A79
ICPC
Malignancy NOS
91.8
24.7
27
*
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.6
24.7
59
132
Z31.5
ICD-10 Finland
Genetic counselling
5.2
23.7
49
97
137
Kela drug reimbursment
Uraemia requiring dialysis
9.5
23.6
28
30
ZX090
NOMESCO Finland
Other technic of radiotherapy
47.6
23.4
28
6
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
7.4
22.1
32
44
HAC20
NOMESCO Finland
Total mastectomy
116.9
21.6
23
*
L03AA13
ATC
pegfilgrastim; parenteral
116.9
21.6
23
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
20.9
20
*
343
Kela drug reimbursment
Pazopanib
+∞
20.9
20
*
L01XE17
ATC
[U] axitinib
+∞
20.9
20
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
20.9
20
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
78.1
20.7
23
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
213.2
20.6
21
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
111.8
20.6
22
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.4
20.4
159
725
R50.9
ICD-10 Finland
Fever, unspecified
2.1
20.1
208
1065
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
6.1
20.0
35
59
Z90.5
ICD-10 Finland
Acquired absence of kidney
58.4
19.9
23
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
19.8
19
*
361
Kela drug reimbursment
Axitinib
+∞
19.8
19
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
19.8
19
*
L01XE05
ATC
[U] sorafenib
+∞
19.8
19
*
L03AA02
ATC
filgrastim; parenteral
106.6
19.6
21
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.7
19.1
111
440
SPAT1153
SPAT
Removal of sutures
1.8
19.0
403
2615
HA1AA
NOMESCO Finland
X-ray mammography
4.1
18.9
52
130
KAC01
NOMESCO Finland
Percutaneous endoscopic nephrectomy
+∞
18.8
18
*
TKE00
NOMESCO Finland
Needle biopsy of prostate
3.6
18.6
61
173
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
192.6
18.6
19
*
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
6.8
17.9
28
42
HAB40
NOMESCO Finland
Wedge excision of mammary gland
23.1
17.8
25
11
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
17.7
17
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
17.7
17
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.5
17.7
118
501
E83.50
ICD-10 Finland
Hypercalcemia
6.0
17.5
31
53
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
29.2
17.4
23
8
205
Kela drug reimbursment
Chronic hypertension
1.7
17.1
513
3641
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.1
16.9
187
979
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
16.9
421
2843
M05BX04
ATC
denosumab; parenteral
2.7
16.8
94
366
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
16.7
16
*
1890A
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,NEPHROBLASTOMA]
+∞
16.7
16
*
ZXC96
NOMESCO Finland
Robot assisted procedure
16.6
16.6
26
16
JFB46
NOMESCO Finland
Resection of sigmoid colon
7.4
16.6
24
33
127
Kela drug reimbursment
Transplant complication
7.4
16.6
24
33
Z51.0
ICD-10 Finland
Radiotherapy session
172.1
16.5
17
*
M05BA02
ATC
clodronic acid; systemic
172.1
16.5
17
*
L02BA01
ATC
tamoxifen; oral
172.1
16.5
17
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
40.6
16.4
20
5
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
3.0
16.1
72
248
J01MA02
ATC
ciprofloxacin; systemic
1.6
16.1
535
3879
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.7
16.1
87
333
C50.99
ICD-10 Finland
Breast, unspecified
+∞
15.7
15
*
KAC20
NOMESCO Finland
Nephroureterectomy
+∞
15.7
15
*
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
15.7
15
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
15.7
15
*
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
+∞
15.7
15
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
15.7
15
*
BCA30
NOMESCO Finland
Unilateral adrenalectomy
+∞
15.7
15
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
15.7
15
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
15.7
15
*
L01EG02
ATC
everolimus; oral
+∞
15.7
15
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
15.7
15
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
15.7
15
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
15.7
15
*
ZX120
NOMESCO Finland
Intravenous
2.4
15.4
110
481
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.9
15.3
201
1116
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
13.2
15.2
26
20
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
18.0
15.2
23
13
L02AB02
ATC
medroxyprogesterone; systemic
20.3
15.1
22
11
JN6AD
NOMESCO Finland
CT of torso and neck
12.0
15.1
27
23
B02AA02
ATC
tranexamic acid; systemic
2.1
14.8
142
703
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
4.8
14.8
33
70
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
14.6
14
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
14.6
14
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
14.6
14
*
B03XA01
ATC
erythropoietin; parenteral
6.7
14.5
23
35
JAH00
NOMESCO Finland
Laparotomy
3.7
14.5
46
128
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
14.2
458
3274
GD1AD
NOMESCO Finland
Thorax CT examination
2.6
14.1
86
349
UJF32
NOMESCO Finland
Coloscopy
1.7
14.1
334
2207
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
43.0
14.1
17
*
ZXA05
NOMESCO Finland
Left side
1.7
14.1
333
2201
N28.1
ICD-10 Finland
Cyst of kidney
4.7
14.0
32
69
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.5
14.0
88
363
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
53.9
13.8
16
*
WX402
NOMESCO Finland
General anaesthesia
1.9
13.6
202
1165
KCD02
NOMESCO Finland
Transurethral resection of bladder
12.2
13.6
24
20
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
13.6
13
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
13.6
13
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
13.6
13
*
PHE70
NOMESCO Finland
Thrombectomy of inferior vena cava
+∞
13.6
13
*
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.0
13.5
61
212
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
141.4
13.5
14
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
141.4
13.5
14
*
C50
ICD-10 Finland
Malignant neoplasm of breast
141.4
13.5
14
*
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
4.8
13.3
30
64
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.9
13.3
62
219
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
10.6
13.3
25
24
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
4.2
13.1
35
86
C08CA01
ATC
amlodipine; oral
1.5
12.8
588
4525
V03AE02
ATC
sevelamer; oral
14.2
12.8
21
15
AA1BD
NOMESCO Finland
Extensive CT of head and brain
4.3
12.7
32
75
C79.7
ICD-10 Finland
Secondary malignant neoplasm of adrenal gland
+∞
12.5
12
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
12.5
12
*
Z85.5
ICD-10 Finland
Personal history of malignant neoplasm of urinary tract
+∞
12.5
12
*
L01EK01
ATC
axitinib; oral
+∞
12.5
12
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
12.5
12
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
131.2
12.5
13
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
131.2
12.5
13
*
A06AH03
ATC
naloxegol; oral
11.2
12.0
22
20
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
5.7
12.0
22
39
C03CA01
ATC
furosemide; systemic
1.5
11.7
569
4408
C90.0
ICD-10 Finland
Multiple myeloma
+∞
11.5
11
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
11.5
11
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
11.5
11
*
KA4AT
NOMESCO Finland
Cytology of kidney with ultrasound guidance
+∞
11.5
11
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
11.5
11
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
11.5
11
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
11.5
11
*
D41.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Urinary organ, unspecified
121.0
11.4
12
*
GDC00
NOMESCO Finland
Lobectomy of lung
121.0
11.4
12
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
11.4
414
3009
RD211, ,
NOMESCO Finland
2.8
11.3
58
216
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.6
11.3
66
263
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.1
11.3
47
156
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
4.2
11.1
29
70
ZZR00
NOMESCO Finland
Flap of skin
10.1
11.0
21
21
C02AC05
ATC
moxonidine; oral
2.3
10.8
83
376
ZXA00
NOMESCO Finland
Right side
1.6
10.7
350
2480
XJH00
NOMESCO Finland
Transanal ultrasonography
2.1
10.6
96
465
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
11.3
10.6
19
17
D44.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thyroid gland
8.6
10.6
22
26
Z94.0
ICD-10 Finland
Kidney transplant status
8.6
10.6
22
26
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
10.4
10
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
10.4
10
*
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
+∞
10.4
10
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
10.4
10
*
AA049
NOMESCO Finland
Radiotherapy of metasthasis in the brain
+∞
10.4
10
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
10.4
10
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
10.4
10
*
NA049
NOMESCO Finland
Radiotherapy of methastasis in spine
+∞
10.4
10
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
10.4
10
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
10.4
10
*
L01EX03
ATC
pazopanib; oral
+∞
10.4
10
*
S18
ICPC
Laceration/cut
1.5
10.4
548
4286
7124
FHL
Nephrectomy (simple
32.8
10.3
13
*
J01MA12
ATC
levofloxacin; systemic
1.6
10.3
240
1566
D37.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Colon
5.0
10.3
22
45
R93.4
ICD-10 Finland
Abnormal findings on diagnostic imaging of urinary organs
5.3
10.1
20
38
R4110
NOMESCO Finland
Physiotherapy
1.6
9.9
312
2188
H02AB06
ATC
prednisolone; systemic
1.5
9.8
577
4590
BAA40
NOMESCO Finland
Unilateral lobectomy of thyroid gland
3.8
9.8
29
77
BAA60
NOMESCO Finland
Total thyroidectomy
4.0
9.8
27
68
B05DB
ATC
Hypertonic solutions
8.8
9.8
20
23
TPH04
NOMESCO Finland
Cathetrisation of vein
1.6
9.6
260
1758
XX2RW, ,
NOMESCO Finland
10.1
9.5
18
18
Z3231
NOMESCO Finland
Registered nurse
1.5
9.5
307
2164
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
9.4
9
*
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
9.4
9
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
9.4
9
*
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
+∞
9.4
9
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
9.4
9
*
M907, C6488,
ICD-10 Finland
+∞
9.4
9
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
9.4
9
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
9.4
9
*
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
+∞
9.4
9
*
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
9.4
9
*
A04AD12
ATC
aprepitant; systemic
+∞
9.4
9
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
9.4
9
*
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
+∞
9.4
9
*
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
+∞
9.4
9
*
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
+∞
9.4
9
*
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
5.2
9.4
19
37
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
21.9
9.4
13
6
L04AA06
ATC
mycophenolic acid; systemic
4.1
9.3
25
62
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.1
9.2
83
402
B01AB04
ATC
dalteparin; parenteral
2.4
9.1
62
266
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
9.0
117
645
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.4
9.0
62
268
B05DA
ATC
Isotonic solutions
7.5
8.9
20
27
JMA10
NOMESCO Finland
Transabdominal total splenectomy
18.7
8.9
13
7
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
12.6
8.9
15
12
JFB30
NOMESCO Finland
Right hemicolectomy
8.0
8.9
19
24
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
4.9
8.8
19
39
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
9.5
8.8
17
18
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
4.3
8.7
22
52
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
4.8
8.6
19
40
D70.82
ICD-10 Finland
Drug-induced neutropenia
16.4
8.6
13
8
1530
FHL
Urethrocystoscopy
2.9
8.5
39
137
L02AE03
ATC
goserelin; implant
27.7
8.5
11
*
N05CF01
ATC
zopiclone; oral
1.4
8.5
424
3252
L02BG06
ATC
exemestane; oral
90.6
8.4
9
*
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
+∞
8.3
8
*
JLC30
NOMESCO Finland
Pancreatoduodenectomy
+∞
8.3
8
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
8.3
8
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
8.3
8
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
8.3
8
*
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
8.3
8
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
8.3
8
*
C68.9
ICD-10 Finland
Malignant neoplasm: Urinary organ, unspecified
+∞
8.3
8
*
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
+∞
8.3
8
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
8.3
8
*
C18.79
ICD-10 Finland
Malignant tumor of the sigmoid or other unspecified histology
+∞
8.3
8
*
L02BG03
ATC
anastrozole; oral
+∞
8.3
8
*
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
8.6
8.3
17
20
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
2.4
8.2
56
241
321
Kela drug reimbursment
Paricalcitol and cinacalcet
7.6
8.2
18
24
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
4.4
8.2
20
46
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
8.2
170
1076
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
4.6
8.1
19
42
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
4.1
8.1
22
55
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
33.6
8.1
10
*
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
11.8
8.1
14
12
Z49.2
ICD-10 Finland
Other dialysis
6.9
8.1
19
28
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.9
8.1
94
500
D13.6
ICD-10 Finland
Benign neoplasm: Pancreas
9.0
8.0
16
18
196
Kela drug reimbursment
Paricalcitol and cinacalcet
10.1
8.0
15
15
A02BC02
ATC
pantoprazole; systemic
1.4
8.0
810
6994
306
Kela drug reimbursment
Erythropoietin and darbepoetin
22.2
8.0
11
5
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.0
8.0
80
403
E87.5
ICD-10 Finland
Hyperkalaemia
2.8
8.0
40
148
A06AD11
ATC
lactulose; oral
1.5
7.9
243
1686
ZX112
NOMESCO Finland
Subcutaneous
6.6
7.9
19
29
H05BX01
ATC
cinacalcet; oral
7.8
7.9
17
22
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
6.1
7.9
20
33
H02AB09
ATC
hydrocortisone; systemic
3.4
7.8
27
80
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
3.3
7.8
28
85
J01EA01
ATC
trimethoprim; systemic
1.5
7.8
299
2175
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.4
7.7
359
2708
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
45.2
7.7
9
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
45.2
7.7
9
*
C44.50
ICD-10 Finland
Malignant tumor of the skin on the torso without histology
45.2
7.7
9
*
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
45.2
7.7
9
*
N43.3
ICD-10 Finland
Hydrocele, unspecified
2.7
7.7
39
145
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
18.5
7.6
11
6
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
18.5
7.6
11
6
TK810
NOMESCO Finland
Hemofiltration
6.7
7.6
18
27
G04CA02
ATC
tamsulosin; oral
1.4
7.6
402
3105
JLC10
NOMESCO Finland
Distal pancreatectomy
25.2
7.6
10
*
C08CA02
ATC
felodipine; oral
1.7
7.5
159
1009
S15
ICPC
Foreign body in skin
2.0
7.5
77
391
KH1AD
NOMESCO Finland
CT of urinary organs
2.5
7.5
44
177
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
2.3
7.4
53
233
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
80.5
7.4
8
*
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
80.5
7.4
8
*
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
13.4
7.4
12
9
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
6.0
7.4
19
32
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.9
7.4
91
494
R4190
NOMESCO Finland
Nutritional therapy
3.1
7.3
30
99
SPAT1109
SPAT
Analgesia with portable analgesic pump
8.4
7.3
15
18
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
3.6
7.3
23
64
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
6.9
7.3
17
25
8316/3-C64.9
ICD-O-3
Cyst-associated renal cell carcinoma of kidney, NOS
+∞
7.3
7
*
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
+∞
7.3
7
*
8140/3-C18.2
ICD-O-3
Adenocarcinoma, NOS, of ascending colon
+∞
7.3
7
*
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
+∞
7.3
7
*
C79.3
ICD-10 Finland
Secondary malignant neoplasm of brain and cerebral meninges
+∞
7.3
7
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
7.3
7
*
C18.7
ICD-10 Finland
Malignant neoplasm: Sigmoid colon
+∞
7.3
7
*
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
+∞
7.3
7
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
7.3
7
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
7.3
7
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
+∞
7.3
7
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
7.3
7
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
7.3
7
*
8318/3-C64.9
ICD-O-3
Renal cell carcinoma, sarcomatoid of kidney, NOS
+∞
7.3
7
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
7.3
7
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
7.3
7
*
KA3CT
NOMESCO Finland
Biopsy of kidney under CT guidance
+∞
7.3
7
*
L02AE04
ATC
triptorelin; parenteral
+∞
7.3
7
*
163
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
7.3
7
*
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
+∞
7.3
7
*
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
+∞
7.3
7
*
1891X
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Renal pelvis[NEOPLASMA MALIGNUM PELVIS RENIS,EI HIST VAHV]
+∞
7.3
7
*
2230A
ICD-9 Finland
Benign neoplasm of kidney and other urinary organs, Kidney, except pelvis
+∞
7.3
7
*
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
9.4
7.3
14
15
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
9.4
7.3
14
15
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
3.4
7.3
25
74
212
Kela drug reimbursment
Gout
2.5
7.2
42
168
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
20.1
7.1
10
5
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
20.1
7.1
10
5
T81.9
ICD-10 Finland
Unspecified complication of procedure
3.4
7.1
25
75
N02BE01
ATC
paracetamol; systemic, rectal
1.5
7.1
1072
9807
3025
Kela drug reimbursment
Calcium carbonate
7.0
7.0
16
23
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.9
7.0
32
113
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
5.5
6.9
19
35
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
13.9
6.9
11
8
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
3.6
6.9
22
62
JAH01
NOMESCO Finland
Laparoscopy
2.7
6.8
36
137
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
40.3
6.8
8
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
40.3
6.8
8
*
N99.0
ICD-10 Finland
Postprocedural renal failure
40.3
6.8
8
*
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
4.3
6.8
17
40
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.0
6.7
73
379
7321
FHL
TU biopsy, coagulation or laser
16.8
6.7
10
6
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
3.9
6.7
19
49
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
3.2
6.7
25
78
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
3.0
6.7
28
94
M10
ICD-10 Finland
Gout
2.0
6.7
73
381
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
3.7
6.6
20
54
K65.0
ICD-10 Finland
Acute peritonitis
3.7
6.6
20
54
TKW99
NOMESCO Finland
Other minor surgical procedure in urology
6.5
6.6
16
25
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.7
6.6
34
128
TK820
NOMESCO Finland
Peritoneal dialysis
8.7
6.6
13
15
D37.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Stomach
10.1
6.5
12
12
A12AA12
ATC
[U] calcium acetate
10.1
6.5
12
12
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
2.9
6.5
29
101
L04AD01
ATC
ciclosporin; systemic
4.0
6.4
18
46
PG5AC
NOMESCO Finland
Contrast examination of injection gate to artery or vein
70.2
6.4
7
*
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
70.2
6.4
7
*
G04BE03
ATC
sildenafil; oral
7.4
6.4
14
19
C08CA13
ATC
lercanidipine; oral
1.5
6.4
206
1441
N18
ICD-10 Finland
Chronic kidney disease
3.0
6.4
27
91
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.5
6.3
198
1376
M10.9
ICD-10 Finland
Gout, unspecified
1.7
6.3
117
717
J01DB01
ATC
cefalexin; oral
1.4
6.3
928
8339
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
11.1
6.3
11
10
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
9.3
6.3
12
13
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
2.9
6.3
29
103
GDA20
NOMESCO Finland
Excision of lesion of lung
18.1
6.3
9
5
D45
ICD-10 Finland
Polycythaemia vera
18.1
6.3
9
5
C66
ICD-10 Finland
Malignant neoplasm of ureter
+∞
6.3
6
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
6.3
6
*
GDB21
NOMESCO Finland
Thoracoscopic segmental resection of lung
+∞
6.3
6
*
C73
ICD-10 Finland
Malignant neoplasm of thyroid gland
+∞
6.3
6
*
C56
ICD-10 Finland
Malignant neoplasm of ovary
+∞
6.3
6
*
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
6.3
6
*
352
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
6.3
6
*
L02BX02
ATC
degarelix; parenteral
+∞
6.3
6
*
Z80.5
ICD-10 Finland
Family history of malignant neoplasm of urinary tract
+∞
6.3
6
*
PJD43
NOMESCO Finland
Excision of aortic lymph nodes
+∞
6.3
6
*
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
+∞
6.3
6
*
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
+∞
6.3
6
*
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
+∞
6.3
6
*
U79
ICPC
Neoplasm urinary tract unspecified
+∞
6.3
6
*
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
+∞
6.3
6
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
6.3
6
*
C68.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of urinary organs
+∞
6.3
6
*
Z80.8
ICD-10 Finland
Family history of malignant neoplasm of other organs or systems
26.8
6.2
8
*
JKA20
NOMESCO Finland
Cholecystectomy
2.3
6.2
43
187
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
6.2
193
1342
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
6.3
6.2
15
24
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
3.4
6.2
21
62
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
3.0
6.1
26
88
KWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in urological surgery
12.6
6.1
10
8
D34
ICD-10 Finland
Benign neoplasm of thyroid gland
10.1
6.0
11
11
R33
ICD-10 Finland
Retention of urine
1.6
6.0
140
910

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Urology
34 [38004474]
6.2e-01
2.7e+00
5.3e+00
—
5.1e+00
4.3e+00
2.9e+00
cases:6.61%
controls:3.68%
cases:20.58%
controls:1.70%
cases:39.71%
controls:0.31%
—
—
cases:30.39%
controls:0.27%
cases:55.74%
controls:1.74%
cases:50.80%
controls:5.22%
87
483
1230
12645
271
223
1046
12905
523
41
794
13087
—
392
36
898
13081
690
226
548
12750
542
621
525
11277
Medical Oncology
90 [38004507]
3.8e+00
3.5e+00
—
—
—
6.0e+00
5.5e+00
cases:2.66%
controls:0.06%
cases:1.75%
controls:0.05%
—
—
—
—
—
—
cases:15.91%
controls:0.05%
cases:17.62%
controls:0.08%
35
8
1282
13120
23
7
1294
13121
—
—
—
197
6
1041
12970
188
10
879
11888
General Surgery
2 [38004447]
2.4e-01
1.1e+00
3.5e+00
3.8e+00
3.7e+00
2.0e+00
1.1e+00
cases:25.06%
controls:20.90%
cases:17.46%
controls:6.67%
cases:23.54%
controls:0.89%
cases:1.67%
controls:0.04%
cases:26.36%
controls:0.85%
cases:34.17%
controls:6.81%
cases:44.14%
controls:20.34%
330
2744
987
10384
230
875
1087
12253
310
117
1007
13011
22
5
1295
13123
340
111
950
13006
423
884
815
12092
471
2420
596
9478
Inpatient Hospital
21 [8717]
1.1e-01
8.2e-01
3.3e+00
5.3e+00
3.6e+00
1.4e+00
6.1e-01
cases:32.42%
controls:30.04%
cases:23.54%
controls:11.97%
cases:31.97%
controls:1.62%
cases:10.63%
controls:0.06%
cases:35.04%
controls:1.39%
cases:34.57%
controls:11.47%
cases:44.42%
controls:30.29%
427
3943
890
9185
310
1571
1007
11557
421
213
896
12915
140
8
1177
13120
452
182
838
12935
428
1488
810
11488
474
3604
593
8294
Oncology Clinic/Center
261QX0200X [38004268]
3.2e+00
4.2e+00
—
1.0e+50
1.0e+50
4.1e+00
3.5e+00
cases:4.56%
controls:0.20%
cases:3.87%
controls:0.06%
—
—
cases:99.54%
controls:0.00%
cases:0.85%
controls:0.00%
cases:2.26%
controls:0.04%
cases:6.75%
controls:0.22%
60
26
1257
13102
51
8
1266
13120
—
1311
0
6
13128
11
0
1279
13117
28
5
1210
12971
72
26
995
11872
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
1.3e-02
1.3e+00
4.6e+00
—
3.9e+00
1.8e+00
7.7e-01
cases:1.44%
controls:1.42%
cases:2.81%
controls:0.82%
cases:6.45%
controls:0.07%
—
—
cases:2.17%
controls:0.05%
cases:3.96%
controls:0.69%
cases:5.06%
controls:2.41%
19
187
1298
12941
37
107
1280
13021
85
9
1232
13119
—
28
6
1262
13111
49
89
1189
12887
54
287
1013
11611
Outpatient Visit
OP [9202]
2.3e-01
6.2e-01
2.1e+00
3.9e+00
2.0e+00
1.8e+00
1.4e+00
cases:60.44%
controls:54.88%
cases:52.01%
controls:36.85%
cases:40.47%
controls:7.76%
cases:14.50%
controls:0.33%
cases:35.27%
controls:6.85%
cases:78.76%
controls:37.51%
cases:88.85%
controls:66.99%
796
7204
521
5924
685
4838
632
8290
533
1019
784
12109
191
43
1126
13085
455
899
835
12218
975
4867
263
8109
948
7971
119
3927
Cystoscopy
UKC02 [2001306005]
1.8e-01
1.9e+00
3.9e+00
1.0e+50
3.1e+00
2.0e+00
1.1e+00
cases:1.82%
controls:1.52%
cases:2.81%
controls:0.42%
cases:2.58%
controls:0.05%
cases:0.38%
controls:0.00%
cases:0.85%
controls:0.04%
cases:2.91%
controls:0.42%
cases:5.53%
controls:1.85%
24
200
1293
12928
37
55
1280
13073
34
7
1283
13121
5
0
1312
13128
11
5
1279
13112
36
54
1202
12922
59
220
1008
11678
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
2.8e-01
1.3e+00
2.7e+00
—
3.3e+00
2.8e+00
1.7e+00
cases:1.67%
controls:1.27%
cases:1.44%
controls:0.39%
cases:0.68%
controls:0.05%
—
—
cases:1.71%
controls:0.06%
cases:6.62%
controls:0.45%
cases:7.69%
controls:1.43%
22
167
1295
12961
19
51
1298
13077
9
6
1308
13122
—
22
8
1268
13109
82
58
1156
12918
82
170
985
11728
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
1.6e-01
1.8e+00
4.3e+00
—
3.2e+00
1.6e+00
7.7e-01
cases:0.99%
controls:0.85%
cases:3.11%
controls:0.54%
cases:3.95%
controls:0.05%
—
—
cases:1.24%
controls:0.05%
cases:4.28%
controls:0.86%
cases:6.19%
controls:2.95%
13
111
1304
13017
41
71
1276
13057
52
7
1265
13121
—
16
7
1274
13110
53
111
1185
12865
66
351
1001
11547
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
-2.0e-01
1.1e+00
4.6e+00
—
3.3e+00
1.8e+00
7.3e-01
cases:1.82%
controls:2.22%
cases:3.57%
controls:1.21%
cases:8.05%
controls:0.09%
—
—
cases:2.48%
controls:0.09%
cases:5.74%
controls:0.96%
cases:6.75%
controls:3.38%
24
292
1293
12836
47
159
1270
12969
106
12
1211
13116
—
32
12
1258
13105
71
125
1167
12851
72
402
995
11496
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
-1.3e-01
1.7e+00
4.3e+00
—
3.1e+00
1.6e+00
7.6e-01
cases:0.84%
controls:0.95%
cases:3.26%
controls:0.59%
cases:4.18%
controls:0.06%
—
—
cases:1.40%
controls:0.06%
cases:4.28%
controls:0.86%
cases:5.62%
controls:2.71%
11
125
1306
13003
43
78
1274
13050
55
8
1262
13120
—
18
8
1272
13109
53
112
1185
12864
60
323
1007
11575
Nephrology
39 [38004479]
1.1e+00
1.6e+00
1.8e+00
—
2.5e+00
2.2e+00
2.2e+00
cases:1.97%
controls:0.64%
cases:2.13%
controls:0.45%
cases:1.29%
controls:0.21%
—
—
cases:2.17%
controls:0.19%
cases:4.44%
controls:0.50%
cases:7.03%
controls:0.85%
26
84
1291
13044
28
59
1289
13069
17
27
1300
13101
—
28
25
1262
13092
55
65
1183
12911
75
101
992
11797
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
-3.1e-01
1.5e+00
3.9e+00
—
3.0e+00
1.9e+00
1.1e+00
cases:2.35%
controls:3.17%
cases:7.29%
controls:1.74%
cases:9.49%
controls:0.21%
—
—
cases:3.26%
controls:0.18%
cases:11.31%
controls:1.92%
cases:15.46%
controls:5.95%
31
416
1286
12712
96
229
1221
12899
125
28
1192
13100
—
42
23
1248
13094
140
249
1098
12727
165
708
902
11190
Outpatient Hospital
22 [8756]
1.8e-01
8.4e-01
3.6e+00
—
4.0e+00
1.8e+00
8.0e-01
cases:25.13%
controls:21.97%
cases:15.79%
controls:7.50%
cases:25.13%
controls:0.92%
—
—
cases:28.14%
controls:0.71%
cases:29.64%
controls:6.67%
cases:37.11%
controls:21.04%
331
2884
986
10244
208
984
1109
12144
331
121
986
13007
—
363
93
927
13024
367
866
871
12110
396
2503
671
9395
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
-7.4e-02
1.1e+00
4.3e+00
—
3.2e+00
1.6e+00
7.2e-01
cases:3.11%
controls:3.34%
cases:5.32%
controls:1.78%
cases:14.05%
controls:0.22%
—
—
cases:3.72%
controls:0.15%
cases:6.87%
controls:1.51%
cases:10.68%
controls:5.49%
41
439
1276
12689
70
234
1247
12894
185
29
1132
13099
—
48
20
1242
13097
85
196
1153
12780
114
653
953
11245
Bacteria [Presence] in Urine
87829-8 [36304419]
-3.9e-01
1.6e+00
4.1e+00
—
2.6e+00
1.7e+00
9.4e-01
cases:1.44%
controls:2.13%
cases:5.09%
controls:1.12%
cases:5.47%
controls:0.09%
—
—
cases:1.78%
controls:0.14%
cases:7.03%
controls:1.32%
cases:9.84%
controls:4.09%
19
279
1298
12849
67
147
1250
12981
72
12
1245
13116
—
23
18
1267
13099
87
171
1151
12805
105
487
962
11411
Neoplasm of uncertain or unknown behaviour: Kidney
D41.0 [45581311]
—
5.9e+00
—
1.0e+50
1.0e+50
—
5.0e+00
—
—
cases:16.78%
controls:0.05%
—
—
cases:19.21%
controls:0.00%
cases:18.68%
controls:0.00%
—
—
cases:10.87%
controls:0.08%
—
221
7
1096
13121
—
253
0
1064
13128
241
0
1049
13117
—
116
10
951
11888
Scheduled procedure
ZXD10 [2001311387]
1.1e-01
6.6e-01
3.7e+00
—
4.0e+00
1.6e+00
9.1e-01
cases:5.32%
controls:4.77%
cases:2.66%
controls:1.39%
cases:5.32%
controls:0.14%
—
—
cases:5.27%
controls:0.10%
cases:4.93%
controls:1.08%
cases:8.81%
controls:3.74%
70
626
1247
12502
35
183
1282
12945
70
18
1247
13110
—
68
13
1222
13104
61
140
1177
12836
94
445
973
11453
Extensive body CT
JN4BD [2001310899]
7.5e-01
2.3e+00
1.0e+50
1.0e+50
1.0e+50
4.4e+00
4.1e+00
cases:0.53%
controls:0.25%
cases:1.14%
controls:0.11%
cases:1.52%
controls:0.00%
cases:0.68%
controls:0.00%
cases:0.62%
controls:0.00%
cases:5.41%
controls:0.07%
cases:8.34%
controls:0.15%
7
33
1310
13095
15
15
1302
13113
20
0
1297
13128
9
0
1308
13128
8
0
1282
13117
67
9
1171
12967
89
18
978
11880
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
-3.1e-01
1.5e+00
4.0e+00
—
2.7e+00
1.7e+00
8.7e-01
cases:1.59%
controls:2.16%
cases:5.09%
controls:1.18%
cases:5.54%
controls:0.11%
—
—
cases:1.86%
controls:0.13%
cases:7.51%
controls:1.46%
cases:10.22%
controls:4.54%
21
283
1296
12845
67
155
1250
12973
73
14
1244
13114
—
24
17
1266
13100
93
190
1145
12786
109
540
958
11358
Cells panel - Urine sediment
58434-2 [40761535]
2.8e-01
1.5e+00
3.5e+00
—
2.6e+00
1.8e+00
1.1e+00
cases:1.44%
controls:1.09%
cases:2.35%
controls:0.56%
cases:3.04%
controls:0.09%
—
—
cases:1.32%
controls:0.10%
cases:3.07%
controls:0.53%
cases:4.22%
controls:1.46%
19
143
1298
12985
31
73
1286
13055
40
12
1277
13116
—
17
13
1273
13104
38
69
1200
12907
45
174
1022
11724
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
-3.5e-01
1.4e+00
3.8e+00
—
2.6e+00
1.7e+00
9.2e-01
cases:1.82%
controls:2.57%
cases:5.77%
controls:1.42%
cases:6.76%
controls:0.17%
—
—
cases:2.17%
controls:0.16%
cases:8.89%
controls:1.75%
cases:12.56%
controls:5.44%
24
338
1293
12790
76
186
1241
12942
89
22
1228
13106
—
28
21
1262
13096
110
227
1128
12749
134
647
933
11251
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
5.0e-01
1.1e+00
2.6e+00
1.0e+50
3.6e+00
2.1e+00
1.0e+00
cases:1.06%
controls:0.65%
cases:1.67%
controls:0.54%
cases:0.84%
controls:0.06%
cases:5.32%
controls:0.00%
cases:1.63%
controls:0.05%
cases:4.44%
controls:0.59%
cases:5.53%
controls:2.11%
14
85
1303
13043
22
71
1295
13057
11
8
1306
13120
70
0
1247
13128
21
6
1269
13111
55
76
1183
12900
59
251
1008
11647
Body CT examination
JN4AD [2001310897]
-1.0e+50
3.1e+00
—
1.0e+50
—
3.8e+00
3.4e+00
cases:0.00%
controls:0.07%
cases:0.99%
controls:0.05%
—
—
cases:0.46%
controls:0.00%
—
—
cases:5.41%
controls:0.12%
cases:10.40%
controls:0.39%
0
9
1317
13119
13
6
1304
13122
—
6
0
1311
13128
—
67
16
1171
12960
111
46
956
11852
Hematology
82 [38004501]
7.2e-01
1.6e+00
2.8e+00
—
2.3e+00
2.1e+00
1.5e+00
cases:0.68%
controls:0.34%
cases:0.76%
controls:0.15%
cases:0.61%
controls:0.04%
—
—
cases:0.47%
controls:0.05%
cases:1.21%
controls:0.15%
cases:1.87%
controls:0.41%
9
44
1308
13084
10
20
1307
13108
8
5
1309
13123
—
6
6
1284
13111
15
20
1223
12956
20
49
1047
11849
enoxaparin; parenteral
B01AB05 [21600976]
1.5e-01
5.4e-01
3.0e+00
—
4.3e+00
1.9e+00
9.5e-01
cases:3.04%
controls:2.63%
cases:1.75%
controls:1.03%
cases:3.11%
controls:0.17%
—
—
cases:8.99%
controls:0.13%
cases:6.14%
controls:0.99%
cases:7.40%
controls:3.01%
40
345
1277
12783
23
135
1294
12993
41
22
1276
13106
—
116
17
1174
13100
76
128
1162
12848
79
358
988
11540
Thorax X-ray examination
GD1AA [2001303617]
5.0e-02
7.8e-01
2.9e+00
1.0e+50
2.8e+00
2.2e+00
1.3e+00
cases:4.78%
controls:4.56%
cases:4.18%
controls:1.97%
cases:3.19%
controls:0.18%
cases:0.68%
controls:0.00%
cases:2.87%
controls:0.18%
cases:14.46%
controls:1.83%
cases:19.68%
controls:6.24%
63
599
1254
12529
55
258
1262
12870
42
24
1275
13104
9
0
1308
13128
37
23
1253
13094
179
238
1059
12738
210
742
857
11156
More than one and less than three hours
ZXE10 [2001311401]
3.8e-02
6.9e-01
3.8e+00
—
3.8e+00
1.6e+00
7.0e-01
cases:4.10%
controls:3.95%
cases:2.20%
controls:1.12%
cases:5.01%
controls:0.11%
—
—
cases:4.11%
controls:0.09%
cases:4.68%
controls:0.96%
cases:6.28%
controls:3.23%
54
519
1263
12609
29
147
1288
12981
66
15
1251
13113
—
53
12
1237
13105
58
125
1180
12851
67
384
1000
11514
tinzaparin; parenteral
B01AB10 [21600981]
—
1.5e+00
—
—
5.1e+00
3.4e+00
1.5e+00
—
—
cases:0.53%
controls:0.12%
—
—
—
—
cases:5.81%
controls:0.04%
cases:3.15%
controls:0.11%
cases:2.91%
controls:0.69%
—
7
16
1310
13112
—
—
75
5
1215
13112
39
14
1199
12962
31
82
1036
11816
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M
77147-7 [46236952]
4.3e-01
1.9e+00
4.1e+00
—
—
2.5e+00
1.4e+00
cases:0.91%
controls:0.59%
cases:1.59%
controls:0.25%
cases:2.73%
controls:0.05%
—
—
—
—
cases:3.63%
controls:0.32%
cases:4.50%
controls:1.14%
12
78
1305
13050
21
33
1296
13095
36
6
1281
13122
—
—
45
41
1193
12935
48
136
1019
11762
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
-2.9e-02
4.7e-01
2.1e+00
4.1e+00
2.2e+00
6.0e-01
2.7e-01
cases:17.08%
controls:17.50%
cases:21.03%
controls:14.25%
cases:17.54%
controls:2.57%
cases:7.82%
controls:0.14%
cases:19.46%
controls:2.54%
cases:25.20%
controls:15.67%
cases:35.15%
controls:29.27%
225
2297
1092
10831
277
1871
1040
11257
231
338
1086
12790
103
18
1214
13110
251
333
1039
12784
312
2033
926
10943
375
3483
692
8415
ABO and Rh group [Type] in Blood
882-1 [3003694]
-2.4e-01
1.3e+00
4.3e+00
—
3.1e+00
9.6e-01
7.2e-02
cases:1.44%
controls:1.82%
cases:2.81%
controls:0.75%
cases:5.01%
controls:0.07%
—
—
cases:1.01%
controls:0.05%
cases:1.62%
controls:0.62%
cases:2.62%
controls:2.45%
19
239
1298
12889
37
99
1280
13029
66
9
1251
13119
—
13
6
1277
13111
20
81
1218
12895
28
291
1039
11607
Inpatient Visit
IP [9201]
1.5e-01
8.3e-01
3.2e+00
—
3.5e+00
1.5e+00
7.5e-01
cases:9.64%
controls:8.40%
cases:5.69%
controls:2.57%
cases:6.83%
controls:0.31%
—
—
cases:7.60%
controls:0.24%
cases:9.05%
controls:2.23%
cases:13.03%
controls:6.58%
127
1103
1190
12025
75
338
1242
12790
90
41
1227
13087
—
98
32
1192
13085
112
290
1126
12686
139
783
928
11115
Treatment plan or consultation
WZC00 [2001310885]
1.3e-01
8.0e-01
3.1e+00
—
3.3e+00
2.1e+00
1.2e+00
cases:2.20%
controls:1.94%
cases:1.21%
controls:0.55%
cases:1.29%
controls:0.06%
—
—
cases:2.09%
controls:0.08%
cases:4.93%
controls:0.63%
cases:8.15%
controls:2.58%
29
255
1288
12873
16
72
1301
13056
17
8
1300
13120
—
27
10
1263
13107
61
82
1177
12894
87
307
980
11591
Essential (primary) hypertension
I10 [45591453]
2.9e-01
6.8e-01
1.7e+00
3.9e+00
1.9e+00
7.3e-01
5.3e-01
cases:17.31%
controls:13.49%
cases:11.92%
controls:6.44%
cases:5.69%
controls:1.05%
cases:3.19%
controls:0.07%
cases:5.66%
controls:0.93%
cases:13.89%
controls:7.23%
cases:30.65%
controls:20.59%
228
1771
1089
11357
157
846
1160
12282
75
138
1242
12990
42
9
1275
13119
73
122
1217
12995
172
938
1066
12038
327
2450
740
9448
Emergency Room Visit
ER [9203]
8.2e-02
7.8e-01
2.4e+00
2.9e+00
2.3e+00
9.1e-01
4.6e-01
cases:26.58%
controls:25.02%
cases:19.13%
controls:9.80%
cases:10.86%
controls:1.13%
cases:0.68%
controls:0.04%
cases:9.53%
controls:1.07%
cases:20.52%
controls:9.38%
cases:38.14%
controls:28.05%
350
3284
967
9844
252
1286
1065
11842
143
149
1174
12979
9
5
1308
13123
123
140
1167
12977
254
1217
984
11759
407
3337
660
8561
Leukocytes [#/volume] in Urine
30405-5 [3018095]
-5.2e-01
1.3e+00
3.6e+00
—
2.3e+00
1.6e+00
8.2e-01
cases:1.67%
controls:2.77%
cases:6.00%
controls:1.65%
cases:6.83%
controls:0.20%
—
—
cases:2.25%
controls:0.23%
cases:9.13%
controls:1.97%
cases:13.03%
controls:6.19%
22
364
1295
12764
79
216
1238
12912
90
26
1227
13102
—
29
30
1261
13087
113
256
1125
12720
139
737
928
11161
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
-1.1e-01
1.5e+00
3.6e+00
1.0e+50
2.4e+00
1.5e+00
7.5e-01
cases:1.90%
controls:2.11%
cases:5.09%
controls:1.23%
cases:4.33%
controls:0.12%
cases:0.91%
controls:0.00%
cases:1.94%
controls:0.18%
cases:4.44%
controls:1.04%
cases:6.37%
controls:3.13%
25
277
1292
12851
67
162
1250
12966
57
16
1260
13112
12
0
1305
13128
25
24
1265
13093
55
135
1183
12841
68
372
999
11526
CBC panel - Blood by Automated count
58410-2 [40761511]
-1.2e-02
4.8e-01
2.2e+00
3.7e+00
2.2e+00
6.7e-01
3.5e-01
cases:16.48%
controls:16.64%
cases:18.00%
controls:11.91%
cases:16.25%
controls:2.05%
cases:4.71%
controls:0.12%
cases:16.05%
controls:2.01%
cases:21.97%
controls:12.63%
cases:32.43%
controls:25.25%
217
2184
1100
10944
237
1563
1080
11565
214
269
1103
12859
62
16
1255
13112
207
264
1083
12853
272
1639
966
11337
346
3004
721
8894
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
-5.0e-01
1.1e+00
3.5e+00
—
2.2e+00
1.8e+00
9.9e-01
cases:1.14%
controls:1.86%
cases:2.58%
controls:0.87%
cases:3.04%
controls:0.10%
—
—
cases:0.93%
controls:0.10%
cases:5.25%
controls:0.88%
cases:7.78%
controls:3.03%
15
244
1302
12884
34
114
1283
13014
40
13
1277
13115
—
12
13
1278
13104
65
114
1173
12862
83
361
984
11537
Supplier / Service Provider
OMOP5117446 [33004]
-1.1e+00
-4.6e-01
1.2e+00
—
3.6e+00
3.1e+00
3.2e+00
cases:10.86%
controls:26.34%
cases:5.47%
controls:8.37%
cases:3.11%
controls:0.98%
—
—
cases:2.40%
controls:0.07%
cases:6.79%
controls:0.33%
cases:14.25%
controls:0.65%
143
3458
1174
9670
72
1099
1245
12029
41
128
1276
13000
—
31
9
1259
13108
84
43
1154
12933
152
77
915
11821
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
2.7e-01
5.9e-01
2.8e+00
—
3.7e+00
2.3e+00
7.3e-01
cases:0.61%
controls:0.46%
cases:0.84%
controls:0.46%
cases:0.61%
controls:0.04%
—
—
cases:1.55%
controls:0.04%
cases:3.31%
controls:0.35%
cases:2.91%
controls:1.42%
8
61
1309
13067
11
61
1306
13067
8
5
1309
13123
—
20
5
1270
13112
41
45
1197
12931
31
169
1036
11729
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
-4.9e-01
8.2e-01
2.6e+00
1.0e+50
2.7e+00
2.5e+00
1.7e+00
cases:0.38%
controls:0.62%
cases:0.76%
controls:0.34%
cases:0.68%
controls:0.05%
cases:0.38%
controls:0.00%
cases:0.93%
controls:0.06%
cases:3.47%
controls:0.30%
cases:5.15%
controls:0.99%
5
81
1312
13047
10
44
1307
13084
9
7
1308
13121
5
0
1312
13128
12
8
1278
13109
43
39
1195
12937
55
118
1012
11780
Upper gastrointestinal surgery
106 [44777669]
3.7e-01
1.3e+00
2.4e+00
1.0e+50
2.5e+00
1.7e+00
1.1e+00
cases:7.82%
controls:5.52%
cases:7.29%
controls:2.11%
cases:3.19%
controls:0.30%
cases:0.38%
controls:0.00%
cases:2.79%
controls:0.23%
cases:8.08%
controls:1.59%
cases:17.53%
controls:6.32%
103
725
1214
12403
96
277
1221
12851
42
39
1275
13089
5
0
1312
13128
36
30
1254
13087
100
206
1138
12770
187
752
880
11146
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
-2.6e-02
4.6e-01
2.1e+00
3.8e+00
2.2e+00
5.9e-01
2.7e-01
cases:17.24%
controls:17.61%
cases:21.03%
controls:14.43%
cases:17.62%
controls:2.64%
cases:6.00%
controls:0.14%
cases:19.46%
controls:2.61%
cases:25.36%
controls:15.87%
cases:35.43%
controls:29.48%
227
2312
1090
10816
277
1894
1040
11234
232
346
1085
12782
79
18
1238
13110
251
342
1039
12775
314
2059
924
10917
378
3507
689
8391
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
-2.4e-02
4.4e-01
2.0e+00
4.1e+00
2.1e+00
5.6e-01
2.2e-01
cases:19.36%
controls:19.74%
cases:24.15%
controls:17.01%
cases:20.96%
controls:3.40%
cases:8.81%
controls:0.16%
cases:21.63%
controls:3.43%
cases:28.43%
controls:18.56%
cases:37.21%
controls:32.14%
255
2591
1062
10537
318
2233
999
10895
276
447
1041
12681
116
21
1201
13107
279
450
1011
12667
352
2408
886
10568
397
3824
670
8074
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
-2.4e-02
4.4e-01
2.0e+00
4.1e+00
2.0e+00
5.5e-01
2.2e-01
cases:19.36%
controls:19.74%
cases:24.07%
controls:16.99%
cases:20.96%
controls:3.40%
cases:8.81%
controls:0.16%
cases:21.71%
controls:3.46%
cases:28.43%
controls:18.57%
cases:37.21%
controls:32.20%
255
2592
1062
10536
317
2231
1000
10897
276
446
1041
12682
116
21
1201
13107
280
454
1010
12663
352
2410
886
10566
397
3831
670
8067
Platelets [#/volume] in Blood
26515-7 [3007461]
-1.9e-02
4.4e-01
2.0e+00
4.1e+00
2.1e+00
5.6e-01
2.2e-01
cases:19.36%
controls:19.67%
cases:23.99%
controls:16.93%
cases:20.96%
controls:3.38%
cases:8.43%
controls:0.16%
cases:21.63%
controls:3.42%
cases:28.35%
controls:18.50%
cases:37.11%
controls:32.06%
255
2582
1062
10546
316
2222
1001
10906
276
444
1041
12684
111
21
1206
13107
279
448
1011
12669
351
2401
887
10575
396
3814
671
8084
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
-2.3e-02
4.4e-01
2.0e+00
4.1e+00
2.1e+00
5.6e-01
2.2e-01
cases:19.36%
controls:19.73%
cases:24.07%
controls:16.99%
cases:20.96%
controls:3.40%
cases:8.43%
controls:0.16%
cases:21.63%
controls:3.43%
cases:28.43%
controls:18.55%
cases:37.21%
controls:32.15%
255
2590
1062
10538
317
2230
1000
10898
276
446
1041
12682
111
21
1206
13107
279
450
1011
12667
352
2407
886
10569
397
3825
670
8073
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
-2.3e-02
4.4e-01
2.0e+00
4.1e+00
2.1e+00
5.6e-01
2.2e-01
cases:19.36%
controls:19.73%
cases:24.07%
controls:16.99%
cases:20.96%
controls:3.40%
cases:8.43%
controls:0.16%
cases:21.63%
controls:3.43%
cases:28.43%
controls:18.55%
cases:37.11%
controls:32.12%
255
2590
1062
10538
317
2230
1000
10898
276
446
1041
12682
111
21
1206
13107
279
450
1011
12667
352
2407
886
10569
396
3822
671
8076
Leukocytes [#/volume] in Blood
26464-8 [3010813]
-2.3e-02
4.4e-01
2.0e+00
4.1e+00
2.0e+00
5.5e-01
2.2e-01
cases:19.36%
controls:19.73%
cases:24.07%
controls:16.99%
cases:20.96%
controls:3.41%
cases:8.43%
controls:0.16%
cases:21.63%
controls:3.44%
cases:28.43%
controls:18.58%
cases:37.21%
controls:32.18%
255
2590
1062
10538
317
2230
1000
10898
276
448
1041
12680
111
21
1206
13107
279
451
1011
12666
352
2411
886
10565
397
3829
670
8069
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
-3.4e-01
1.3e+00
3.3e+00
—
3.0e+00
1.7e+00
4.8e-01
cases:0.76%
controls:1.07%
cases:2.13%
controls:0.62%
cases:2.43%
controls:0.09%
—
—
cases:0.78%
controls:0.04%
cases:2.58%
controls:0.49%
cases:3.19%
controls:2.00%
10
140
1307
12988
28
81
1289
13047
32
12
1285
13116
—
10
5
1280
13112
32
63
1206
12913
34
238
1033
11660
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
-1.7e-01
1.3e+00
3.4e+00
—
2.3e+00
1.4e+00
8.4e-01
cases:5.92%
controls:6.94%
cases:12.45%
controls:3.82%
cases:14.43%
controls:0.56%
—
—
cases:5.19%
controls:0.56%
cases:15.27%
controls:4.18%
cases:23.52%
controls:11.68%
78
911
1239
12217
164
502
1153
12626
190
73
1127
13055
—
67
74
1223
13043
189
543
1049
12433
251
1390
816
10508
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
-1.5e-01
5.2e-01
2.0e+00
3.4e+00
2.1e+00
7.5e-01
3.3e-01
cases:9.87%
controls:11.29%
cases:16.10%
controls:10.21%
cases:13.36%
controls:1.96%
cases:1.97%
controls:0.07%
cases:14.11%
controls:1.89%
cases:21.16%
controls:11.30%
cases:28.87%
controls:22.67%
130
1482
1187
11646
212
1340
1105
11788
176
257
1141
12871
26
9
1291
13119
182
248
1108
12869
262
1466
976
11510
308
2697
759
9201
INR in Blood by Coagulation assay
34714-6 [3032080]
-1.6e-01
7.2e-01
1.7e+00
3.9e+00
1.5e+00
8.3e-01
4.6e-01
cases:4.56%
controls:5.30%
cases:6.76%
controls:3.40%
cases:7.29%
controls:1.36%
cases:2.81%
controls:0.06%
cases:5.12%
controls:1.16%
cases:7.67%
controls:3.50%
cases:13.12%
controls:8.71%
60
696
1257
12432
89
446
1228
12682
96
178
1221
12950
37
8
1280
13120
66
152
1224
12965
95
454
1143
12522
140
1036
927
10862
Tissue Pathology biopsy report
66121-5 [40768804]
2.5e-01
7.9e-01
2.3e+00
1.0e+50
3.5e+00
1.5e+00
1.0e+00
cases:3.72%
controls:2.91%
cases:2.35%
controls:1.08%
cases:0.91%
controls:0.09%
cases:8.05%
controls:0.00%
cases:2.71%
controls:0.08%
cases:5.25%
controls:1.21%
cases:9.56%
controls:3.66%
49
382
1268
12746
31
142
1286
12986
12
12
1305
13116
106
0
1211
13128
35
11
1255
13106
65
157
1173
12819
102
435
965
11463
MCH [Entitic mass]
28539-5 [3035941]
-2.1e-02
4.4e-01
2.0e+00
4.1e+00
2.1e+00
5.6e-01
2.2e-01
cases:19.36%
controls:19.69%
cases:24.07%
controls:16.96%
cases:20.96%
controls:3.40%
cases:8.43%
controls:0.16%
cases:21.63%
controls:3.42%
cases:28.43%
controls:18.53%
cases:37.02%
controls:32.12%
255
2585
1062
10543
317
2226
1000
10902
276
446
1041
12682
111
21
1206
13107
279
449
1011
12668
352
2404
886
10572
395
3822
672
8076
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
1.0e-02
3.8e-01
1.9e+00
4.4e+00
1.9e+00
5.0e-01
4.5e-02
cases:15.03%
controls:14.91%
cases:16.93%
controls:12.26%
cases:13.59%
controls:2.35%
cases:7.52%
controls:0.10%
cases:15.19%
controls:2.50%
cases:20.11%
controls:13.20%
cases:24.93%
controls:24.10%
198
1957
1119
11171
223
1609
1094
11519
179
309
1138
12819
99
13
1218
13115
196
328
1094
12789
249
1713
989
11263
266
2868
801
9030
Osmolality of Urine
2695-5 [3026782]
-8.7e-01
1.2e+00
3.3e+00
—
2.1e+00
1.7e+00
8.0e-01
cases:0.91%
controls:2.15%
cases:2.81%
controls:0.91%
cases:2.89%
controls:0.11%
—
—
cases:1.16%
controls:0.14%
cases:4.85%
controls:0.89%
cases:6.00%
controls:2.79%
12
282
1305
12846
37
119
1280
13009
38
15
1279
13113
—
15
18
1275
13099
60
115
1178
12861
64
332
1003
11566
General anesthesia, balanced
WX408 [2001310808]
1.1e-01
9.3e-01
4.3e+00
1.0e+50
—
2.5e+00
1.3e+00
cases:1.97%
controls:1.77%
cases:1.52%
controls:0.60%
cases:2.81%
controls:0.04%
cases:3.64%
controls:0.00%
—
—
cases:4.20%
controls:0.35%
cases:4.22%
controls:1.24%
26
233
1291
12895
20
79
1297
13049
37
5
1280
13123
48
0
1269
13128
—
52
46
1186
12930
45
148
1022
11750
Uroflowmetry
44856007 [4261340]
3.3e-01
1.1e+00
2.0e+00
—
2.2e+00
2.3e+00
1.4e+00
cases:2.13%
controls:1.54%
cases:1.44%
controls:0.46%
cases:0.61%
controls:0.08%
—
—
cases:0.47%
controls:0.05%
cases:4.44%
controls:0.46%
cases:7.40%
controls:1.90%
28
202
1289
12926
19
61
1298
13067
8
11
1309
13117
—
6
7
1284
13110
55
60
1183
12916
79
226
988
11672
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
-1.8e-01
3.9e-01
1.9e+00
4.1e+00
2.0e+00
5.8e-01
1.7e-01
cases:9.64%
controls:11.29%
cases:13.59%
controls:9.67%
cases:12.22%
controls:1.97%
cases:5.16%
controls:0.09%
cases:12.56%
controls:1.89%
cases:17.85%
controls:10.86%
cases:23.43%
controls:20.56%
127
1482
1190
11646
179
1269
1138
11859
161
259
1156
12869
68
12
1249
13116
162
248
1128
12869
221
1409
1017
11567
250
2446
817
9452
Oxygen saturation in Arterial blood
2708-6 [3016502]
1.6e-01
5.3e-01
2.6e+00
—
3.5e+00
2.2e+00
7.0e-01
cases:0.61%
controls:0.52%
cases:0.84%
controls:0.50%
cases:0.68%
controls:0.05%
—
—
cases:1.55%
controls:0.05%
cases:3.39%
controls:0.39%
cases:3.19%
controls:1.61%
8
68
1309
13060
11
65
1306
13063
9
7
1308
13121
—
20
6
1270
13111
42
51
1196
12925
34
192
1033
11706
Other and unspecified abdominal pain
R10.4 [45568113]
3.2e-03
1.3e+00
3.2e+00
—
2.3e+00
1.3e+00
7.9e-01
cases:3.64%
controls:3.63%
cases:3.87%
controls:1.08%
cases:1.97%
controls:0.08%
—
—
cases:1.16%
controls:0.11%
cases:3.31%
controls:0.92%
cases:8.43%
controls:4.01%
48
477
1269
12651
51
142
1266
12986
26
11
1291
13117
—
15
15
1275
13102
41
119
1197
12857
90
477
977
11421
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
-6.4e-01
1.2e+00
2.9e+00
1.0e+50
3.0e+00
1.2e+00
6.3e-01
cases:1.52%
controls:2.85%
cases:4.02%
controls:1.23%
cases:1.82%
controls:0.11%
cases:0.38%
controls:0.00%
cases:1.71%
controls:0.08%
cases:4.20%
controls:1.36%
cases:8.62%
controls:4.77%
20
374
1297
12754
53
162
1264
12966
24
14
1293
13114
5
0
1312
13128
22
11
1268
13106
52
177
1186
12799
92
568
975
11330
Internal Medicine
11 [38004456]
1.4e-01
7.1e-01
1.9e+00
3.3e+00
1.7e+00
7.8e-01
5.4e-01
cases:23.69%
controls:21.27%
cases:16.93%
controls:9.10%
cases:9.11%
controls:1.51%
cases:0.99%
controls:0.04%
cases:7.05%
controls:1.36%
cases:17.77%
controls:9.02%
cases:35.99%
controls:24.61%
312
2792
1005
10336
223
1195
1094
11933
120
198
1197
12930
13
5
1304
13123
91
179
1199
12938
220
1171
1018
11805
384
2928
683
8970
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
-1.8e-02
5.5e-01
2.2e+00
3.1e+00
2.1e+00
6.8e-01
2.6e-01
cases:18.45%
controls:18.73%
cases:24.53%
controls:15.85%
cases:20.50%
controls:2.89%
cases:3.19%
controls:0.15%
cases:21.01%
controls:3.02%
cases:29.40%
controls:17.41%
cases:37.02%
controls:31.13%
243
2459
1074
10669
323
2081
994
11047
270
380
1047
12748
42
20
1275
13108
271
396
1019
12721
364
2259
874
10717
395
3704
672
8194
oxycodone; oral, parenteral
N02AA05 [21604260]
5.4e-02
7.4e-01
2.3e+00
—
3.1e+00
2.3e+00
1.2e+00
cases:0.68%
controls:0.65%
cases:0.68%
controls:0.33%
cases:0.99%
controls:0.10%
—
—
cases:2.17%
controls:0.10%
cases:4.44%
controls:0.49%
cases:5.15%
controls:1.65%
9
85
1308
13043
9
43
1308
13085
13
13
1304
13115
—
28
13
1262
13104
55
63
1183
12913
55
196
1012
11702
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
-3.0e-02
7.3e-01
1.7e+00
3.0e+00
2.2e+00
7.4e-01
4.5e-01
cases:14.27%
controls:14.65%
cases:17.69%
controls:9.42%
cases:8.81%
controls:1.82%
cases:1.37%
controls:0.07%
cases:13.72%
controls:1.69%
cases:19.22%
controls:10.16%
cases:31.96%
controls:22.99%
188
1923
1129
11205
233
1237
1084
11891
116
239
1201
12889
18
9
1299
13119
177
222
1113
12895
238
1319
1000
11657
341
2735
726
9163
Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34548-8 [3045783]
4.7e-01
1.1e+00
2.5e+00
—
2.9e+00
1.3e+00
1.1e+00
cases:3.57%
controls:2.26%
cases:3.42%
controls:1.21%
cases:2.51%
controls:0.22%
—
—
cases:3.72%
controls:0.21%
cases:4.20%
controls:1.16%
cases:6.65%
controls:2.40%
47
297
1270
12831
45
159
1272
12969
33
29
1284
13099
—
48
28
1242
13089
52
150
1186
12826
71
285
996
11613
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
1.7e-01
6.5e-01
2.1e+00
—
3.5e+00
1.7e+00
7.0e-01
cases:7.21%
controls:6.13%
cases:4.48%
controls:2.38%
cases:3.34%
controls:0.40%
—
—
cases:12.64%
controls:0.42%
cases:11.39%
controls:2.34%
cases:13.03%
controls:6.90%
95
805
1222
12323
59
313
1258
12815
44
53
1273
13075
—
163
55
1127
13062
141
304
1097
12672
139
821
928
11077
Physiotherapy
R4110 [2001310233]
-1.7e-01
5.8e-01
3.7e+00
—
2.9e+00
1.5e+00
5.8e-01
cases:2.13%
controls:2.50%
cases:1.75%
controls:0.98%
cases:3.19%
controls:0.08%
—
—
cases:1.47%
controls:0.08%
cases:3.39%
controls:0.76%
cases:4.97%
controls:2.83%
28
328
1289
12800
23
129
1294
12999
42
11
1275
13117
—
19
11
1271
13106
42
99
1196
12877
53
337
1014
11561
Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]
3.8e-01
1.3e+00
3.2e+00
—
2.1e+00
1.2e+00
6.1e-01
cases:2.96%
controls:2.04%
cases:4.63%
controls:1.28%
cases:4.48%
controls:0.19%
—
—
cases:1.86%
controls:0.23%
cases:5.49%
controls:1.65%
cases:9.37%
controls:5.34%
39
268
1278
12860
61
168
1256
12960
59
25
1258
13103
—
24
30
1266
13087
68
214
1170
12762
100
635
967
11263
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
1.2e-01
1.0e+00
3.1e+00
—
2.2e+00
1.3e+00
8.1e-01
cases:3.34%
controls:2.96%
cases:4.78%
controls:1.74%
cases:4.63%
controls:0.23%
—
—
cases:2.02%
controls:0.22%
cases:7.11%
controls:1.97%
cases:12.65%
controls:6.08%
44
389
1273
12739
63
228
1254
12900
61
30
1256
13098
—
26
29
1264
13088
88
255
1150
12721
135
723
932
11175
Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 [3020059]
2.4e-02
1.1e+00
2.7e+00
—
2.6e+00
1.3e+00
6.9e-01
cases:1.44%
controls:1.41%
cases:2.28%
controls:0.77%
cases:0.68%
controls:0.05%
—
—
cases:0.85%
controls:0.06%
cases:2.58%
controls:0.71%
cases:5.44%
controls:2.81%
19
185
1298
12943
30
101
1287
13027
9
6
1308
13122
—
11
8
1279
13109
32
92
1206
12884
58
334
1009
11564
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
-1.2e-01
1.2e+00
2.3e+00
—
2.6e+00
1.4e+00
8.8e-01
cases:3.64%
controls:4.09%
cases:7.29%
controls:2.27%
cases:3.57%
controls:0.37%
—
—
cases:4.26%
controls:0.32%
cases:9.21%
controls:2.43%
cases:16.59%
controls:7.62%
48
537
1269
12591
96
298
1221
12830
47
49
1270
13079
—
55
42
1235
13075
114
315
1124
12661
177
907
890
10991
Right side
ZXA00 [2001311346]
1.7e-01
6.9e-01
3.6e+00
—
3.6e+00
1.2e+00
4.3e-01
cases:3.42%
controls:2.90%
cases:1.67%
controls:0.85%
cases:2.51%
controls:0.07%
—
—
cases:2.64%
controls:0.08%
cases:2.75%
controls:0.85%
cases:4.22%
controls:2.78%
45
381
1272
12747
22
111
1295
13017
33
9
1284
13119
—
34
10
1256
13107
34
110
1204
12866
45
331
1022
11567
Laboratory Visit
OMOP4822461 [32036]
-1.7e-02
3.2e-01
1.6e+00
4.4e+00
1.6e+00
3.9e-01
1.6e-01
cases:21.41%
controls:21.70%
cases:26.42%
controls:20.61%
cases:24.83%
controls:6.08%
cases:18.75%
controls:0.27%
cases:23.64%
controls:6.10%
cases:30.13%
controls:22.63%
cases:38.14%
controls:34.45%
282
2849
1035
10279
348
2706
969
10422
327
798
990
12330
247
36
1070
13092
305
800
985
12317
373
2937
865
10039
407
4099
660
7799
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
7.8e-02
4.1e-01
2.4e+00
—
3.2e+00
2.0e+00
6.7e-01
cases:0.68%
controls:0.63%
cases:0.84%
controls:0.56%
cases:0.68%
controls:0.06%
—
—
cases:1.55%
controls:0.06%
cases:3.63%
controls:0.52%
cases:3.37%
controls:1.76%
9
83
1308
13045
11
73
1306
13055
9
8
1308
13120
—
20
8
1270
13109
45
68
1193
12908
36
209
1031
11689
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
7.8e-02
4.1e-01
2.4e+00
—
3.2e+00
2.0e+00
6.6e-01
cases:0.68%
controls:0.63%
cases:0.84%
controls:0.56%
cases:0.68%
controls:0.06%
—
—
cases:1.55%
controls:0.06%
cases:3.63%
controls:0.52%
cases:3.37%
controls:1.77%
9
83
1308
13045
11
73
1306
13055
9
8
1308
13120
—
20
8
1270
13109
45
68
1193
12908
36
210
1031
11688
Teaching
WZC30 [2001310891]
4.8e-02
1.3e+00
3.3e+00
1.0e+50
—
2.3e+00
1.4e+00
cases:0.61%
controls:0.58%
cases:0.91%
controls:0.25%
cases:0.99%
controls:0.04%
cases:0.38%
controls:0.00%
—
—
cases:2.42%
controls:0.24%
cases:4.22%
controls:1.08%
8
76
1309
13052
12
33
1305
13095
13
5
1304
13123
5
0
1312
13128
—
30
31
1208
12945
45
128
1022
11770
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
-7.5e-02
1.2e+00
2.8e+00
—
2.7e+00
8.6e-01
8.0e-01
cases:4.48%
controls:4.81%
cases:4.71%
controls:1.52%
cases:2.05%
controls:0.13%
—
—
cases:1.94%
controls:0.14%
cases:3.72%
controls:1.60%
cases:10.87%
controls:5.21%
59
632
1258
12496
62
199
1255
12929
27
17
1290
13111
—
25
18
1265
13099
46
208
1192
12768
116
620
951
11278
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
-5.4e-03
1.1e+00
2.4e+00
—
2.4e+00
1.5e+00
8.2e-01
cases:3.72%
controls:3.74%
cases:7.21%
controls:2.45%
cases:3.72%
controls:0.34%
—
—
cases:3.72%
controls:0.36%
cases:9.69%
controls:2.39%
cases:14.90%
controls:7.16%
49
491
1268
12637
95
322
1222
12806
49
45
1268
13083
—
48
47
1242
13070
120
310
1118
12666
159
852
908
11046
Left side
ZXA05 [2001311347]
1.3e-01
5.1e-01
3.7e+00
1.0e+50
3.0e+00
1.4e+00
3.5e-01
cases:2.89%
controls:2.54%
cases:1.21%
controls:0.73%
cases:2.43%
controls:0.06%
cases:1.44%
controls:0.00%
cases:2.09%
controls:0.11%
cases:2.26%
controls:0.56%
cases:3.56%
controls:2.55%
38
334
1279
12794
16
96
1301
13032
32
8
1285
13120
19
0
1298
13128
27
14
1263
13103
28
73
1210
12903
38
303
1029
11595
Specific gravity of Urine by Refractometry
5810-7 [3019150]
2.4e-01
1.0e+00
3.3e+00
—
2.2e+00
1.0e+00
4.6e-01
cases:3.49%
controls:2.77%
cases:4.48%
controls:1.65%
cases:4.48%
controls:0.18%
—
—
cases:2.02%
controls:0.22%
cases:5.01%
controls:1.83%
cases:8.81%
controls:5.73%
46
363
1271
12765
59
217
1258
12911
59
23
1258
13105
—
26
29
1264
13088
62
237
1176
12739
94
682
973
11216
Office Visit
OMOP4822458 [581477]
3.1e-01
8.1e-01
2.5e+00
1.0e+50
2.4e+00
1.5e+00
7.2e-01
cases:8.20%
controls:6.14%
cases:4.40%
controls:2.01%
cases:2.73%
controls:0.23%
cases:0.68%
controls:0.00%
cases:2.64%
controls:0.25%
cases:7.84%
controls:1.77%
cases:11.90%
controls:6.17%
108
806
1209
12322
58
264
1259
12864
36
30
1281
13098
9
0
1308
13128
34
33
1256
13084
97
230
1141
12746
127
734
940
11164
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
3.0e-01
1.0e+00
1.5e+00
—
2.3e+00
1.7e+00
1.4e+00
cases:1.67%
controls:1.24%
cases:2.13%
controls:0.77%
cases:0.76%
controls:0.18%
—
—
cases:1.78%
controls:0.18%
cases:4.36%
controls:0.83%
cases:7.50%
controls:2.02%
22
163
1295
12965
28
101
1289
13027
10
23
1307
13105
—
23
24
1267
13093
54
108
1184
12868
80
240
987
11658
Bacteria identified in Urine by Culture
630-4 [3026008]
-5.1e-01
8.6e-01
2.9e+00
—
2.1e+00
1.3e+00
6.2e-01
cases:1.44%
controls:2.38%
cases:3.34%
controls:1.45%
cases:3.57%
controls:0.21%
—
—
cases:1.47%
controls:0.19%
cases:5.33%
controls:1.50%
cases:9.09%
controls:5.13%
19
312
1298
12816
44
190
1273
12938
47
27
1270
13101
—
19
25
1271
13092
66
195
1172
12781
97
610
970
11288
Cathetrisation of vein
TPH04 [2001309597]
-3.3e-01
4.7e-01
3.2e+00
—
2.3e+00
1.5e+00
7.0e-01
cases:0.99%
controls:1.37%
cases:0.84%
controls:0.53%
cases:1.14%
controls:0.05%
—
—
cases:0.78%
controls:0.08%
cases:1.94%
controls:0.45%
cases:4.12%
controls:2.10%
13
180
1304
12948
11
69
1306
13059
15
6
1302
13122
—
10
10
1280
13107
24
59
1214
12917
44
250
1023
11648
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
-1.4e-01
8.3e-01
2.1e+00
—
2.5e+00
1.5e+00
8.1e-01
cases:3.49%
controls:4.01%
cases:5.54%
controls:2.51%
cases:2.89%
controls:0.38%
—
—
cases:4.03%
controls:0.33%
cases:9.85%
controls:2.45%
cases:15.65%
controls:7.65%
46
526
1271
12602
73
329
1244
12799
38
50
1279
13078
—
52
43
1238
13074
122
318
1116
12658
167
910
900
10988
Base excess in Arterial blood by calculation
1925-7 [3003396]
7.8e-02
4.0e-01
2.4e+00
—
3.2e+00
2.0e+00
5.7e-01
cases:0.68%
controls:0.63%
cases:0.84%
controls:0.56%
cases:0.68%
controls:0.06%
—
—
cases:1.55%
controls:0.06%
cases:3.55%
controls:0.52%
cases:3.09%
controls:1.77%
9
83
1308
13045
11
74
1306
13054
9
8
1308
13120
—
20
8
1270
13109
44
67
1194
12909
33
211
1034
11687
pH of Arterial blood
2744-1 [3019977]
7.8e-02
3.8e-01
2.4e+00
—
3.2e+00
2.0e+00
5.9e-01
cases:0.68%
controls:0.63%
cases:0.84%
controls:0.57%
cases:0.68%
controls:0.06%
—
—
cases:1.55%
controls:0.06%
cases:3.63%
controls:0.53%
cases:3.19%
controls:1.79%
9
83
1308
13045
11
75
1306
13053
9
8
1308
13120
—
20
8
1270
13109
45
69
1193
12907
34
213
1033
11685
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
5.6e-01
1.0e+00
1.3e+00
—
2.8e+00
2.1e+00
1.6e+00
cases:1.29%
controls:0.74%
cases:1.37%
controls:0.49%
cases:0.53%
controls:0.14%
—
—
cases:1.94%
controls:0.12%
cases:4.04%
controls:0.51%
cases:6.19%
controls:1.28%
17
97
1300
13031
18
64
1299
13064
7
19
1310
13109
—
25
16
1265
13101
50
66
1188
12910
66
152
1001
11746
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
4.1e-02
9.4e-01
2.9e+00
—
2.0e+00
1.1e+00
5.5e-01
cases:4.56%
controls:4.38%
cases:6.30%
controls:2.57%
cases:5.16%
controls:0.30%
—
—
cases:2.33%
controls:0.32%
cases:8.00%
controls:2.77%
cases:13.78%
controls:8.40%
60
575
1257
12553
83
337
1234
12791
68
39
1249
13089
—
30
42
1260
13075
99
359
1139
12617
147
1000
920
10898
Abdominal ultrasound examination
JN3AE [2001305555]
3.3e-01
1.8e+00
—
1.0e+50
—
3.5e+00
2.2e+00
cases:0.76%
controls:0.55%
cases:1.14%
controls:0.19%
—
—
cases:0.46%
controls:0.00%
—
—
cases:5.90%
controls:0.19%
cases:8.15%
controls:0.94%
10
72
1307
13056
15
25
1302
13103
—
6
0
1311
13128
—
73
25
1165
12951
87
112
980
11786
Bicarbonate [Moles/volume] in Arterial blood
1960-4 [3008152]
-3.2e-03
1.8e-01
2.3e+00
—
3.3e+00
1.9e+00
5.4e-01
cases:0.38%
controls:0.38%
cases:0.46%
controls:0.38%
cases:0.46%
controls:0.05%
—
—
cases:1.47%
controls:0.05%
cases:1.62%
controls:0.25%
cases:1.97%
controls:1.16%
5
50
1312
13078
6
50
1311
13078
6
6
1311
13122
—
19
7
1271
13110
20
33
1218
12943
21
138
1046
11760
pH of Urine
2756-5 [3015736]
1.5e-01
1.0e+00
2.8e+00
—
2.1e+00
1.0e+00
5.2e-01
cases:4.56%
controls:3.95%
cases:6.15%
controls:2.32%
cases:4.78%
controls:0.30%
—
—
cases:2.33%
controls:0.30%
cases:6.95%
controls:2.59%
cases:13.12%
controls:8.20%
60
518
1257
12610
81
304
1236
12824
63
39
1254
13089
—
30
40
1260
13077
86
336
1152
12640
140
976
927
10922
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
7.3e-02
1.0e+00
2.8e+00
—
1.9e+00
1.2e+00
5.5e-01
cases:5.01%
controls:4.68%
cases:7.67%
controls:2.95%
cases:5.69%
controls:0.37%
—
—
cases:2.71%
controls:0.40%
cases:10.02%
controls:3.36%
cases:17.24%
controls:10.69%
66
614
1251
12514
101
387
1216
12741
75
49
1242
13079
—
35
52
1255
13065
124
436
1114
12540
184
1272
883
10626
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
3.2e-02
1.0e+00
2.8e+00
—
2.0e+00
1.1e+00
5.4e-01
cases:5.01%
controls:4.86%
cases:7.97%
controls:3.06%
cases:5.85%
controls:0.39%
—
—
cases:2.95%
controls:0.43%
cases:10.26%
controls:3.50%
cases:17.43%
controls:10.91%
66
638
1251
12490
105
402
1212
12726
77
51
1240
13077
—
38
56
1252
13061
127
454
1111
12522
186
1298
881
10600
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
-1.5e-01
9.5e-01
2.0e+00
—
2.1e+00
1.4e+00
8.9e-01
cases:7.74%
controls:8.87%
cases:13.14%
controls:5.51%
cases:5.69%
controls:0.83%
—
—
cases:5.81%
controls:0.72%
cases:19.31%
controls:5.33%
cases:29.05%
controls:14.37%
102
1164
1215
11964
173
724
1144
12404
75
109
1242
13019
—
75
95
1215
13022
239
692
999
12284
310
1710
757
10188
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
3.6e-02
9.1e-01
2.2e+00
—
2.3e+00
1.3e+00
6.7e-01
cases:2.81%
controls:2.71%
cases:3.11%
controls:1.28%
cases:1.21%
controls:0.14%
—
—
cases:1.24%
controls:0.12%
cases:4.36%
controls:1.26%
cases:8.81%
controls:4.72%
37
356
1280
12772
41
168
1276
12960
16
18
1301
13110
—
16
16
1274
13101
54
164
1184
12812
94
562
973
11336
Abnormal findings on diagnostic imaging of lung
R91 [45548995]
5.6e-02
1.6e+00
2.8e+00
—
—
1.6e+00
1.4e+00
cases:0.53%
controls:0.50%
cases:1.29%
controls:0.25%
cases:0.61%
controls:0.04%
—
—
—
—
cases:1.13%
controls:0.24%
cases:3.19%
controls:0.84%
7
66
1310
13062
17
33
1300
13095
8
5
1309
13123
—
—
14
31
1224
12945
34
100
1033
11798
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
4.1e-02
9.8e-01
2.8e+00
—
2.0e+00
1.1e+00
5.3e-01
cases:5.01%
controls:4.82%
cases:7.52%
controls:2.96%
cases:5.85%
controls:0.39%
—
—
cases:2.79%
controls:0.40%
cases:9.85%
controls:3.48%
cases:17.15%
controls:10.90%
66
633
1251
12495
99
389
1218
12739
77
51
1240
13077
—
36
53
1254
13064
122
451
1116
12525
183
1297
884
10601
ANTIHYPERTENSIVE_DRUG - yes
ANTIHYPERTENSIVE_DRUG-1 [2002330215]
1.6e+00
1.7e+00
—
—
—
1.9e+00
2.0e+00
cases:0.76%
controls:0.15%
cases:0.76%
controls:0.14%
—
—
—
—
—
—
cases:0.89%
controls:0.13%
cases:1.41%
controls:0.18%
10
20
1307
13108
10
18
1307
13110
—
—
—
11
17
1227
12959
15
22
1052
11876
pH of Serum or Plasma
2753-2 [3018418]
-1.4e-01
8.7e-01
2.0e+00
—
2.3e+00
1.3e+00
7.1e-01
cases:2.13%
controls:2.45%
cases:3.49%
controls:1.50%
cases:1.59%
controls:0.22%
—
—
cases:2.25%
controls:0.22%
cases:5.57%
controls:1.51%
cases:9.93%
controls:5.16%
28
321
1289
12807
46
197
1271
12931
21
29
1296
13099
—
29
29
1261
13088
69
196
1169
12780
106
614
961
11284
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
-3.0e-01
7.4e-01
2.0e+00
—
2.5e+00
1.3e+00
6.9e-01
cases:3.49%
controls:4.67%
cases:5.85%
controls:2.86%
cases:3.19%
controls:0.45%
—
—
cases:4.42%
controls:0.39%
cases:10.10%
controls:2.90%
cases:16.96%
controls:9.27%
46
613
1271
12515
77
376
1240
12752
42
59
1275
13069
—
57
51
1233
13066
125
376
1113
12600
181
1103
886
10795
Bacteria identified in Blood by Culture
600-7 [3023368]
-7.6e-02
5.1e-01
2.8e+00
—
2.5e+00
1.2e+00
6.2e-01
cases:1.75%
controls:1.88%
cases:1.90%
controls:1.15%
cases:1.67%
controls:0.11%
—
—
cases:2.33%
controls:0.19%
cases:3.80%
controls:1.14%
cases:7.69%
controls:4.29%
23
247
1294
12881
25
151
1292
12977
22
14
1295
13114
—
30
25
1260
13092
47
148
1191
12828
82
510
985
11388
Urgent procedure
ZXD05 [2001311386]
3.5e-02
9.2e-01
3.1e+00
1.0e+50
3.0e+00
4.1e-01
4.5e-01
cases:2.89%
controls:2.79%
cases:2.13%
controls:0.86%
cases:1.14%
controls:0.05%
cases:0.53%
controls:0.00%
cases:1.09%
controls:0.05%
cases:1.29%
controls:0.86%
cases:4.69%
controls:3.04%
38
366
1279
12762
28
113
1289
13015
15
7
1302
13121
7
0
1310
13128
14
7
1276
13110
16
112
1222
12864
50
362
1017
11536
Extracorporeal dialysis
Z49.1 [45537649]
—
—
—
—
2.3e+00
2.4e+00
2.3e+00
—
—
—
—
—
—
—
—
cases:0.39%
controls:0.04%
cases:0.48%
controls:0.05%
cases:0.94%
controls:0.09%
—
—
—
—
5
5
1285
13112
6
6
1232
12970
10
11
1057
11887
Cancer Ag 19-9 [Units/volume] in Serum or Plasma
24108-3 [3022914]
—
2.7e+00
—
—
—
2.8e+00
1.4e+00
—
—
cases:0.76%
controls:0.05%
—
—
—
—
—
—
cases:0.97%
controls:0.06%
cases:1.12%
controls:0.27%
—
10
7
1307
13121
—
—
—
12
8
1226
12968
12
32
1055
11866
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
-7.6e-02
5.0e-01
2.5e+00
—
2.2e+00
1.1e+00
4.4e-01
cases:5.54%
controls:5.96%
cases:5.39%
controls:3.34%
cases:5.16%
controls:0.45%
—
—
cases:3.49%
controls:0.41%
cases:9.94%
controls:3.44%
cases:15.65%
controls:10.70%
73
782
1244
12346
71
438
1246
12690
68
59
1249
13069
—
45
54
1245
13063
123
447
1115
12529
167
1273
900
10625
Removal of sutures
SPAT1153 [2001700254]
3.4e-01
5.7e-01
1.2e+00
—
3.9e+00
1.9e+00
9.7e-01
cases:3.87%
controls:2.79%
cases:1.82%
controls:1.04%
cases:0.38%
controls:0.11%
—
—
cases:4.81%
controls:0.11%
cases:4.36%
controls:0.71%
cases:7.78%
controls:3.08%
51
366
1266
12762
24
137
1293
12991
5
15
1312
13113
—
62
14
1228
13103
54
92
1184
12884
83
367
984
11531
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
-2.3e-02
9.6e-01
1.7e+00
—
1.9e+00
1.2e+00
8.8e-01
cases:4.86%
controls:4.97%
cases:8.20%
controls:3.31%
cases:3.64%
controls:0.69%
—
—
cases:4.19%
controls:0.65%
cases:10.99%
controls:3.51%
cases:18.56%
controls:8.61%
64
652
1253
12476
108
435
1209
12693
48
90
1269
13038
—
54
85
1236
13032
136
455
1102
12521
198
1025
869
10873
Kidney ultrasound examination
KA1AE [2001305627]
1.8e+00
2.8e+00
—
1.0e+50
—
—
2.1e+00
cases:0.53%
controls:0.09%
cases:0.61%
controls:0.04%
—
—
cases:1.14%
controls:0.00%
—
—
—
—
cases:0.94%
controls:0.12%
7
12
1310
13116
8
5
1309
13123
—
15
0
1302
13128
—
—
10
14
1057
11884
Short blood count panel - Blood
55429-5 [40758558]
-1.8e-02
8.6e-01
1.9e+00
—
2.0e+00
1.3e+00
5.3e-01
cases:2.05%
controls:2.09%
cases:2.66%
controls:1.14%
cases:1.59%
controls:0.25%
—
—
cases:1.55%
controls:0.21%
cases:4.28%
controls:1.16%
cases:6.19%
controls:3.72%
27
274
1290
12854
35
150
1282
12978
21
33
1296
13095
—
20
27
1270
13090
53
151
1185
12825
66
443
1001
11455
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
-7.7e-02
8.7e-01
2.5e+00
—
1.6e+00
1.1e+00
6.0e-01
cases:7.44%
controls:7.99%
cases:10.10%
controls:4.51%
cases:6.76%
controls:0.62%
—
—
cases:2.95%
controls:0.61%
cases:12.52%
controls:4.72%
cases:20.99%
controls:12.75%
98
1049
1219
12079
133
592
1184
12536
89
81
1228
13047
—
38
80
1252
13037
155
613
1083
12363
224
1517
843
10381
Ultrasound examination of upper part of abdomen
JN1AE [2001305517]
1.3e-01
2.9e+00
1.0e+50
—
—
2.3e+00
1.4e+00
cases:0.38%
controls:0.34%
cases:1.21%
controls:0.07%
cases:0.46%
controls:0.00%
—
—
—
—
cases:1.05%
controls:0.11%
cases:1.87%
controls:0.47%
5
44
1312
13084
16
9
1301
13119
6
0
1311
13128
—
—
13
14
1225
12962
20
56
1047
11842
Emergency Room and Inpatient Visit
ERIP [262]
4.9e-02
7.5e-01
2.7e+00
—
1.7e+00
9.0e-01
5.3e-01
cases:1.67%
controls:1.59%
cases:2.51%
controls:1.20%
cases:1.52%
controls:0.11%
—
—
cases:1.01%
controls:0.19%
cases:3.47%
controls:1.44%
cases:9.18%
controls:5.64%
22
209
1295
12919
33
158
1284
12970
20
14
1297
13114
—
13
25
1277
13092
43
187
1195
12789
98
671
969
11227
Protein [Mass/volume] in Urine
2888-6 [3037121]
4.9e-01
2.5e+00
—
—
1.0e+50
1.7e+00
2.4e+00
cases:0.53%
controls:0.33%
cases:2.28%
controls:0.20%
—
—
—
—
cases:0.54%
controls:0.00%
cases:1.05%
controls:0.20%
cases:3.09%
controls:0.30%
7
43
1310
13085
30
26
1287
13102
—
—
7
0
1283
13117
13
26
1225
12950
33
36
1034
11862
Cancer Ag 125 [Units/volume] in Serum or Plasma
10334-1 [3037551]
—
2.4e+00
—
—
—
2.4e+00
1.6e+00
—
—
cases:0.84%
controls:0.08%
—
—
—
—
—
—
cases:0.57%
controls:0.05%
cases:1.22%
controls:0.26%
—
11
10
1306
13118
—
—
—
7
7
1231
12969
13
31
1054
11867
oxycodone and naloxone; oral
N02AA55 [21604265]
-1.2e-01
1.6e-01
2.2e+00
—
3.0e+00
1.1e+00
3.7e-01
cases:0.84%
controls:0.94%
cases:0.46%
controls:0.39%
cases:0.53%
controls:0.06%
—
—
cases:1.47%
controls:0.08%
cases:1.29%
controls:0.44%
cases:2.81%
controls:1.97%
11
123
1306
13005
6
51
1311
13077
7
8
1310
13120
—
19
10
1271
13107
16
57
1222
12919
30
234
1037
11664
dexamethasone; oral, parenteral
H02AB02 [21602730]
5.2e-02
1.0e+00
—
—
2.7e+00
2.2e+00
1.2e+00
cases:1.29%
controls:1.23%
cases:0.91%
controls:0.33%
—
—
—
—
cases:0.70%
controls:0.05%
cases:2.50%
controls:0.29%
cases:5.06%
controls:1.51%
17
161
1300
12967
12
43
1305
13085
—
—
9
6
1281
13111
31
37
1207
12939
54
180
1013
11718
Extensive abdominal CT
JN3BD [2001305556]
1.0e-01
2.4e+00
—
1.0e+50
1.0e+50
2.5e+00
1.3e+00
cases:0.68%
controls:0.62%
cases:1.44%
controls:0.14%
—
—
cases:0.46%
controls:0.00%
cases:0.78%
controls:0.00%
cases:1.37%
controls:0.12%
cases:1.97%
controls:0.57%
9
81
1308
13047
19
18
1298
13110
—
6
0
1311
13128
10
0
1280
13117
17
15
1221
12961
21
68
1046
11830
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
9.5e-02
8.2e-01
1.7e+00
—
2.3e+00
1.3e+00
7.1e-01
cases:0.99%
controls:0.90%
cases:1.29%
controls:0.57%
cases:0.84%
controls:0.15%
—
—
cases:0.39%
controls:0.04%
cases:1.94%
controls:0.54%
cases:4.31%
controls:2.18%
13
118
1304
13010
17
75
1300
13053
11
20
1306
13108
—
5
5
1285
13112
24
70
1214
12906
46
259
1021
11639
Abdominal CT examination both without and with contrast
JN3CD [2001305561]
—
3.0e+00
1.0e+50
1.0e+50
—
1.0e+50
2.9e+00
—
—
cases:0.91%
controls:0.05%
cases:1.14%
controls:0.00%
cases:0.38%
controls:0.00%
—
—
cases:1.37%
controls:0.00%
cases:1.59%
controls:0.09%
—
12
6
1305
13122
15
0
1302
13128
5
0
1312
13128
—
17
0
1221
12976
17
11
1050
11887
Unspecified haematuria
R31 [45553726]
1.7e-02
3.0e+00
—
—
—
1.8e+00
1.0e+00
cases:0.76%
controls:0.75%
cases:4.78%
controls:0.26%
—
—
—
—
—
—
cases:1.53%
controls:0.26%
cases:3.00%
controls:1.08%
10
98
1307
13030
63
34
1254
13094
—
—
—
19
34
1219
12942
32
128
1035
11770
Hyaline casts [#/volume] in Urine by Automated count
51484-4 [3030981]
—
6.9e-01
3.0e+00
—
—
1.7e+00
1.0e+00
—
—
cases:0.61%
controls:0.30%
cases:1.37%
controls:0.07%
—
—
—
—
cases:2.10%
controls:0.39%
cases:4.12%
controls:1.51%
—
8
40
1309
13088
18
9
1299
13119
—
—
26
50
1212
12926
44
180
1023
11718
Obstetrics / Gynecology
16 [38004461]
2.2e-01
6.4e-01
2.1e+00
—
1.6e+00
8.0e-01
6.2e-01
cases:6.91%
controls:5.64%
cases:3.57%
controls:1.91%
cases:1.52%
controls:0.19%
—
—
cases:1.01%
controls:0.21%
cases:3.88%
controls:1.79%
cases:9.47%
controls:5.31%
91
741
1226
12387
47
251
1270
12877
20
25
1297
13103
—
13
27
1277
13090
48
232
1190
12744
101
632
966
11266
Ultrasound measurement of residual urine
KC1EE [2001305918]
1.9e-01
9.2e-01
—
—
2.3e+00
2.1e+00
1.3e+00
cases:1.29%
controls:1.07%
cases:0.91%
controls:0.37%
—
—
—
—
cases:0.47%
controls:0.05%
cases:2.83%
controls:0.35%
cases:4.87%
controls:1.36%
17
141
1300
12987
12
48
1305
13080
—
—
6
6
1284
13111
35
46
1203
12930
52
162
1015
11736
cefalexin; oral
J01DB01 [21602870]
1.2e-01
5.8e-01
1.9e+00
—
1.9e+00
8.2e-01
5.0e-01
cases:24.15%
controls:21.96%
cases:11.92%
controls:7.08%
cases:4.78%
controls:0.72%
—
—
cases:5.19%
controls:0.82%
cases:15.02%
controls:7.24%
cases:33.93%
controls:23.71%
318
2883
999
10245
157
929
1160
12199
63
94
1254
13034
—
67
107
1223
13010
186
939
1052
12037
362
2821
705
9077
12 lead EKG panel
34534-8 [3044889]
7.3e-02
4.5e-01
2.8e+00
—
1.5e+00
6.6e-01
3.2e-01
cases:10.40%
controls:9.74%
cases:8.58%
controls:5.64%
cases:8.96%
controls:0.61%
—
—
cases:2.87%
controls:0.66%
cases:10.66%
controls:5.79%
cases:20.15%
controls:15.51%
137
1279
1180
11849
113
741
1204
12387
118
80
1199
13048
—
37
86
1253
13031
132
751
1106
12225
215
1845
852
10053
Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
2039-6 [3003785]
6.7e-01
2.2e+00
—
—
—
2.2e+00
1.3e+00
cases:0.76%
controls:0.39%
cases:1.59%
controls:0.18%
—
—
—
—
—
—
cases:1.53%
controls:0.18%
cases:2.62%
controls:0.72%
10
51
1307
13077
21
24
1296
13104
—
—
—
19
23
1219
12953
28
86
1039
11812
Laceration/cut
S18 [2002000983]
2.1e-01
2.4e-01
—
—
3.6e+00
1.4e+00
6.3e-01
cases:4.86%
controls:3.98%
cases:2.05%
controls:1.61%
—
—
—
—
cases:6.98%
controls:0.20%
cases:5.82%
controls:1.52%
cases:11.06%
controls:6.19%
64
523
1253
12605
27
212
1290
12916
—
—
90
26
1200
13091
72
197
1166
12779
118
737
949
11161
Coloscopy
UJF32 [2001305029]
4.3e-01
1.0e+00
2.4e+00
—
2.0e+00
1.3e+00
8.3e-01
cases:3.80%
controls:2.51%
cases:2.20%
controls:0.80%
cases:0.61%
controls:0.05%
—
—
cases:0.39%
controls:0.05%
cases:2.58%
controls:0.72%
cases:6.94%
controls:3.15%
50
330
1267
12798
29
105
1288
13023
8
7
1309
13121
—
5
7
1285
13110
32
93
1206
12883
74
375
993
11523
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
-2.1e-01
1.2e+00
2.1e+00
—
—
1.5e+00
7.4e-01
cases:1.21%
controls:1.50%
cases:1.44%
controls:0.46%
cases:0.68%
controls:0.08%
—
—
—
—
cases:2.42%
controls:0.53%
cases:4.31%
controls:2.10%
16
197
1301
12931
19
60
1298
13068
9
11
1308
13117
—
—
30
69
1208
12907
46
250
1021
11648
Normoblasts [#/volume] in Blood
715-3 [3021589]
-3.7e-01
6.0e-01
1.9e+00
—
1.8e+00
7.5e-01
4.2e-01
cases:2.35%
controls:3.36%
cases:4.86%
controls:2.72%
cases:4.18%
controls:0.62%
—
—
cases:3.18%
controls:0.54%
cases:6.87%
controls:3.37%
cases:11.90%
controls:8.14%
31
441
1286
12687
64
357
1253
12771
55
82
1262
13046
—
41
71
1249
13046
85
437
1153
12539
127
969
940
10929
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
—
5.1e-01
—
—
2.2e+00
1.8e+00
1.4e+00
—
—
cases:0.53%
controls:0.32%
—
—
—
—
cases:0.62%
controls:0.07%
cases:2.10%
controls:0.35%
cases:4.22%
controls:1.04%
—
7
42
1310
13086
—
—
8
9
1282
13108
26
45
1212
12931
45
124
1022
11774
Kidney transplant status
Z94.0 [45566477]
1.8e+00
1.6e+00
2.0e+00
—
—
1.8e+00
1.9e+00
cases:0.53%
controls:0.09%
cases:0.46%
controls:0.09%
cases:0.38%
controls:0.05%
—
—
—
—
cases:0.65%
controls:0.11%
cases:0.75%
controls:0.12%
7
12
1310
13116
6
12
1311
13116
5
7
1312
13121
—
—
8
14
1230
12962
8
14
1059
11884
Gastroenterology
10 [38004455]
4.1e-01
9.9e-01
1.5e+00
—
1.4e+00
8.5e-01
6.3e-01
cases:4.33%
controls:2.93%
cases:3.26%
controls:1.24%
cases:1.06%
controls:0.23%
—
—
cases:0.93%
controls:0.24%
cases:2.75%
controls:1.19%
cases:7.69%
controls:4.26%
57
384
1260
12744
43
163
1274
12965
14
30
1303
13098
—
12
31
1278
13086
34
155
1204
12821
82
507
985
11391
Kidney symptom/complaint
U14 [2002001145]
—
—
—
—
—
2.9e+00
2.5e+00
—
—
—
—
—
—
—
—
—
—
cases:0.81%
controls:0.05%
cases:1.12%
controls:0.09%
—
—
—
—
—
10
6
1228
12970
12
11
1055
11887
Intubation
WX704 [2001310820]
—
—
3.1e+00
1.0e+50
—
2.3e+00
-7.4e-02
—
—
—
—
cases:0.99%
controls:0.05%
cases:0.99%
controls:0.00%
—
—
cases:0.97%
controls:0.10%
cases:0.56%
controls:0.61%
—
—
13
6
1304
13122
13
0
1304
13128
—
12
13
1226
12963
6
72
1061
11826
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
-7.2e-01
5.6e-01
—
—
2.6e+00
1.9e+00
8.9e-01
cases:0.61%
controls:1.24%
cases:1.06%
controls:0.61%
—
—
—
—
cases:1.55%
controls:0.12%
cases:3.39%
controls:0.55%
cases:5.15%
controls:2.18%
8
163
1309
12965
14
80
1303
13048
—
—
20
16
1270
13101
42
71
1196
12905
55
259
1012
11639
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
6.2e-02
4.1e-01
1.8e+00
—
1.9e+00
9.1e-01
7.0e-01
cases:1.59%
controls:1.50%
cases:1.67%
controls:1.12%
cases:0.76%
controls:0.13%
—
—
cases:0.93%
controls:0.14%
cases:2.91%
controls:1.19%
cases:6.00%
controls:3.08%
21
197
1296
12931
22
147
1295
12981
10
17
1307
13111
—
12
18
1278
13099
36
155
1202
12821
64
367
1003
11531
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
-2.6e-01
1.1e+00
2.6e+00
—
2.1e+00
1.5e+00
3.8e-01
cases:0.61%
controls:0.78%
cases:1.06%
controls:0.35%
cases:0.53%
controls:0.04%
—
—
cases:0.39%
controls:0.05%
cases:1.70%
controls:0.37%
cases:1.78%
controls:1.23%
8
103
1309
13025
14
46
1303
13082
7
5
1310
13123
—
5
6
1285
13111
21
48
1217
12928
19
146
1048
11752
Clinical Cytogenetics and Genomics
OMOP4822000 [32411]
8.0e-01
—
—
—
—
2.6e+00
2.7e+00
cases:0.46%
controls:0.21%
—
—
—
—
—
—
—
—
cases:0.89%
controls:0.07%
cases:2.16%
controls:0.14%
6
27
1311
13101
—
—
—
—
11
9
1227
12967
23
17
1044
11881
Repeated or continuing anesthesia shots throug a catheter
WX602 [2001310813]
8.7e-01
—
1.0e+50
1.0e+50
1.0e+50
3.4e+00
1.9e+00
cases:0.38%
controls:0.16%
—
—
cases:1.21%
controls:0.00%
cases:2.66%
controls:0.00%
cases:0.93%
controls:0.00%
cases:1.13%
controls:0.04%
cases:1.59%
controls:0.25%
5
21
1312
13107
—
16
0
1301
13128
35
0
1282
13128
12
0
1278
13117
14
5
1224
12971
17
30
1050
11868
Genetic counselling
Z31.5 [45590715]
—
—
—
—
—
2.4e+00
2.8e+00
—
—
—
—
—
—
—
—
—
—
cases:0.48%
controls:0.05%
cases:1.41%
controls:0.08%
—
—
—
—
—
6
6
1232
12970
15
10
1052
11888
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
1.3e-01
3.1e-01
1.2e+00
—
2.3e+00
8.5e-01
4.9e-01
cases:21.79%
controls:19.62%
cases:14.88%
controls:11.40%
cases:7.21%
controls:2.31%
—
—
cases:18.37%
controls:2.24%
cases:24.88%
controls:12.35%
cases:40.11%
controls:29.06%
287
2576
1030
10552
196
1496
1121
11632
95
303
1222
12825
—
237
294
1053
12823
308
1602
930
11374
428
3457
639
8441
fentanyl; nasal, sublingual, transdermal
N02AB03 [21604272]
—
—
—
—
—
3.4e+00
1.7e+00
—
—
—
—
—
—
—
—
—
—
cases:1.62%
controls:0.05%
cases:1.78%
controls:0.34%
—
—
—
—
—
20
7
1218
12969
19
40
1048
11858
Basophils [#/volume] in Blood
26444-0 [3006315]
-2.5e-01
6.4e-01
1.5e+00
—
1.4e+00
9.2e-01
7.0e-01
cases:3.57%
controls:4.52%
cases:5.39%
controls:2.92%
cases:2.13%
controls:0.50%
—
—
cases:2.02%
controls:0.53%
cases:7.51%
controls:3.14%
cases:14.81%
controls:7.96%
47
594
1270
12534
71
383
1246
12745
28
65
1289
13063
—
26
69
1264
13048
93
407
1145
12569
158
947
909
10951
Monocytes [#/volume] in Blood
26484-6 [3001604]
-2.6e-01
6.5e-01
1.4e+00
—
1.4e+00
9.3e-01
7.0e-01
cases:3.49%
controls:4.48%
cases:5.39%
controls:2.90%
cases:2.05%
controls:0.50%
—
—
cases:2.02%
controls:0.52%
cases:7.51%
controls:3.11%
cases:14.71%
controls:7.89%
46
588
1271
12540
71
381
1246
12747
27
65
1290
13063
—
26
68
1264
13049
93
404
1145
12572
157
939
910
10959
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
4.0e-02
1.1e+00
2.3e+00
—
1.4e+00
1.1e+00
5.2e-01
cases:3.34%
controls:3.21%
cases:2.58%
controls:0.84%
cases:1.14%
controls:0.11%
—
—
cases:0.47%
controls:0.11%
cases:2.67%
controls:0.92%
cases:5.90%
controls:3.59%
44
422
1273
12706
34
110
1283
13018
15
15
1302
13113
—
6
15
1284
13102
33
119
1205
12857
63
427
1004
11471
Eosinophils [#/volume] in Blood
26449-9 [3013115]
-2.2e-01
6.2e-01
1.4e+00
—
1.3e+00
9.2e-01
7.2e-01
cases:3.87%
controls:4.78%
cases:5.47%
controls:3.02%
cases:2.13%
controls:0.51%
—
—
cases:2.02%
controls:0.53%
cases:7.67%
controls:3.22%
cases:15.56%
controls:8.25%
51
628
1266
12500
72
397
1245
12731
28
67
1289
13061
—
26
70
1264
13047
95
418
1143
12558
166
982
901
10916
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
-1.8e-01
6.4e-01
1.4e+00
—
1.3e+00
9.0e-01
7.0e-01
cases:4.02%
controls:4.77%
cases:5.69%
controls:3.08%
cases:2.13%
controls:0.51%
—
—
cases:2.09%
controls:0.57%
cases:7.75%
controls:3.31%
cases:15.28%
controls:8.24%
53
626
1264
12502
75
404
1242
12724
28
67
1289
13061
—
27
75
1263
13042
96
429
1142
12547
163
980
904
10918
Chronic disorders of vitamin D metabolism
123 [2001600122]
1.4e+00
—
—
—
—
2.7e+00
2.3e+00
cases:0.53%
controls:0.13%
—
—
—
—
—
—
—
—
cases:0.81%
controls:0.05%
cases:1.78%
controls:0.18%
7
17
1310
13111
—
—
—
—
10
7
1228
12969
19
22
1048
11876
Systemic arterial pressure
364090009 [4238447]
—
—
—
1.0e+50
—
3.2e+00
1.7e+00
—
—
—
—
—
—
cases:2.28%
controls:0.00%
—
—
cases:0.97%
controls:0.04%
cases:0.84%
controls:0.16%
—
—
—
30
0
1287
13128
—
12
5
1226
12971
9
19
1058
11879
Abdominal CT examination
JN3AD [2001305554]
—
1.6e+00
—
—
—
1.9e+00
1.4e+00
—
—
cases:1.14%
controls:0.22%
—
—
—
—
—
—
cases:0.65%
controls:0.10%
cases:3.19%
controls:0.84%
—
15
29
1302
13099
—
—
—
8
13
1230
12963
34
100
1033
11798
Cytology report of Urine Cyto stain
47525-1 [3049717]
—
3.0e+00
—
—
—
1.9e+00
7.3e-01
—
—
cases:1.59%
controls:0.08%
—
—
—
—
—
—
cases:0.73%
controls:0.11%
cases:0.94%
controls:0.45%
—
21
11
1296
13117
—
—
—
9
14
1229
12962
10
54
1057
11844
darbepoetin alfa; parenteral
B03XA02 [21601134]
-1.0e+50
—
—
—
—
2.5e+00
2.4e+00
cases:0.00%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.73%
controls:0.06%
cases:1.59%
controls:0.15%
0
6
1317
13122
—
—
—
—
9
8
1229
12968
17
18
1050
11880
Immunohistochemistry procedure
117617002 [4035726]
1.1e+00
2.2e+00
1.0e+50
1.0e+50
—
—
2.6e+00
cases:0.53%
controls:0.18%
cases:0.68%
controls:0.08%
cases:0.38%
controls:0.00%
cases:6.61%
controls:0.00%
—
—
—
—
cases:2.44%
controls:0.19%
7
23
1310
13105
9
10
1308
13118
5
0
1312
13128
87
0
1230
13128
—
—
26
23
1041
11875
trimethoprim; oral, parenteral
J01EA01 [21602931]
2.0e-01
6.1e-01
1.2e+00
—
1.9e+00
9.2e-01
3.1e-01
cases:4.48%
controls:3.71%
cases:3.11%
controls:1.72%
cases:0.91%
controls:0.27%
—
—
cases:1.40%
controls:0.22%
cases:3.96%
controls:1.62%
cases:6.75%
controls:5.04%
59
487
1258
12641
41
226
1276
12902
12
35
1305
13093
—
18
29
1272
13088
49
210
1189
12766
72
600
995
11298
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]
-6.6e-01
1.2e+00
—
—
2.3e+00
1.4e+00
9.3e-01
cases:0.38%
controls:0.73%
cases:0.76%
controls:0.22%
—
—
—
—
cases:0.39%
controls:0.04%
cases:0.89%
controls:0.23%
cases:2.16%
controls:0.87%
5
96
1312
13032
10
29
1307
13099
—
—
5
5
1285
13112
11
30
1227
12946
23
103
1044
11795
Chronic kidney disease
N18 [45582391]
—
—
—
—
—
2.6e+00
2.0e+00
—
—
—
—
—
—
—
—
—
—
cases:0.89%
controls:0.07%
cases:1.78%
controls:0.24%
—
—
—
—
—
11
9
1227
12967
19
28
1048
11870
Monocytes/Leukocytes in Blood
26485-3 [3019069]
-5.0e-01
6.5e-01
1.3e+00
—
1.3e+00
8.0e-01
5.8e-01
cases:2.66%
controls:4.32%
cases:5.09%
controls:2.73%
cases:1.75%
controls:0.48%
—
—
cases:1.63%
controls:0.47%
cases:5.98%
controls:2.79%
cases:12.00%
controls:7.10%
35
567
1282
12561
67
358
1250
12770
23
63
1294
13065
—
21
61
1269
13056
74
362
1164
12614
128
845
939
11053
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
-5.1e-01
6.5e-01
1.3e+00
—
1.2e+00
7.8e-01
5.7e-01
cases:2.66%
controls:4.35%
cases:5.09%
controls:2.73%
cases:1.82%
controls:0.48%
—
—
cases:1.63%
controls:0.48%
cases:5.90%
controls:2.81%
cases:12.00%
controls:7.14%
35
571
1282
12557
67
358
1250
12770
24
63
1293
13065
—
21
63
1269
13054
73
364
1165
12612
128
849
939
11049
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
-5.3e-01
6.6e-01
1.4e+00
—
1.2e+00
8.2e-01
5.7e-01
cases:2.66%
controls:4.42%
cases:5.16%
controls:2.73%
cases:1.82%
controls:0.47%
—
—
cases:1.63%
controls:0.52%
cases:6.22%
controls:2.85%
cases:12.18%
controls:7.29%
35
580
1282
12548
68
358
1249
12770
24
62
1293
13066
—
21
68
1269
13049
77
370
1161
12606
130
867
937
11031
Dentistry
C5 [903277]
6.4e-01
4.6e-01
—
—
2.1e+00
1.5e+00
8.9e-01
cases:2.28%
controls:1.21%
cases:0.76%
controls:0.48%
—
—
—
—
cases:0.62%
controls:0.08%
cases:1.78%
controls:0.39%
cases:3.19%
controls:1.34%
30
159
1287
12969
10
63
1307
13065
—
—
8
10
1282
13107
22
50
1216
12926
34
159
1033
11739
Intravenous general anesthesia
WX404 [2001310807]
-9.2e-03
8.8e-01
—
1.0e+50
2.9e+00
1.6e+00
7.1e-01
cases:1.29%
controls:1.30%
cases:0.91%
controls:0.38%
—
—
cases:0.91%
controls:0.00%
cases:0.70%
controls:0.04%
cases:1.29%
controls:0.26%
cases:1.31%
controls:0.65%
17
171
1300
12957
12
50
1305
13078
—
12
0
1305
13128
9
5
1281
13112
16
34
1222
12942
14
77
1053
11821
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
—
1.0e+00
—
—
2.3e+00
1.3e+00
8.7e-01
—
—
cases:0.61%
controls:0.22%
—
—
—
—
cases:0.47%
controls:0.05%
cases:0.89%
controls:0.24%
cases:1.87%
controls:0.79%
—
8
29
1309
13099
—
—
6
6
1284
13111
11
31
1227
12945
20
94
1047
11804
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
-4.3e-01
5.0e-01
2.0e+00
—
1.6e+00
8.7e-01
3.2e-01
cases:1.75%
controls:2.66%
cases:2.66%
controls:1.63%
cases:1.44%
controls:0.19%
—
—
cases:0.85%
controls:0.18%
cases:3.88%
controls:1.66%
cases:6.84%
controls:5.04%
23
349
1294
12779
35
214
1282
12914
19
25
1298
13103
—
11
23
1279
13094
48
215
1190
12761
73
600
994
11298
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
-5.4e-01
6.4e-01
1.3e+00
—
1.2e+00
8.1e-01
5.4e-01
cases:2.66%
controls:4.49%
cases:5.32%
controls:2.86%
cases:1.75%
controls:0.50%
—
—
cases:1.71%
controls:0.51%
cases:6.38%
controls:2.94%
cases:12.09%
controls:7.41%
35
589
1282
12539
70
376
1247
12752
23
65
1294
13063
—
22
67
1268
13050
79
381
1159
12595
129
882
938
11016
pH of Specimen
17433-4 [3019225]
-2.8e-01
5.6e-01
1.3e+00
—
2.6e+00
9.6e-01
9.4e-01
cases:0.76%
controls:1.00%
cases:0.99%
controls:0.56%
cases:0.38%
controls:0.10%
—
—
cases:0.70%
controls:0.05%
cases:1.45%
controls:0.56%
cases:3.37%
controls:1.34%
10
131
1307
12997
13
74
1304
13054
5
13
1312
13115
—
9
7
1281
13110
18
73
1220
12903
36
160
1031
11738
Thyroperoxidase Ab [Units/volume] in Serum or Plasma
8099-4 [3027238]
—
1.4e+00
—
—
—
1.8e+00
1.2e+00
—
—
cases:0.76%
controls:0.18%
—
—
—
—
—
—
cases:0.57%
controls:0.09%
cases:1.69%
controls:0.52%
—
10
24
1307
13104
—
—
—
7
12
1231
12964
18
62
1049
11836
Basophils/Leukocytes in Blood
30180-4 [3022096]
-5.0e-01
6.2e-01
1.3e+00
—
1.1e+00
7.6e-01
5.7e-01
cases:2.66%
controls:4.33%
cases:4.94%
controls:2.73%
cases:1.82%
controls:0.48%
—
—
cases:1.47%
controls:0.48%
cases:5.82%
controls:2.81%
cases:12.00%
controls:7.17%
35
568
1282
12560
65
358
1252
12770
24
63
1293
13065
—
19
63
1271
13054
72
364
1166
12612
128
853
939
11045
Excision of other lesion extending through all layers of skin in head or neck
QAE10 [2001309784]
2.2e+00
—
—
—
—
2.0e+00
2.2e+00
cases:1.82%
controls:0.21%
—
—
—
—
—
—
—
—
cases:0.40%
controls:0.05%
cases:1.69%
controls:0.18%
24
28
1293
13100
—
—
—
—
5
7
1233
12969
18
22
1049
11876
Pulmonary Disease
29 [38004472]
1.5e-01
6.7e-01
1.5e+00
—
1.2e+00
5.7e-01
5.2e-01
cases:8.58%
controls:7.46%
cases:7.37%
controls:3.90%
cases:2.96%
controls:0.71%
—
—
cases:1.86%
controls:0.59%
cases:7.03%
controls:4.11%
cases:15.37%
controls:9.77%
113
979
1204
12149
97
512
1220
12616
39
93
1278
13035
—
24
77
1266
13040
87
533
1151
12443
164
1162
903
10736
Other and unspecified ventral hernia without obstruction or gangrene
K43.9 [45533594]
6.9e-01
—
—
—
—
2.3e+00
2.0e+00
cases:0.53%
controls:0.27%
—
—
—
—
—
—
—
—
cases:0.81%
controls:0.08%
cases:2.91%
controls:0.39%
7
35
1310
13093
—
—
—
—
10
11
1228
12965
31
46
1036
11852
Very extensive body CT
JN4CD [2001310902]
1.1e+00
—
1.0e+50
1.0e+50
—
1.0e+50
4.3e+00
cases:0.38%
controls:0.13%
—
—
cases:1.75%
controls:0.00%
cases:0.38%
controls:0.00%
—
—
cases:1.78%
controls:0.00%
cases:3.00%
controls:0.04%
5
17
1312
13111
—
23
0
1294
13128
5
0
1312
13128
—
22
0
1216
12976
32
5
1035
11893
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
-9.9e-02
1.9e+00
—
—
—
1.4e+00
9.4e-01
cases:0.46%
controls:0.50%
cases:1.21%
controls:0.18%
—
—
—
—
—
—
cases:1.13%
controls:0.27%
cases:2.44%
controls:0.97%
6
66
1311
13062
16
24
1301
13104
—
—
—
14
35
1224
12941
26
115
1041
11783
Enzyme measurement
122444009 [4046263]
—
2.6e+00
—
—
—
1.4e+00
1.7e+00
—
—
cases:0.84%
controls:0.06%
—
—
—
—
—
—
cases:0.40%
controls:0.10%
cases:1.31%
controls:0.25%
—
11
8
1306
13120
—
—
—
5
13
1233
12963
14
30
1053
11868
Severe anaemia associated with chronic renal failure
138 [2001600134]
—
-1.0e+50
—
—
—
2.4e+00
1.9e+00
—
—
cases:0.00%
controls:0.04%
—
—
—
—
—
—
cases:0.48%
controls:0.05%
cases:1.03%
controls:0.15%
—
0
5
1317
13123
—
—
—
6
6
1232
12970
11
18
1056
11880
tranexamic acid; oral, parenteral
B02AA02 [21601036]
4.6e-01
1.8e+00
—
—
2.1e+00
1.5e+00
9.6e-01
cases:1.21%
controls:0.77%
cases:1.21%
controls:0.20%
—
—
—
—
cases:0.39%
controls:0.05%
cases:0.73%
controls:0.17%
cases:1.87%
controls:0.72%
16
101
1301
13027
16
26
1301
13102
—
—
5
6
1285
13111
9
22
1229
12954
20
86
1047
11812
Gas panel - Arterial blood
24336-0 [3019060]
-2.0e-01
3.1e-01
2.5e+00
—
—
1.8e+00
7.1e-01
cases:0.38%
controls:0.46%
cases:0.46%
controls:0.34%
cases:0.53%
controls:0.05%
—
—
—
—
cases:1.37%
controls:0.24%
cases:1.97%
controls:0.97%
5
61
1312
13067
6
44
1311
13084
7
6
1310
13122
—
—
17
31
1221
12945
21
116
1046
11782
Needle biopsy of prostate
TKE00 [2001306182]
1.3e+00
2.5e+00
—
—
—
—
1.7e+00
cases:0.76%
controls:0.20%
cases:0.53%
controls:0.05%
—
—
—
—
—
—
—
—
cases:1.41%
controls:0.25%
10
26
1307
13102
7
6
1310
13122
—
—
—
—
15
30
1052
11868
Pure hypercholesterolaemia
E78.01 [2000501514]
-3.6e-01
1.4e-01
1.9e+00
1.0e+50
2.3e+00
2.3e-01
-1.2e-03
cases:1.59%
controls:2.27%
cases:1.14%
controls:0.99%
cases:0.91%
controls:0.14%
cases:0.53%
controls:0.00%
cases:1.01%
controls:0.11%
cases:1.78%
controls:1.41%
cases:4.59%
controls:4.60%
21
298
1296
12830
15
130
1302
12998
12
18
1305
13110
7
0
1310
13128
13
14
1277
13103
22
183
1216
12793
49
547
1018
11351
Hydrocele, unspecified
N43.3 [45572714]
—
—
—
—
—
2.4e+00
1.8e+00
—
—
—
—
—
—
—
—
—
—
cases:0.40%
controls:0.04%
cases:0.84%
controls:0.14%
—
—
—
—
—
5
5
1233
12971
9
17
1058
11881
Gas panel - Venous blood
24339-4 [3000991]
4.3e-01
7.2e-01
—
1.0e+50
2.2e+00
2.0e+00
6.7e-01
cases:0.46%
controls:0.30%
cases:0.68%
controls:0.34%
—
—
cases:3.04%
controls:0.00%
cases:0.47%
controls:0.05%
cases:2.83%
controls:0.41%
cases:2.53%
controls:1.31%
6
39
1311
13089
9
44
1308
13084
—
40
0
1277
13128
6
7
1284
13110
35
53
1203
12923
27
156
1040
11742
calcium carbonate; oral
A12AA04 [21600863]
1.0e+00
1.4e+00
—
—
—
1.7e+00
2.4e+00
cases:0.46%
controls:0.17%
cases:0.53%
controls:0.13%
—
—
—
—
—
—
cases:0.89%
controls:0.17%
cases:2.53%
controls:0.24%
6
22
1311
13106
7
17
1310
13111
—
—
—
11
22
1227
12954
27
28
1040
11870
calcium carbonate
A02AC01 [21600065]
1.0e+00
1.4e+00
—
—
—
1.7e+00
2.4e+00
cases:0.46%
controls:0.17%
cases:0.53%
controls:0.13%
—
—
—
—
—
—
cases:0.89%
controls:0.17%
cases:2.53%
controls:0.24%
6
22
1311
13106
7
17
1310
13111
—
—
—
11
22
1227
12954
27
28
1040
11870
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
-1.9e-01
4.8e-02
2.6e+00
1.0e+50
—
1.4e+00
5.3e-01
cases:1.14%
controls:1.37%
cases:0.46%
controls:0.43%
cases:0.84%
controls:0.06%
cases:0.84%
controls:0.00%
—
—
cases:1.86%
controls:0.45%
cases:2.81%
controls:1.67%
15
180
1302
12948
6
57
1311
13071
11
8
1306
13120
11
0
1306
13128
—
23
59
1215
12917
30
199
1037
11699
Emergency Medicine
93 [38004510]
-5.9e-02
5.9e-01
1.5e+00
—
1.4e+00
5.1e-01
1.6e-01
cases:6.00%
controls:6.34%
cases:6.61%
controls:3.77%
cases:1.90%
controls:0.44%
—
—
cases:2.17%
controls:0.53%
cases:6.54%
controls:4.02%
cases:14.90%
controls:12.99%
79
832
1238
12296
87
495
1230
12633
25
58
1292
13070
—
28
69
1262
13048
81
521
1157
12455
159
1545
908
10353
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
-2.0e-01
5.7e-01
1.3e+00
—
1.0e+00
5.8e-01
5.0e-01
cases:7.67%
controls:9.22%
cases:8.43%
controls:4.93%
cases:2.58%
controls:0.70%
—
—
cases:1.86%
controls:0.67%
cases:8.97%
controls:5.23%
cases:21.56%
controls:14.27%
101
1211
1216
11917
111
647
1206
12481
34
92
1283
13036
—
24
88
1266
13029
111
679
1127
12297
230
1698
837
10200
Thorax extensive CT-examination
GD1BD [2001303621]
—
1.8e+00
—
—
—
2.2e+00
—
—
—
cases:0.53%
controls:0.09%
—
—
—
—
—
—
cases:0.48%
controls:0.05%
—
—
—
7
12
1310
13116
—
—
—
6
7
1232
12969
—
Acute tubulo-interstitial nephritis
N10 [45543856]
-7.7e-01
1.1e+00
—
—
2.8e+00
1.1e+00
3.3e-01
cases:0.46%
controls:0.98%
cases:1.06%
controls:0.34%
—
—
—
—
cases:0.85%
controls:0.05%
cases:0.97%
controls:0.32%
cases:2.34%
controls:1.69%
6
129
1311
12999
14
45
1303
13083
—
—
11
7
1279
13110
12
42
1226
12934
25
201
1042
11697
Weakness/tiredness general
A04 [2002000145]
-1.1e-01
1.4e+00
—
—
2.5e+00
8.4e-01
2.1e-01
cases:0.61%
controls:0.68%
cases:0.99%
controls:0.24%
—
—
—
—
cases:0.47%
controls:0.04%
cases:0.73%
controls:0.32%
cases:1.69%
controls:1.37%
8
89
1309
13039
13
32
1304
13096
—
—
6
5
1284
13112
9
41
1229
12935
18
163
1049
11735
Urate [Moles/volume] in Serum or Plasma
14933-6 [3026493]
2.4e-01
8.6e-01
1.3e+00
—
1.5e+00
8.3e-01
6.8e-01
cases:3.57%
controls:2.82%
cases:3.26%
controls:1.41%
cases:0.68%
controls:0.19%
—
—
cases:0.78%
controls:0.17%
cases:3.63%
controls:1.63%
cases:7.97%
controls:4.20%
47
370
1270
12758
43
185
1274
12943
9
25
1308
13103
—
10
22
1280
13095
45
211
1193
12765
85
500
982
11398
Bacteria identified in Isolate by Culture
43409-2 [3042936]
-1.9e-01
—
2.0e+00
—
1.9e+00
7.3e-01
6.3e-01
cases:0.84%
controls:1.01%
—
—
cases:0.46%
controls:0.06%
—
—
cases:0.54%
controls:0.08%
cases:1.13%
controls:0.55%
cases:3.19%
controls:1.72%
11
132
1306
12996
—
6
8
1311
13120
—
7
11
1283
13106
14
71
1224
12905
34
205
1033
11693
Pathology report gross observation
24419-4 [3002256]
5.3e-01
1.3e+00
—
1.0e+50
—
2.5e+00
1.3e+00
cases:0.76%
controls:0.45%
cases:0.76%
controls:0.20%
—
—
cases:1.29%
controls:0.00%
—
—
cases:1.37%
controls:0.12%
cases:2.81%
controls:0.76%
10
59
1307
13069
10
26
1307
13102
—
17
0
1300
13128
—
17
15
1221
12961
30
90
1037
11808
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
—
2.6e-01
—
—
2.3e+00
1.5e+00
4.9e-01
—
—
cases:0.46%
controls:0.35%
—
—
—
—
cases:0.54%
controls:0.05%
cases:1.70%
controls:0.39%
cases:2.81%
controls:1.75%
—
6
46
1311
13082
—
—
7
7
1283
13110
21
50
1217
12926
30
208
1037
11690
Idiopathic gout
M10.0 [45577131]
—
—
—
—
—
2.5e+00
1.3e+00
—
—
—
—
—
—
—
—
—
—
cases:0.48%
controls:0.04%
cases:1.41%
controls:0.40%
—
—
—
—
—
6
5
1232
12971
15
48
1052
11850
Chronic kidney disease, unspecified
N18.9 [45553438]
6.3e-01
8.7e-01
—
—
1.7e+00
1.8e+00
2.0e+00
cases:0.91%
controls:0.49%
cases:0.76%
controls:0.32%
—
—
—
—
cases:0.54%
controls:0.10%
cases:2.18%
controls:0.36%
cases:6.56%
controls:0.98%
12
64
1305
13064
10
42
1307
13086
—
—
7
13
1283
13104
27
47
1211
12929
70
117
997
11781
loperamide oxide; oral
A07DA05 [21600648]
—
—
—
—
—
2.2e+00
1.6e+00
—
—
—
—
—
—
—
—
—
—
cases:2.02%
controls:0.24%
cases:3.37%
controls:0.71%
—
—
—
—
—
25
31
1213
12945
36
84
1031
11814
loperamide; oral
A07DA03 [21600646]
—
—
—
—
—
2.2e+00
1.6e+00
—
—
—
—
—
—
—
—
—
—
cases:2.02%
controls:0.24%
cases:3.37%
controls:0.71%
—
—
—
—
—
25
31
1213
12945
36
84
1031
11814
alfacalcidol; oral, parenteral
A11CC03 [21600818]
1.7e+00
1.4e+00
—
—
—
1.3e+00
2.1e+00
cases:0.84%
controls:0.16%
cases:0.61%
controls:0.14%
—
—
—
—
—
—
cases:0.73%
controls:0.21%
cases:2.44%
controls:0.31%
11
21
1306
13107
8
19
1309
13109
—
—
—
9
27
1229
12949
26
37
1041
11861
Urinary tract ultrasound examination
KH1AE [2001306329]
—
1.9e+00
—
—
—
1.5e+00
1.7e+00
—
—
cases:0.68%
controls:0.10%
—
—
—
—
—
—
cases:0.57%
controls:0.12%
cases:2.06%
controls:0.37%
—
9
13
1308
13115
—
—
—
7
16
1231
12960
22
44
1045
11854
denosumab; parenteral
M05BX04 [21604169]
—
6.5e-01
—
—
—
2.3e+00
1.4e+00
—
—
cases:0.38%
controls:0.20%
—
—
—
—
—
—
cases:2.42%
controls:0.25%
cases:2.34%
controls:0.60%
—
5
26
1312
13102
—
—
—
30
33
1208
12943
25
71
1042
11827
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
4.4e-02
8.3e-01
1.7e+00
—
2.0e+00
1.3e+00
7.0e-01
cases:0.99%
controls:0.94%
cases:1.37%
controls:0.60%
cases:0.84%
controls:0.15%
—
—
cases:0.39%
controls:0.05%
cases:2.10%
controls:0.61%
cases:4.59%
controls:2.34%
13
124
1304
13004
18
79
1299
13049
11
20
1306
13108
—
5
7
1285
13110
26
79
1212
12897
49
279
1018
11619
Endocrinology
46 [38004485]
2.4e-01
5.0e-01
1.7e+00
—
1.2e+00
1.1e+00
8.3e-01
cases:2.13%
controls:1.68%
cases:1.44%
controls:0.88%
cases:0.99%
controls:0.18%
—
—
cases:0.47%
controls:0.14%
cases:2.50%
controls:0.83%
cases:4.40%
controls:1.98%
28
221
1289
12907
19
115
1298
13013
13
24
1304
13104
—
6
19
1284
13098
31
108
1207
12868
47
235
1020
11663
Other chronic renal failure
N18.8 [45534123]
—
—
—
—
—
1.8e+00
1.8e+00
—
—
—
—
—
—
—
—
—
—
cases:0.73%
controls:0.12%
cases:1.59%
controls:0.27%
—
—
—
—
—
9
16
1229
12960
17
32
1050
11866
EKG study
11524-6 [3013512]
-3.6e-01
2.5e-01
2.3e+00
—
1.3e+00
4.2e-01
3.4e-01
cases:2.73%
controls:3.88%
cases:3.04%
controls:2.39%
cases:2.58%
controls:0.27%
—
—
cases:1.01%
controls:0.29%
cases:3.88%
controls:2.59%
cases:9.28%
controls:6.82%
36
510
1281
12618
40
314
1277
12814
34
35
1283
13093
—
13
38
1277
13079
48
336
1190
12640
99
811
968
11087
Fractional oxyhemoglobin in Arterial blood
2714-4 [3014007]
7.4e-01
1.3e+00
—
1.0e+50
—
2.6e+00
9.7e-01
cases:0.61%
controls:0.29%
cases:0.76%
controls:0.21%
—
—
cases:5.16%
controls:0.00%
—
—
cases:2.67%
controls:0.21%
cases:2.34%
controls:0.90%
8
38
1309
13090
10
27
1307
13101
—
68
0
1249
13128
—
33
27
1205
12949
25
107
1042
11791
Case Management Agency
251B00000X [38004193]
1.1e-01
1.9e-01
7.0e-01
1.1e+00
8.9e-01
4.4e-01
3.8e-01
cases:44.87%
controls:42.25%
cases:37.59%
controls:33.33%
cases:22.48%
controls:12.63%
cases:2.13%
controls:0.69%
cases:25.19%
controls:12.14%
cases:46.20%
controls:35.71%
cases:63.45%
controls:54.35%
591
5546
726
7582
495
4375
822
8753
296
1658
1021
11470
28
90
1289
13038
325
1593
965
11524
572
4634
666
8342
677
6467
390
5431
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 [3029187]
-8.2e-02
6.0e-01
1.7e+00
—
6.2e-01
7.2e-01
5.0e-01
cases:2.58%
controls:2.80%
cases:3.26%
controls:1.81%
cases:1.21%
controls:0.22%
—
—
cases:0.47%
controls:0.25%
cases:3.63%
controls:1.80%
cases:9.93%
controls:6.25%
34
367
1283
12761
43
238
1274
12890
16
29
1301
13099
—
6
33
1284
13084
45
234
1193
12742
106
744
961
11154
Differential panel, method unspecified - Blood
69738-3 [42870588]
-4.6e-01
7.9e-01
1.3e+00
—
1.0e+00
8.3e-01
6.4e-01
cases:1.75%
controls:2.75%
cases:3.80%
controls:1.76%
cases:1.21%
controls:0.34%
—
—
cases:0.93%
controls:0.34%
cases:4.36%
controls:1.94%
cases:8.53%
controls:4.69%
23
361
1294
12767
50
231
1267
12897
16
45
1301
13083
—
12
45
1278
13072
54
252
1184
12724
91
558
976
11340
pH of Venous blood
2746-6 [3012544]
—
2.5e-01
2.0e+00
—
2.1e+00
1.4e+00
5.9e-01
—
—
cases:0.61%
controls:0.47%
cases:0.38%
controls:0.05%
—
—
cases:0.54%
controls:0.07%
cases:1.94%
controls:0.47%
cases:3.47%
controls:1.96%
—
8
62
1309
13066
5
7
1312
13121
—
7
9
1283
13108
24
61
1214
12915
37
233
1030
11665
Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 [3006217]
7.4e-01
1.2e+00
—
1.0e+50
—
2.5e+00
9.9e-01
cases:0.61%
controls:0.29%
cases:0.76%
controls:0.23%
—
—
cases:5.01%
controls:0.00%
—
—
cases:2.58%
controls:0.22%
cases:2.34%
controls:0.88%
8
38
1309
13090
10
30
1307
13098
—
66
0
1251
13128
—
32
28
1206
12948
25
105
1042
11793
Intravenous
ZX120 [2001311495]
—
5.1e-01
—
—
—
1.7e+00
1.8e+00
—
—
cases:0.38%
controls:0.23%
—
—
—
—
—
—
cases:1.13%
controls:0.20%
cases:2.72%
controls:0.48%
—
5
30
1312
13098
—
—
—
14
26
1224
12950
29
57
1038
11841
Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2030-5 [3028653]
7.4e-01
1.2e+00
—
1.0e+50
—
2.5e+00
9.4e-01
cases:0.61%
controls:0.29%
cases:0.76%
controls:0.22%
—
—
cases:5.16%
controls:0.00%
—
—
cases:2.67%
controls:0.22%
cases:2.34%
controls:0.92%
8
38
1309
13090
10
29
1307
13099
—
68
0
1249
13128
—
33
28
1205
12948
25
110
1042
11788
One hour or less
ZXE00 [2001311394]
1.2e-01
4.7e-01
1.9e+00
—
1.4e+00
7.5e-01
7.8e-01
cases:4.63%
controls:4.12%
cases:2.05%
controls:1.29%
cases:0.53%
controls:0.08%
—
—
cases:0.54%
controls:0.13%
cases:2.02%
controls:0.96%
cases:7.50%
controls:3.58%
61
541
1256
12587
27
169
1290
12959
7
10
1310
13118
—
7
17
1283
13100
25
125
1213
12851
80
426
987
11472
General Practice
1 [38004446]
-1.1e-01
3.0e-01
1.1e+00
—
1.8e+00
5.7e-01
1.9e-01
cases:9.57%
controls:10.57%
cases:6.53%
controls:4.91%
cases:2.20%
controls:0.74%
—
—
cases:3.88%
controls:0.69%
cases:8.48%
controls:4.96%
cases:18.74%
controls:16.02%
126
1387
1191
11741
86
645
1231
12483
29
97
1288
13031
—
50
91
1240
13026
105
644
1133
12332
200
1906
867
9992
lercanidipine; oral
C08CA13 [21601759]
5.0e-01
6.6e-01
1.2e+00
—
3.6e-01
7.1e-01
8.5e-01
cases:3.34%
controls:2.05%
cases:3.34%
controls:1.75%
cases:1.59%
controls:0.49%
—
—
cases:0.85%
controls:0.59%
cases:3.88%
controls:1.95%
cases:7.12%
controls:3.18%
44
269
1273
12859
44
230
1273
12898
21
64
1296
13064
—
11
78
1279
13039
48
253
1190
12723
76
378
991
11520
Clinic/Center
261Q00000X [38004207]
—
—
—
—
—
2.0e+00
1.4e+00
—
—
—
—
—
—
—
—
—
—
cases:0.65%
controls:0.08%
cases:1.22%
controls:0.31%
—
—
—
—
—
8
11
1230
12965
13
37
1054
11861
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
—
3.0e-01
2.0e+00
—
2.1e+00
1.3e+00
5.4e-01
—
—
cases:0.61%
controls:0.45%
cases:0.38%
controls:0.05%
—
—
cases:0.54%
controls:0.07%
cases:1.86%
controls:0.50%
cases:3.28%
controls:1.93%
—
8
59
1309
13069
5
7
1312
13121
—
7
9
1283
13108
23
65
1215
12911
35
230
1032
11668
Hyperplasia of prostate
N40 [45563015]
1.9e-01
9.3e-01
1.5e+00
—
7.4e-01
5.7e-01
4.2e-01
cases:4.40%
controls:3.68%
cases:4.02%
controls:1.63%
cases:1.52%
controls:0.35%
—
—
cases:0.54%
controls:0.26%
cases:3.39%
controls:1.95%
cases:9.09%
controls:6.16%
58
483
1259
12645
53
214
1264
12914
20
46
1297
13082
—
7
34
1283
13083
42
253
1196
12723
97
733
970
11165
Base excess in Venous blood by calculation
1927-3 [3002032]
—
2.9e-01
2.0e+00
—
2.1e+00
1.3e+00
5.5e-01
—
—
cases:0.61%
controls:0.46%
cases:0.38%
controls:0.05%
—
—
cases:0.54%
controls:0.07%
cases:1.78%
controls:0.49%
cases:3.28%
controls:1.92%
—
8
60
1309
13068
5
7
1312
13121
—
7
9
1283
13108
22
63
1216
12913
35
228
1032
11670
lactulose; oral
A06AD11 [21600571]
-3.8e-01
4.0e-03
6.9e-01
—
1.7e+00
1.1e+00
6.3e-01
cases:1.21%
controls:1.77%
cases:1.06%
controls:1.06%
cases:0.61%
controls:0.30%
—
—
cases:1.55%
controls:0.30%
cases:3.39%
controls:1.17%
cases:5.15%
controls:2.81%
16
232
1301
12896
14
139
1303
12989
8
40
1309
13088
—
20
39
1270
13078
42
152
1196
12824
55
334
1012
11564
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
-3.2e-03
8.2e-01
1.6e+00
—
2.1e+00
1.1e+00
6.0e-01
cases:1.06%
controls:1.07%
cases:1.44%
controls:0.64%
cases:0.84%
controls:0.17%
—
—
cases:0.39%
controls:0.05%
cases:2.02%
controls:0.67%
cases:4.59%
controls:2.57%
14
140
1303
12988
19
84
1298
13044
11
22
1306
13106
—
5
6
1285
13111
25
87
1213
12889
49
306
1018
11592
Protein [Mass/volume] in Serum or Plasma
2885-2 [3020630]
—
1.1e+00
—
—
—
1.4e+00
8.5e-01
—
—
cases:0.99%
controls:0.34%
—
—
—
—
—
—
cases:1.29%
controls:0.32%
cases:2.62%
controls:1.14%
—
13
44
1304
13084
—
—
—
16
42
1222
12934
28
136
1039
11762
Pulmonary embolism without mention of acute cor pulmonale
I26.9 [45552785]
—
1.6e+00
—
—
1.0e+50
1.7e+00
8.1e-01
—
—
cases:0.68%
controls:0.14%
—
—
—
—
cases:0.39%
controls:0.00%
cases:0.81%
controls:0.15%
cases:1.03%
controls:0.46%
—
9
18
1308
13110
—
—
5
0
1285
13117
10
19
1228
12957
11
55
1056
11843
Plastic And Reconstructive Surgery
24 [38004467]
1.3e+00
8.6e-01
—
—
—
1.1e+00
8.8e-01
cases:2.66%
controls:0.73%
cases:0.91%
controls:0.39%
—
—
—
—
—
—
cases:1.13%
controls:0.37%
cases:3.09%
controls:1.30%
35
96
1282
13032
12
51
1305
13077
—
—
—
14
48
1224
12928
33
155
1034
11743
Cathetrisation of artery
TPH07 [2001309747]
-2.5e-01
—
—
1.0e+50
—
2.4e+00
9.0e-01
cases:0.38%
controls:0.49%
—
—
—
—
cases:4.10%
controls:0.00%
—
—
cases:2.58%
controls:0.25%
cases:1.87%
controls:0.77%
5
64
1312
13064
—
—
54
0
1263
13128
—
32
32
1206
12944
20
92
1047
11806
Transanal ultrasonography
XJH00 [2001305132]
2.5e-01
1.3e+00
—
—
—
2.2e+00
1.1e+00
cases:0.61%
controls:0.47%
cases:0.61%
controls:0.16%
—
—
—
—
—
—
cases:0.89%
controls:0.10%
cases:1.50%
controls:0.52%
8
62
1309
13066
8
21
1309
13107
—
—
—
11
13
1227
12963
16
62
1051
11836
Potassium [Moles/volume] in Arterial blood
32713-0 [3043409]
5.4e-01
1.0e+00
—
1.0e+50
—
2.3e+00
9.9e-01
cases:0.38%
controls:0.22%
cases:0.38%
controls:0.14%
—
—
cases:2.05%
controls:0.00%
—
—
cases:0.89%
controls:0.09%
cases:1.41%
controls:0.53%
5
29
1312
13099
5
18
1312
13110
—
27
0
1290
13128
—
11
12
1227
12964
15
63
1052
11835
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
3.1e-02
5.1e-01
—
—
1.8e+00
1.4e+00
5.2e-01
cases:0.68%
controls:0.66%
cases:0.84%
controls:0.50%
—
—
—
—
cases:0.54%
controls:0.09%
cases:1.94%
controls:0.46%
cases:4.12%
controls:2.50%
9
87
1308
13041
11
66
1306
13062
—
—
7
12
1283
13105
24
60
1214
12916
44
297
1023
11601
metronidazole; oral, rectal
P01AB01 [21604857]
2.5e-01
6.7e-01
1.8e+00
—
1.6e+00
8.0e-01
6.3e-01
cases:5.69%
controls:4.49%
cases:2.20%
controls:1.14%
cases:0.68%
controls:0.11%
—
—
cases:0.47%
controls:0.09%
cases:2.83%
controls:1.29%
cases:8.34%
controls:4.61%
75
590
1242
12538
29
150
1288
12978
9
15
1308
13113
—
6
12
1284
13105
35
167
1203
12809
89
549
978
11349
Supine thorax X-ray examination
GD1QA [2001303648]
-1.4e-01
-6.2e-02
3.2e+00
—
2.1e+00
8.1e-01
3.0e-02
cases:1.06%
controls:1.22%
cases:0.38%
controls:0.40%
cases:1.29%
controls:0.05%
—
—
cases:0.39%
controls:0.05%
cases:1.37%
controls:0.62%
cases:2.72%
controls:2.64%
14
160
1303
12968
5
53
1312
13075
17
7
1300
13121
—
5
6
1285
13111
17
80
1221
12896
29
314
1038
11584
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
14928-6 [3026989]
-3.6e-02
4.6e-01
—
—
—
1.6e+00
1.6e+00
cases:0.46%
controls:0.47%
cases:0.46%
controls:0.29%
—
—
—
—
—
—
cases:1.21%
controls:0.24%
cases:2.44%
controls:0.52%
6
62
1311
13066
6
38
1311
13090
—
—
—
15
31
1223
12945
26
62
1041
11836
Excision of other lesion extending through all layers of skin of trunk
QBE10 [2001309853]
1.6e+00
—
—
—
—
—
1.6e+00
cases:0.91%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
cases:1.41%
controls:0.29%
12
24
1305
13104
—
—
—
—
—
15
35
1052
11863
Body temperature
8310-5 [3020891]
4.4e-01
1.1e+00
—
1.0e+50
—
2.1e+00
1.1e+00
cases:0.38%
controls:0.24%
cases:0.61%
controls:0.20%
—
—
cases:2.13%
controls:0.00%
—
—
cases:1.37%
controls:0.17%
cases:2.34%
controls:0.82%
5
32
1312
13096
8
26
1309
13102
—
28
0
1289
13128
—
17
22
1221
12954
25
98
1042
11800
Lactate [Moles/volume] in Arterial blood
2518-9 [3018405]
5.1e-01
6.5e-01
—
1.0e+50
—
2.1e+00
1.1e+00
cases:0.38%
controls:0.23%
cases:0.38%
controls:0.20%
—
—
cases:2.05%
controls:0.00%
—
—
cases:0.97%
controls:0.12%
cases:1.78%
controls:0.61%
5
30
1312
13098
5
26
1312
13102
—
27
0
1290
13128
—
12
16
1226
12960
19
72
1048
11826
macrogol; oral
A06AD15 [21600575]
-3.3e-01
—
—
—
2.1e+00
1.1e+00
3.7e-01
cases:0.38%
controls:0.53%
—
—
—
—
—
—
cases:0.62%
controls:0.08%
cases:1.21%
controls:0.42%
cases:1.69%
controls:1.18%
5
69
1312
13059
—
—
—
8
10
1282
13107
15
55
1223
12921
18
140
1049
11758
Thorax CT examination
GD1AD [2001303618]
—
—
—
—
—
1.8e+00
1.3e+00
—
—
—
—
—
—
—
—
—
—
cases:0.57%
controls:0.09%
cases:1.22%
controls:0.34%
—
—
—
—
—
7
12
1231
12964
13
40
1054
11858
Fever, unspecified
R50.9 [45582716]
-2.4e-01
1.0e+00
—
—
—
1.9e+00
1.2e+00
cases:0.53%
controls:0.68%
cases:0.91%
controls:0.33%
—
—
—
—
—
—
cases:1.29%
controls:0.20%
cases:4.31%
controls:1.29%
7
89
1310
13039
12
43
1305
13085
—
—
—
16
26
1222
12950
46
154
1021
11744
Flexible bronchoscopy
UGC12 [2001303610]
1.7e-02
1.9e+00
—
—
—
1.6e+00
1.2e+00
cases:0.38%
controls:0.37%
cases:0.84%
controls:0.13%
—
—
—
—
—
—
cases:0.57%
controls:0.12%
cases:1.50%
controls:0.45%
5
49
1312
13079
11
17
1306
13111
—
—
—
7
15
1231
12961
16
53
1051
11845
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
-5.3e-02
3.5e-01
1.1e+00
1.9e+00
1.2e+00
3.9e-01
2.1e-01
cases:16.63%
controls:17.38%
cases:18.30%
controls:13.58%
cases:6.61%
controls:2.20%
cases:0.46%
controls:0.07%
cases:6.51%
controls:2.13%
cases:20.52%
controls:14.86%
cases:33.74%
controls:29.13%
219
2282
1098
10846
241
1783
1076
11345
87
289
1230
12839
6
9
1311
13119
84
279
1206
12838
254
1928
984
11048
360
3466
707
8432
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
-2.6e-01
4.5e-01
1.5e+00
—
1.1e+00
3.6e-01
1.3e-01
cases:5.47%
controls:6.95%
cases:5.09%
controls:3.30%
cases:1.97%
controls:0.46%
—
—
cases:1.16%
controls:0.38%
cases:4.68%
controls:3.31%
cases:11.90%
controls:10.62%
72
913
1245
12215
67
433
1250
12695
26
61
1291
13067
—
15
50
1275
13067
58
430
1180
12546
127
1263
940
10635
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
6.0e-01
7.6e-01
6.3e-01
—
4.8e-01
1.0e+00
6.7e-01
cases:6.30%
controls:3.56%
cases:3.26%
controls:1.56%
cases:0.68%
controls:0.37%
—
—
cases:0.54%
controls:0.34%
cases:3.88%
controls:1.46%
cases:8.90%
controls:4.78%
83
467
1234
12661
43
205
1274
12923
9
48
1308
13080
—
7
44
1283
13073
48
190
1190
12786
95
569
972
11329
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
-8.1e-01
8.4e-02
3.0e+00
—
1.9e+00
7.4e-01
6.3e-01
cases:0.38%
controls:0.85%
cases:0.46%
controls:0.42%
cases:1.06%
controls:0.05%
—
—
cases:0.39%
controls:0.06%
cases:0.89%
controls:0.42%
cases:2.34%
controls:1.26%
5
111
1312
13017
6
55
1311
13073
14
7
1303
13121
—
5
8
1285
13109
11
55
1227
12921
25
150
1042
11748
Panorama tomography of teeth and jaws or similar X-ray examination
EB1HA [2001301913]
-2.0e-01
3.6e-01
1.2e+00
—
2.1e+00
8.4e-01
3.2e-01
cases:2.96%
controls:3.60%
cases:1.75%
controls:1.23%
cases:0.46%
controls:0.14%
—
—
cases:0.78%
controls:0.09%
cases:2.26%
controls:0.99%
cases:6.00%
controls:4.44%
39
472
1278
12656
23
161
1294
12967
6
18
1311
13110
—
10
12
1280
13105
28
128
1210
12848
64
528
1003
11370
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
-5.9e-01
5.9e-01
1.0e+00
—
2.1e+00
9.1e-01
2.1e-01
cases:1.90%
controls:3.36%
cases:2.81%
controls:1.58%
cases:0.84%
controls:0.30%
—
—
cases:1.01%
controls:0.13%
cases:3.88%
controls:1.60%
cases:6.19%
controls:5.06%
25
441
1292
12687
37
208
1280
12920
11
40
1306
13088
—
13
17
1277
13100
48
207
1190
12769
66
602
1001
11296
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
-1.5e-01
6.8e-01
1.8e+00
—
1.1e+00
5.5e-01
4.4e-01
cases:3.49%
controls:4.03%
cases:4.02%
controls:2.08%
cases:1.67%
controls:0.27%
—
—
cases:0.93%
controls:0.30%
cases:3.63%
controls:2.13%
cases:10.78%
controls:7.24%
46
529
1271
12599
53
273
1264
12855
22
35
1295
13093
—
12
39
1278
13078
45
277
1193
12699
115
862
952
11036
Protein [Presence] in Urine by Test strip
20454-5 [3014051]
-1.4e-01
8.2e-01
2.1e+00
—
1.3e+00
6.0e-01
1.4e-02
cases:1.59%
controls:1.84%
cases:2.73%
controls:1.22%
cases:1.14%
controls:0.14%
—
—
cases:0.62%
controls:0.18%
cases:2.67%
controls:1.49%
cases:5.15%
controls:5.08%
21
241
1296
12887
36
160
1281
12968
15
19
1302
13109
—
8
23
1282
13094
33
193
1205
12783
55
605
1012
11293
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
5.7e-01
1.0e+00
—
—
—
1.2e+00
1.7e+00
cases:1.82%
controls:1.04%
cases:1.06%
controls:0.39%
—
—
—
—
—
—
cases:1.05%
controls:0.33%
cases:3.56%
controls:0.65%
24
136
1293
12992
14
51
1303
13077
—
—
—
13
43
1225
12933
38
77
1029
11821
FEV1
20150-9 [3024653]
5.7e-01
1.0e+00
—
—
—
1.2e+00
1.7e+00
cases:1.82%
controls:1.04%
cases:1.06%
controls:0.39%
—
—
—
—
—
—
cases:1.05%
controls:0.33%
cases:3.56%
controls:0.65%
24
136
1293
12992
14
51
1303
13077
—
—
—
13
43
1225
12933
38
77
1029
11821
FEV1/FVC
19926-5 [3011505]
5.7e-01
1.0e+00
—
—
—
1.2e+00
1.7e+00
cases:1.82%
controls:1.04%
cases:1.06%
controls:0.39%
—
—
—
—
—
—
cases:1.05%
controls:0.33%
cases:3.56%
controls:0.65%
24
136
1293
12992
14
51
1303
13077
—
—
—
13
43
1225
12933
38
77
1029
11821
allopurinol; oral, parenteral
M04AA01 [21604131]
5.9e-01
8.0e-01
2.9e-01
—
7.0e-01
5.5e-01
9.6e-01
cases:4.78%
controls:2.70%
cases:4.25%
controls:1.96%
cases:0.68%
controls:0.51%
—
—
cases:1.01%
controls:0.50%
cases:4.04%
controls:2.38%
cases:9.28%
controls:3.77%
63
355
1254
12773
56
257
1261
12871
9
67
1308
13061
—
13
66
1277
13051
50
309
1188
12667
99
449
968
11449
Bacterial infection, unspecified
A49.9 [45590816]
4.5e-01
5.1e-01
—
—
—
1.7e+00
1.2e+00
cases:0.84%
controls:0.53%
cases:0.46%
controls:0.27%
—
—
—
—
—
—
cases:1.13%
controls:0.21%
cases:3.37%
controls:1.08%
11
70
1306
13058
6
36
1311
13092
—
—
—
14
27
1224
12949
36
128
1031
11770
FEV1 percent change
69983-5 [42868472]
4.5e-01
1.0e+00
—
—
—
1.3e+00
1.6e+00
cases:1.44%
controls:0.93%
cases:0.84%
controls:0.30%
—
—
—
—
—
—
cases:0.97%
controls:0.26%
cases:2.53%
controls:0.55%
19
122
1298
13006
11
39
1306
13089
—
—
—
12
34
1226
12942
27
65
1040
11833
FEV1/FVC --post bronchodilation
69970-2 [42868459]
4.5e-01
1.0e+00
—
—
—
1.3e+00
1.6e+00
cases:1.44%
controls:0.93%
cases:0.84%
controls:0.30%
—
—
—
—
—
—
cases:0.97%
controls:0.26%
cases:2.53%
controls:0.55%
19
122
1298
13006
11
39
1306
13089
—
—
—
12
34
1226
12942
27
65
1040
11833
FEV1 --post bronchodilation
20155-8 [3023550]
4.5e-01
1.0e+00
—
—
—
1.3e+00
1.6e+00
cases:1.44%
controls:0.93%
cases:0.84%
controls:0.30%
—
—
—
—
—
—
cases:0.97%
controls:0.26%
cases:2.53%
controls:0.55%
19
122
1298
13006
11
39
1306
13089
—
—
—
12
34
1226
12942
27
65
1040
11833
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
4.5e-01
1.0e+00
—
—
—
1.3e+00
1.6e+00
cases:1.44%
controls:0.93%
cases:0.84%
controls:0.30%
—
—
—
—
—
—
cases:0.97%
controls:0.26%
cases:2.53%
controls:0.55%
19
122
1298
13006
11
39
1306
13089
—
—
—
12
34
1226
12942
27
65
1040
11833
FVC percent change Respiratory system
69982-7 [42868471]
4.5e-01
1.0e+00
—
—
—
1.3e+00
1.6e+00
cases:1.44%
controls:0.93%
cases:0.84%
controls:0.30%
—
—
—
—
—
—
cases:0.97%
controls:0.26%
cases:2.53%
controls:0.55%
19
122
1298
13006
11
39
1306
13089
—
—
—
12
34
1226
12942
27
65
1040
11833
Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
38917-1 [3042194]
—
—
—
—
—
2.8e+00
7.7e-01
—
—
—
—
—
—
—
—
—
—
cases:0.65%
controls:0.04%
cases:0.47%
controls:0.22%
—
—
—
—
—
8
5
1230
12971
5
26
1062
11872
Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
3209-4 [3019250]
—
—
—
—
—
2.8e+00
—
—
—
—
—
—
—
—
—
—
—
cases:0.65%
controls:0.04%
—
—
—
—
—
—
—
8
5
1230
12971
—
Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
27811-9 [3000515]
—
—
—
—
—
2.8e+00
5.3e-01
—
—
—
—
—
—
—
—
—
—
cases:0.65%
controls:0.04%
cases:0.47%
controls:0.28%
—
—
—
—
—
8
5
1230
12971
5
33
1062
11865
ondansetron; oral, parenteral, rectal
A04AA01 [21600493]
—
—
—
—
—
—
2.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.78%
controls:0.11%
—
—
—
—
—
—
19
13
1048
11885
Follitropin [Units/volume] in Serum or Plasma by Immunoassay
83098-4 [42529215]
-1.0e+50
—
—
—
—
—
2.8e+00
cases:0.00%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
cases:0.94%
controls:0.06%
0
9
1317
13119
—
—
—
—
—
10
7
1057
11891
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
D38.1 [45605357]
-1.0e+50
—
1.0e+50
—
1.0e+50
—
2.8e+00
cases:0.00%
controls:0.05%
—
—
cases:0.38%
controls:0.00%
—
—
cases:0.39%
controls:0.00%
—
—
cases:0.94%
controls:0.06%
0
6
1317
13122
—
5
0
1312
13128
—
5
0
1285
13117
—
10
7
1057
11891
Other disorders resulting from impaired renal tubular function
N25.8 [45582397]
—
—
—
—
—
—
2.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.66%
controls:0.04%
—
—
—
—
—
—
7
5
1060
11893
CT of urinary organs
KH1AD [2001306328]
-1.0e+50
2.7e+00
1.0e+50
—
—
—
—
cases:0.00%
controls:0.04%
cases:0.68%
controls:0.05%
cases:0.61%
controls:0.00%
—
—
—
—
—
—
—
—
0
5
1317
13123
9
6
1308
13122
8
0
1309
13128
—
—
—
—
Laparoscopic repair of incisional hernia
JAD11 [2001304419]
—
—
—
—
—
—
2.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.75%
controls:0.05%
—
—
—
—
—
—
8
6
1059
11892
ketoprofen; oral, parenteral, rectal
M01AE03 [21603969]
6.0e-02
3.4e-01
1.2e+00
—
1.5e+00
4.6e-01
1.4e-02
cases:6.76%
controls:6.39%
cases:2.89%
controls:2.08%
cases:0.99%
controls:0.31%
—
—
cases:1.40%
controls:0.30%
cases:3.23%
controls:2.07%
cases:5.53%
controls:5.45%
89
839
1228
12289
38
273
1279
12855
13
41
1304
13087
—
18
40
1272
13077
40
268
1198
12708
59
649
1008
11249
codeine and paracetamol
N02AJ06 [1123647]
2.3e-01
1.9e-01
9.7e-01
—
1.2e+00
4.2e-01
4.9e-01
cases:9.72%
controls:7.90%
cases:4.02%
controls:3.34%
cases:1.67%
controls:0.64%
—
—
cases:2.02%
controls:0.63%
cases:4.85%
controls:3.23%
cases:15.09%
controls:9.82%
128
1037
1189
12091
53
438
1264
12690
22
84
1295
13044
—
26
82
1264
13035
60
419
1178
12557
161
1168
906
10730
Examination and observation for other specified reasons
Z04.8 [45552063]
3.1e-01
8.0e-01
2.6e+00
—
—
9.7e-01
5.1e-01
cases:1.06%
controls:0.78%
cases:0.61%
controls:0.27%
cases:0.53%
controls:0.04%
—
—
—
—
cases:0.65%
controls:0.25%
cases:2.06%
controls:1.25%
14
103
1303
13025
8
36
1309
13092
7
5
1310
13123
—
—
8
32
1230
12944
22
149
1045
11749
Pharmacy visit
OMOP4822462 [581458]
5.1e-02
4.2e-01
6.9e-01
2.1e-01
9.2e-01
6.1e-01
4.6e-01
cases:83.07%
controls:82.34%
cases:82.92%
controls:76.10%
cases:59.15%
controls:42.19%
cases:2.66%
controls:2.16%
cases:65.12%
controls:42.61%
cases:87.16%
controls:78.68%
cases:94.47%
controls:91.54%
1094
10810
223
2318
1092
9990
225
3138
779
5539
538
7589
35
283
1282
12845
840
5589
450
7528
1079
10210
159
2766
1008
10892
59
1006
tamsulosin; oral
G04CA02 [21602669]
1.7e-01
3.0e-01
6.2e-01
—
1.3e+00
8.2e-01
5.0e-01
cases:6.45%
controls:5.50%
cases:5.16%
controls:3.88%
cases:1.67%
controls:0.91%
—
—
cases:4.03%
controls:1.14%
cases:8.56%
controls:3.98%
cases:12.56%
controls:8.02%
85
722
1232
12406
68
510
1249
12618
22
119
1295
13009
—
52
149
1238
12968
106
516
1132
12460
134
954
933
10944
sevelamer; oral
V03AE02 [21605265]
—
—
—
—
—
—
2.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.56%
controls:0.04%
—
—
—
—
—
—
6
5
1061
11893
furosemide; oral, parenteral
C03CA01 [21601518]
2.2e-01
4.2e-01
4.3e-01
—
8.5e-01
7.0e-01
6.3e-01
cases:7.44%
controls:6.06%
cases:7.67%
controls:5.20%
cases:2.05%
controls:1.34%
—
—
cases:3.10%
controls:1.35%
cases:10.90%
controls:5.73%
cases:17.43%
controls:10.09%
98
795
1219
12333
101
682
1216
12446
27
176
1290
12952
—
40
177
1250
12940
135
744
1103
12232
186
1201
881
10697
Excision of hydrocele of testis
KFD20 [2001306210]
—
-1.0e+50
—
—
—
—
2.6e+00
—
—
cases:0.00%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.66%
controls:0.05%
—
0
5
1317
13123
—
—
—
—
7
6
1060
11892
Rectal ultrasound examination of prostate
KE1BE [2001306106]
-2.7e-01
1.1e+00
—
—
-1.0e+50
1.5e+00
1.1e+00
cases:0.46%
controls:0.59%
cases:0.68%
controls:0.22%
—
—
—
—
cases:0.00%
controls:0.04%
cases:0.73%
controls:0.17%
cases:2.44%
controls:0.84%
6
78
1311
13050
9
29
1308
13099
—
—
0
5
1290
13112
9
22
1229
12954
26
100
1041
11798
Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29257-3 [3002482]
—
—
—
—
—
2.5e+00
1.1e+00
—
—
—
—
—
—
—
—
—
—
cases:0.48%
controls:0.04%
cases:0.47%
controls:0.16%
—
—
—
—
—
6
5
1232
12971
5
19
1062
11879
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
-6.1e-02
3.9e-01
1.3e+00
—
1.2e+00
3.7e-01
2.2e-01
cases:4.33%
controls:4.59%
cases:3.49%
controls:2.40%
cases:1.82%
controls:0.48%
—
—
cases:1.32%
controls:0.41%
cases:3.63%
controls:2.55%
cases:8.81%
controls:7.18%
57
602
1260
12526
46
315
1271
12813
24
63
1293
13065
—
17
54
1273
13063
45
331
1193
12645
94
854
973
11044
Very extensive MRI examination of upper part of abdomen with high intensity magnet
JN1DG [2001305530]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.03%
controls:0.08%
—
—
—
—
—
—
11
10
1056
11888
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
3255-7 [3016407]
—
—
—
—
—
2.5e+00
6.8e-01
—
—
—
—
—
—
—
—
—
—
cases:0.57%
controls:0.05%
cases:0.56%
controls:0.29%
—
—
—
—
—
7
6
1231
12970
6
34
1061
11864
pantoprazole; oral, parenteral
A02BC02 [21600097]
1.5e-02
3.2e-01
7.1e-01
-1.0e+50
8.6e-01
4.9e-01
4.5e-01
cases:11.54%
controls:11.39%
cases:9.19%
controls:6.86%
cases:3.11%
controls:1.56%
cases:0.00%
controls:0.07%
cases:3.72%
controls:1.61%
cases:10.99%
controls:7.04%
cases:22.02%
controls:15.31%
152
1495
1165
11633
121
900
1196
12228
41
205
1276
12923
0
9
1317
13119
48
211
1242
12906
136
914
1102
12062
235
1821
832
10077
Thoracic and Cardiac Surgery
OMOP4822009 [45756830]
8.8e-02
9.9e-01
—
—
—
1.5e+00
7.0e-01
cases:1.14%
controls:1.04%
cases:1.14%
controls:0.43%
—
—
—
—
—
—
cases:1.05%
controls:0.24%
cases:1.69%
controls:0.85%
15
137
1302
12991
15
56
1302
13072
—
—
—
13
31
1225
12945
18
101
1049
11797
Thrombin time
3243-3 [3036489]
—
—
—
—
—
2.5e+00
2.2e-01
—
—
—
—
—
—
—
—
—
—
cases:0.73%
controls:0.06%
cases:0.47%
controls:0.38%
—
—
—
—
—
9
8
1229
12968
5
45
1062
11853
esomeprazole; oral, parenteral
A02BC05 [21600100]
3.7e-01
5.7e-01
1.0e+00
-1.0e+50
5.7e-01
4.2e-01
5.2e-01
cases:8.28%
controls:5.87%
cases:5.85%
controls:3.40%
cases:2.05%
controls:0.75%
cases:0.00%
controls:0.05%
cases:1.40%
controls:0.79%
cases:5.09%
controls:3.40%
cases:11.62%
controls:7.27%
109
770
1208
12358
77
447
1240
12681
27
99
1290
13029
0
6
1317
13122
18
104
1272
13013
63
441
1175
12535
124
865
943
11033
Emergency Room - Hospital
23 [8870]
—
2.5e+00
—
—
—
—
1.6e+00
—
—
cases:0.53%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.66%
controls:0.13%
—
7
6
1310
13122
—
—
—
—
7
16
1060
11882
Haematuria
U06 [2002001141]
-1.0e+50
2.5e+00
—
—
—
—
—
cases:0.00%
controls:0.10%
cases:0.53%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
0
13
1317
13115
7
6
1310
13122
—
—
—
—
—
Aortic (valve) stenosis
I35.0 [45576869]
2.0e-01
7.8e-01
2.5e+00
—
—
9.5e-01
2.5e-01
cases:0.76%
controls:0.62%
cases:0.76%
controls:0.35%
cases:0.53%
controls:0.05%
—
—
—
—
cases:1.05%
controls:0.41%
cases:1.50%
controls:1.17%
10
82
1307
13046
10
46
1307
13082
7
6
1310
13122
—
—
13
53
1225
12923
16
139
1051
11759
Cough
R05 [45606792]
2.2e-01
9.2e-01
2.5e+00
—
—
4.1e-01
1.2e-01
cases:1.97%
controls:1.59%
cases:1.14%
controls:0.46%
cases:0.53%
controls:0.05%
—
—
—
—
cases:0.81%
controls:0.54%
cases:2.62%
controls:2.34%
26
209
1291
12919
15
60
1302
13068
7
6
1310
13122
—
—
10
70
1228
12906
28
279
1039
11619
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
T81.0 [45599741]
9.8e-01
1.3e+00
—
—
—
2.5e+00
1.1e+00
cases:0.91%
controls:0.34%
cases:0.46%
controls:0.13%
—
—
—
—
—
—
cases:0.89%
controls:0.08%
cases:1.03%
controls:0.34%
12
45
1305
13083
6
17
1311
13111
—
—
—
11
10
1227
12966
11
41
1056
11857
Biopsy of skin and subcutaneous tissue
TQX10 [2001310152]
1.1e+00
1.3e+00
—
—
—
1.4e+00
1.4e+00
cases:1.21%
controls:0.41%
cases:0.53%
controls:0.15%
—
—
—
—
—
—
cases:0.57%
controls:0.15%
cases:1.97%
controls:0.51%
16
54
1301
13074
7
20
1310
13108
—
—
—
7
19
1231
12957
21
61
1046
11837
pivmecillinam; oral
J01CA08 [21602827]
-9.5e-03
6.6e-01
1.3e+00
—
9.8e-01
4.0e-01
4.7e-01
cases:5.24%
controls:5.29%
cases:3.95%
controls:2.09%
cases:0.84%
controls:0.23%
—
—
cases:0.47%
controls:0.18%
cases:3.07%
controls:2.07%
cases:10.03%
controls:6.50%
69
694
1248
12434
52
274
1265
12854
11
30
1306
13098
—
6
23
1284
13094
38
269
1200
12707
107
773
960
11125
End-stage renal disease
N18.0 [45601717]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.03%
controls:0.09%
—
—
—
—
—
—
11
11
1056
11887
Renal osteodystrophy
N25.0 [45567833]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.84%
controls:0.08%
—
—
—
—
—
—
9
9
1058
11889
Extensive written report from radiologist
XX1XW [2001311008]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.56%
controls:0.05%
—
—
—
—
—
—
6
6
1061
11892
Lymphocytes/Leukocytes in Pleural fluid
26481-2 [3005532]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.56%
controls:0.05%
—
—
—
—
—
—
6
6
1061
11892

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
239
236
12.11
219.65
1.3
1.3
—
—
—
0
0
289
1045
3.25
61.88
10.3
5.7
11.71
11.61
mmol/l
0.08
273
981
346
1485
2.79
53.82
9.4
4.7
1.10
1.02
mmol/l
4.23
323
1342
190
576
3.68
53.27
2.8
1.4
13.63
2.82
ug/l
0.99
156
437
530
2834
2.44
51.92
2.5
1.7
—
—
—
0
0
137
364
4.08
46.17
3.4
2.6
628.26
292.69
mg/l
0.71
99
126
212
781
3.04
42.94
7.5
8.3
1.16
1.31
%
1.14
212
774
192
683
3.11
41.25
1.4
1.1
—
—
—
0
0
289
1299
2.56
39.75
6.7
6.8
95.74
94.82
%
1.24
283
1253
55
76
7.50
37.92
1.7
1.6
49.51
23.08
ng/l
2.01
55
76
671
4388
2.06
36.27
3.3
2.4
—
—
estimate
—
0
0
502
3033
2.05
32.91
3.0
2.2
—
—
—
0
0
701
4766
1.99
32.82
7.8
3.9
34.25
34.94
g/l
2.47
666
4379
292
1456
2.29
31.15
6.7
6.6
7.40
7.42
ph
3.63
158
855
292
1458
2.28
31.04
6.8
6.6
5.22
5.06
kpa
2.04
286
1398
292
1458
2.28
31.04
6.8
6.6
12.87
11.14
kpa
6.47
285
1395
226
1008
2.49
31.01
9.6
7.5
—
—
—
0
0
290
1452
2.27
30.58
6.7
6.6
0.16
1.14
mmol/l
3.97
241
1172
207
897
2.55
30.14
5.9
3.6
140.10
93.20
ng/l
4.71
184
753
548
3577
1.90
27.46
4.7
3.4
103.86
88.16
e6/l
0.10
461
2764
703
4996
1.86
26.70
11.9
5.5
1.21
1.21
mmol/l
0.52
673
4505
421
2540
1.96
26.56
3.5
2.7
3.42
4.91
e6/l
3.51
395
2307
719
5173
1.84
25.97
11.6
3.8
11.16
12.63
umol/l
1.26
694
4861
308
1676
2.09
25.87
4.6
2.4
0.81
0.82
mmol/l
0.53
295
1544
729
5336
1.80
24.21
13.5
5.9
4.40
4.49
e9/l
0.36
641
4530
469
3038
1.84
23.13
4.3
3.3
0.24
0.43
e6/l
1.92
384
2268
74
209
3.69
22.71
2.6
1.8
35143.73
37.95
u/ml
0.52
65
162
743
5589
1.74
21.34
14.2
5.9
1.21
1.21
mmol/l
0.08
650
4773
564
3962
1.73
20.45
5.5
3.9
81.23
115.04
e6/l
0.55
460
2839
483
3269
1.75
19.86
8.2
3.3
7.39
7.40
ph
4.47
387
2364
512
3529
1.73
19.68
6.1
2.1
2.37
2.35
mmol/l
1.74
485
3058
482
3285
1.73
19.18
5.1
4.2
—
—
—
0
0
183
909
2.17
19.06
5.4
1.7
411.90
381.16
nmol/l
1.18
176
823
863
6887
1.71
18.90
6.7
5.0
96.05
3137.73
e6/l
2.32
20
132
53
138
3.96
18.26
1.3
1.3
22.46
8.32
u/l
3.36
41
108
302
1817
1.85
18.21
4.2
2.5
2.08
2.25
g/l
6.52
283
1664
283
1674
1.88
17.99
4.4
2.6
20.03
22.07
%
2.14
266
1544
308
1885
1.82
17.50
3.7
3.0
0.80
1.19
e6/l
2.34
183
1032
97
377
2.70
17.38
2.4
1.9
—
—
—
0
0
314
1955
1.79
16.77
4.2
2.5
10.54
12.39
umol/l
5.52
293
1798
935
7752
1.68
16.47
14.9
5.6
82.10
78.74
u/l
1.65
908
7175
74
256
3.00
16.44
3.0
2.6
1.90
1.81
mg/l
0.35
66
219
464
3345
1.59
13.77
4.3
2.3
69.96
61.39
u/l
0.93
439
3074
406
2844
1.61
13.55
4.3
2.5
388.95
365.22
umol/l
4.45
354
2397
151
792
2.02
13.47
4.4
4.4
—
—
—
0
0
691
5475
1.54
13.36
20.5
20.1
1.32
1.40
inr
2.84
589
4640
320
2148
1.64
12.54
4.1
2.9
504.71
528.58
mosm/kgh2o
1.43
288
1863
441
3203
1.56
12.39
6.6
4.1
0.00
0.00
estimate
0.50
141
1000
266
1713
1.69
12.20
4.0
3.1
1.98
1.97
e6/l
0.01
142
854
214
1305
1.76
11.92
6.2
3.1
5.73
5.84
kpa
0.92
209
1260
28
63
4.52
11.69
1.3
1.1
—
—
—
0
0
215
1320
1.75
11.69
6.0
3.2
7.37
7.38
ph
1.73
141
785
129
679
2.00
11.37
8.0
7.9
24.20
24.80
mmol/l
1.23
129
673
774
6409
1.49
11.31
7.3
4.8
6.95
6.91
mmol/l
0.22
752
6110
473
3546
1.52
11.26
3.7
3.5
—
—
—
0
0
207
1273
1.74
11.16
6.6
3.1
0.69
1.93
mmol/l
5.62
170
1090
152
854
1.88
11.05
2.1
1.9
0.22
0.19
g/l
3.95
136
772
59
226
2.68
10.92
5.1
1.5
52.61
28.06
u/ml
0.71
54
219
38
113
3.43
10.87
2.1
1.9
1.65
1.72
g/24h
0.04
23
65
323
2255
1.57
10.53
5.6
2.2
2.49
2.45
mmol/l
7.35
295
1963
672
5476
1.46
10.22
6.3
4.1
0.00
0.00
estimate
-0.00
156
1109
23
50
4.66
10.02
1.3
1.2
—
—
—
0
0
682
5588
1.45
9.98
6.5
4.1
0.00
0.02
estimate
2.09
156
1064
625
5058
1.44
9.67
6.8
5.3
1.82
1.80
e9/l
0.17
544
4371
632
5136
1.44
9.50
6.7
5.4
0.22
0.20
e9/l
0.66
545
4393
675
5564
1.43
9.31
6.4
4.1
0.00
0.00
estimate
0.50
162
1147
615
4987
1.43
9.28
6.6
5.3
0.04
0.04
e9/l
0.12
529
4199
280
1943
1.56
9.24
4.6
4.0
—
—
—
0
0
612
4967
1.43
9.14
6.6
5.3
0.61
0.62
e9/l
0.30
527
4179
256
1760
1.56
8.77
2.1
1.8
30.15
29.90
s
0.30
256
1710
91
465
2.03
8.73
4.8
3.0
4.15
4.40
pmol/l
1.46
80
406
823
7075
1.42
8.71
6.4
4.6
—
2.05
—
0
12
524
4183
1.41
8.37
6.4
4.1
3.87
0.13
estimate
0.51
137
904
129
764
1.76
7.88
2.2
1.4
—
—
—
0
0
544
4422
1.39
7.62
5.6
3.6
6.40
6.27
ph
1.97
333
2435
96
537
1.85
7.09
5.4
3.6
—
—
—
0
0
154
991
1.63
6.91
2.9
1.6
65.90
66.54
g/l
0.46
144
891
125
768
1.69
6.71
5.8
3.6
7.39
7.41
ph
3.00
115
630
131
819
1.66
6.58
4.5
2.7
118.21
129.38
g/l
5.75
126
796
12
12
10.08
6.54
9.3
7.2
4.83
5.60
mmol/l
0.72
12
12
879
9680
0.73
6.49
6.9
5.7
6.16
6.12
mmol/l
0.32
803
8704
36
141
2.60
6.48
1.4
1.5
1986.00
1446.28
e6/l
0.27
27
100
156
1029
1.58
6.32
2.8
2.1
0.00
0.02
estimate
0.50
31
182
115
710
1.68
6.07
2.1
1.5
—
—
—
0
0
318
2440
1.40
6.03
5.2
3.7
88.40
82.58
%
3.75
313
2379
339
2630
1.39
6.02
7.0
4.3
1.02
1.02
kg/l
0.44
253
1731
17
33
5.20
6.02
9.8
1.1
60.03
38.00
u/ml
—
6
6
406
3249
1.36
5.93
6.8
5.2
—
—
—
0
0
19
54
3.55
5.89
1.2
1.3
7.39
7.43
ph
0.36
14
36
87
506
1.77
5.70
1.9
1.7
1.72
1.95
ug/l
0.12
82
436
48
228
2.15
5.66
1.2
1.2
—
—
—
0
0
28
104
2.73
5.61
1.5
1.5
—
—
—
0
0
210
1515
1.46
5.58
2.0
2.0
—
—
—
0
0
14
24
5.88
5.53
1.4
1.8
—
—
—
0
0
31
123
2.56
5.48
1.5
1.2
49.19
29.04
iu/l
1.65
22
105
29
112
2.62
5.41
1.5
1.2
—
—
—
0
0
154
1051
1.53
5.37
3.2
2.1
9.23
8.33
umol/l
0.21
137
926
136
908
1.55
5.24
2.1
1.6
—
—
—
0
0
536
4532
1.30
5.19
7.1
5.5
8.90
9.14
%
1.21
511
4185
33
139
2.41
5.17
1.5
1.2
—
—
—
0
0
903
9802
0.76
5.12
6.5
6.4
2.43
2.51
mmol/l
2.00
826
8965
82
486
1.73
5.06
1.3
1.2
111.85
117.68
u/ml
0.06
22
196
29
117
2.51
4.98
1.5
1.5
—
—
—
0
0
533
4532
1.29
4.86
6.9
5.4
2.98
2.94
%
0.15
507
4192
380
3090
1.32
4.82
2.5
2.3
3.44
2.83
mg/l
4.07
327
2635
29
119
2.47
4.81
1.3
1.2
148.03
157.91
au/ml
—
6
42
15
34
4.45
4.75
2.9
2.1
41.49
48.12
%
—
10
19
882
9572
0.77
4.73
5.9
5.5
4.33
4.40
mmol/l
1.35
810
8782
20
68
2.97
4.72
2.1
1.6
117.67
94.60
ng/l
0.39
20
68
70
405
1.77
4.71
2.5
1.4
57.90
35.67
mg/l
1.56
62
336
70
406
1.76
4.67
2.5
1.4
59.35
46.09
mg/l
0.95
62
337
15
43
3.52
4.62
1.2
1.1
—
—
—
0
0
530
4532
1.28
4.54
6.8
5.4
59.75
58.82
%
1.03
511
4284
12
23
5.25
4.46
1.6
1.3
18.24
14.49
pmol/l
—
6
8
536
4599
1.28
4.44
7.1
5.5
24.60
25.88
%
1.84
519
4313
29
124
2.37
4.43
1.5
1.5
174706.44
79925.24
e6/l
0.30
18
70
64
368
1.78
4.41
2.4
1.4
3.46
1.46
ratio
0.61
42
218
123
836
1.52
4.39
2.2
1.5
—
—
—
0
0
90
569
1.62
4.39
1.6
1.6
1.84
1.53
g/l
2.26
75
485
876
9483
0.78
4.36
5.7
5.4
1.35
1.43
mmol/l
5.78
802
8626
138
962
1.48
4.36
1.3
1.3
—
—
—
0
0
28
120
2.36
4.27
2.5
1.3
0.17
0.20
nmol/l
0.80
19
98
490
4178
1.27
4.22
5.0
4.2
21.36
8.43
mg/mmol
3.77
342
2643
527
4537
1.27
4.18
7.1
5.5
0.66
0.65
%
0.17
501
4191
486
4152
1.27
4.09
4.2
3.4
6.75
7.32
mmol/l
2.28
411
3488
70
426
1.68
3.98
1.4
1.4
—
—
—
0
0
350
2889
1.29
3.86
9.7
4.7
—
—
—
0
0
268
2137
1.32
3.82
1.7
1.6
1.24
1.39
mg/l
0.49
211
1677
346
4132
0.78
3.80
2.1
1.9
1.58
1.30
mmol/l
4.83
289
3404
476
4095
1.25
3.69
4.3
3.5
111.99
47.50
mg/l
4.19
342
2672
249
3088
0.76
3.65
3.7
3.7
—
—
—
0
0
885
9501
0.80
3.64
8.6
7.4
41.29
40.73
mmol/mol
1.03
818
8766
120
847
1.46
3.59
7.4
3.0
1.23
1.22
mmol/l
0.37
110
705
292
2384
1.29
3.47
1.4
1.3
—
—
—
0
0
515
4498
1.24
3.42
4.0
3.0
223.84
138.37
ug/l
6.31
470
4130
14
47
3.00
3.41
1.1
1.1
—
—
—
0
0
116
825
1.44
3.35
4.2
3.6
0.72
0.76
%
0.09
43
183
494
4308
1.23
3.30
16.0
10.6
0.00
0.00
e9/l
0.07
400
3479
149
1116
1.38
3.21
3.0
1.9
66.29
66.82
e9/l
0.07
113
833
162
1235
1.35
3.13
2.9
2.6
4.45
7.46
ug/l
4.29
144
1083
142
1060
1.38
3.13
10.3
3.5
7.36
7.35
ph
0.10
113
691
366
3105
1.25
3.13
3.8
2.5
34.69
34.48
u/l
0.03
346
2901
332
2787
1.25
3.11
5.1
3.6
0.21
0.29
estimate
0.09
136
859
121
881
1.41
3.09
2.7
2.1
144.26
38.10
u/l
0.47
104
709
28
140
2.02
3.02
2.6
1.4
0.70
13.50
nmol/l
0.50
28
133
110
791
1.43
3.01
4.1
3.5
0.93
0.63
%
0.57
40
183
851
9107
0.82
3.00
5.0
4.6
1.48
1.27
mmol/l
9.33
771
8191
24
114
2.13
2.95
1.3
1.4
—
—
—
0
0
24
114
2.13
2.95
1.3
1.4
—
—
—
0
0
24
114
2.13
2.95
1.3
1.4
—
—
—
0
0
24
114
2.13
2.95
1.3
1.4
—
—
—
0
0
161
1238
1.34
2.95
1.9
1.8
—
—
—
0
0
996
10478
0.81
2.88
46.2
24.9
129.46
134.28
g/l
16.86
983
10295
110
798
1.41
2.88
4.3
3.6
0.16
0.05
%
0.87
37
156
25
122
2.07
2.88
1.5
1.5
—
—
—
0
0
25
122
2.07
2.88
2.4
1.3
—
—
nmol/l
—
0
0
996
10477
0.81
2.87
46.0
24.8
7.10
6.90
e9/l
2.24
970
10116
996
10476
0.81
2.86
47.0
25.2
39.15
39.98
%
5.20
981
10286
996
10476
0.81
2.86
45.7
24.6
30.12
30.51
pg
7.98
981
10291
996
10476
0.81
2.86
45.9
24.7
4.35
4.43
e12/l
4.54
970
10114
185
1458
1.31
2.86
2.8
1.9
1.77
1.77
%
0.04
168
1277
100
714
1.43
2.86
2.6
2.3
11.92
14.91
nmol/l
1.94
86
638
996
10475
0.81
2.85
46.0
24.7
240.14
238.47
e9/l
0.31
973
10170
996
10475
0.81
2.85
45.7
24.7
91.40
91.80
fl
1.77
981
10288
42
247
1.72
2.78
5.4
4.1
—
—
—
0
0
31
166
1.89
2.77
2.0
2.1
4.58
4.58
mmol/24h
0.00
25
143
72
485
1.51
2.76
2.5
2.0
0.08
0.01
estimate
0.43
25
134
47
286
1.67
2.76
1.5
1.4
246.87
299.01
ug/g
0.91
26
176
526
4697
1.20
2.62
2.8
2.4
81.47
78.77
nmol/l
1.34
480
4090
40
237
1.71
2.60
1.4
1.4
55.06
59.20
mmol/l
0.35
33
191
7
15
4.69
2.60
1.0
1.0
—
—
—
0
0
66
446
1.50
2.52
1.3
1.3
—
—
—
0
0
25
129
1.96
2.51
3.0
2.9
—
—
—
0
0
110
822
1.37
2.45
4.5
3.7
0.29
0.01
%
0.47
35
151
47
297
1.60
2.41
2.9
3.5
4.32
1.77
index
0.61
25
144
5
8
6.27
2.37
2.2
1.8
—
—
—
0
0
7
18
3.90
2.25
1.0
1.1
—
—
—
0
0
16
73
2.21
2.21
1.2
1.2
—
—
—
0
0
734
7860
0.85
2.18
39.6
21.9
329.20
331.71
g/l
10.18
726
7802
6
14
4.30
2.15
1.3
1.6
24.00
23.21
%
—
6
14
997
10405
0.84
2.12
42.8
22.3
116.24
84.32
umol/l
25.51
985
10223
30
175
1.73
2.10
2.1
1.1
47.81
21.39
u/l
0.45
23
152
13
56
2.33
2.05
2.2
1.6
1.00
2.88
u/field
—
6
41
469
4218
1.17
2.04
3.8
3.3
2595.73
1786.28
ng/l
2.02
426
3676
6
15
4.01
2.04
1.2
1.3
4280.83
19.57
u/l
—
6
7
866
9122
0.86
1.96
8.2
5.1
2.14
2.03
mu/l
1.27
802
8242
515
4689
1.16
1.88
5.4
4.4
52.67
97.58
ng/l
1.28
438
3657
7
22
3.19
1.88
1.3
1.1
—
—
—
0
0
6
17
3.54
1.84
1.2
1.2
—
—
—
0
0
43
286
1.52
1.84
1.2
1.1
—
—
—
0
0
979
10190
0.85
1.78
19.3
10.7
29.76
24.75
u/l
0.51
946
9742
28
169
1.67
1.78
1.2
1.2
—
—
—
0
0
9
36
2.51
1.74
1.4
1.4
—
—
—
0
0
33
212
1.57
1.66
1.6
1.9
3.22
30.30
iu/l
0.51
11
88
144
1183
1.24
1.66
4.3
2.8
7.61
4.64
e9/l
0.40
127
987
162
1352
1.23
1.61
1.3
1.2
—
—
—
0
0
76
578
1.33
1.59
4.8
4.3
1.51
1.68
%
0.94
71
551
45
313
1.45
1.58
1.7
1.5
—
—
—
0
0
34
224
1.53
1.55
5.6
4.7
2.71
2.94
mmol/l
0.20
23
142
16
85
1.89
1.55
1.0
1.3
84.75
96.81
pmol/l
0.41
16
85
21
122
1.73
1.55
1.4
1.2
249.33
241.65
u/ml
0.04
15
62
34
225
1.52
1.52
5.6
4.7
5.34
5.10
kpa
1.06
34
220
34
226
1.52
1.50
5.6
4.7
8.85
8.32
kpa
0.89
34
220
44
310
1.43
1.47
3.7
2.2
127.00
131.04
g/l
0.57
33
253
5
16
3.13
1.44
1.0
1.0
—
—
—
0
0
12
59
2.04
1.43
1.0
1.1
—
—
—
0
0
9
39
2.32
1.43
1.3
1.5
1058.89
1252.88
e6/l
—
9
33
418
3813
1.14
1.43
2.3
2.2
152.52
264.75
u/l
2.79
397
3586
10
46
2.18
1.40
2.6
3.1
0.60
0.89
index
—
10
46
7
29
2.42
1.39
1.4
1.7
77.29
76.71
%
—
7
24
19
311
0.61
1.38
1.1
1.1
—
—
—
0
0
5
17
2.95
1.36
1.4
1.2
1.20
0.78
mmol/l
—
5
7
993
10264
0.87
1.36
38.6
21.2
4.12
4.01
mmol/l
25.63
974
10004
6
24
2.51
1.30
1.5
1.9
0.60
0.61
mmol/l
—
6
24
138
1162
1.21
1.29
1.4
1.4
—
—
—
0
0
5
18
2.78
1.28
1.4
1.2
—
—
—
0
0
9
44
2.05
1.27
1.2
1.0
—
—
—
0
0
305
2746
1.14
1.26
4.1
3.2
0.14
0.02
—
7
95
993
10245
0.88
1.24
38.4
21.1
139.08
139.74
mmol/l
10.92
976
10005
57
437
1.32
1.19
2.1
1.5
10.68
10.54
g/l
0.08
51
375
8
38
2.11
1.18
1.0
1.1
1502.38
1678.95
miu/ml
—
8
38
55
421
1.32
1.16
1.1
1.2
—
—
—
0
0
31
438
0.70
1.16
2.1
1.8
3.21
3.46
mmol/l
0.73
20
338
43
317
1.37
1.16
1.5
1.8
23.89
20.70
s
1.01
38
286
18
110
1.65
1.15
3.7
1.9
1.87
1.53
u/field
—
8
64
5
20
2.51
1.15
1.6
1.2
30.80
31.27
%
—
5
15
23
150
1.54
1.15
1.5
1.2
—
—
—
0
0
43
318
1.36
1.14
2.6
2.2
242.67
77.50
ug/min
1.24
28
183
8
155
0.51
1.14
1.3
1.2
1.52
1.53
g/l
—
8
155
88
733
1.21
0.97
5.9
4.1
—
—
—
0
0
14
85
1.65
0.94
2.1
1.6
16.01
16.52
%
0.18
14
85
43
331
1.31
0.92
3.9
2.7
1.70
1.65
mmol/l
0.10
43
322
179
1595
1.14
0.89
1.2
1.3
16.76
11.95
u/ml
0.33
76
589
45
351
1.29
0.88
6.6
4.0
7.39
7.41
ph
1.89
45
346
48
378
1.28
0.87
5.4
5.3
1.26
1.34
mmol/l
0.31
42
337
144
1266
1.15
0.87
1.3
1.3
672.00
571.76
titre
0.14
25
313
23
161
1.44
0.87
1.5
1.8
0.85
0.89
%
0.12
17
110
18
120
1.51
0.85
2.5
1.8
10.22
10.30
%
0.03
18
120
10
57
1.76
0.83
1.1
1.0
—
—
—
0
0
11
65
1.70
0.82
3.4
1.5
—
18.96
—
0
7
21
147
1.44
0.80
3.0
2.2
1.25
1.19
mmol/l
1.86
21
147
5
96
0.52
0.78
1.2
1.2
—
—
—
0
0
5
96
0.52
0.78
1.2
1.4
—
—
—
0
0
33
252
1.32
0.77
4.3
3.6
22.14
30.20
mg/l
0.73
21
188
22
157
1.41
0.77
1.5
1.1
—
—
—
0
0
39
306
1.28
0.75
1.2
1.3
—
20.10
—
0
8
14
91
1.54
0.75
2.2
1.5
8.48
8.44
mmol/l
0.01
14
91
5
24
2.09
0.74
1.2
1.8
—
—
—
0
0
9
54
1.67
0.74
1.0
1.1
—
—
—
0
0
7
38
1.85
0.73
1.0
1.1
—
—
—
0
0
747
7727
0.92
0.73
34.0
20.1
14.25
13.75
%
14.06
735
7579
13
195
0.66
0.72
1.1
1.2
—
—
—
0
0
7
39
1.80
0.72
1.1
1.3
35.47
27.98
umol/l
—
7
34
12
76
1.58
0.71
1.0
1.2
—
—
—
0
0
21
151
1.40
0.71
3.0
2.1
105.62
105.30
mmol/l
0.12
21
151
21
151
1.40
0.71
3.0
2.1
4.29
4.12
mmol/l
1.09
21
151
15
101
1.49
0.70
2.7
3.0
12.40
12.02
index
—
10
46
618
5930
1.08
0.70
3.6
3.1
55.57
52.06
u/l
0.51
565
5407
514
5381
0.93
0.68
2.2
2.3
93.95
93.67
pmol/l
0.05
287
2799
29
373
0.77
0.67
1.1
1.1
—
202.60
—
0
10
38
304
1.26
0.65
6.4
4.3
—
—
—
0
0
383
3620
1.08
0.64
1.8
1.8
18.40
19.80
nmol/l
1.10
332
3004
67
572
1.18
0.63
1.3
1.3
102.65
259.20
u/ml
3.28
55
527
5
30
1.67
0.61
1.2
1.5
—
—
—
0
0
18
131
1.38
0.59
2.0
1.8
89.51
89.80
%
0.09
18
131
17
230
0.74
0.57
1.4
1.4
—
—
—
0
0
6
36
1.67
0.56
1.2
1.4
131.33
167.07
mmol/24h
—
6
36
5
88
0.57
0.56
1.0
1.1
—
71.29
—
0
7
181
1959
0.91
0.54
1.3
1.3
0.83
1.81
u/ml
1.86
50
524
6
97
0.62
0.52
1.2
1.4
—
—
—
0
0
6
97
0.62
0.52
1.2
1.4
—
—
—
0
0
966
9840
0.93
0.52
27.1
15.3
—
—
—
0
0
6
99
0.60
0.52
1.2
1.4
—
—
—
0
0
6
99
0.60
0.52
1.2
1.4
—
—
—
0
0
29
233
1.25
0.51
1.6
2.5
28.25
34.48
umol/l
1.29
24
213
6
41
1.47
0.50
1.5
1.4
6.37
10.05
ug/l
—
6
35
6
41
1.47
0.50
3.7
1.3
39.07
38.24
g/l
—
6
41
30
366
0.82
0.48
1.1
1.6
0.19
0.35
mg/l
1.31
13
162
10
143
0.70
0.47
1.0
1.1
—
71.44
—
0
24
73
646
1.14
0.47
3.0
2.1
10.27
11.00
g/l
0.60
62
592
7
48
1.46
0.47
1.3
2.0
17.73
17.11
nmol/l
—
7
39
21
165
1.28
0.45
3.1
2.3
—
—
—
0
0
50
575
0.86
0.43
2.7
2.0
—
—
—
0
0
9
128
0.70
0.43
1.4
1.5
0.60
0.99
g/l
—
9
103
6
93
0.64
0.42
1.3
1.4
14.10
26.18
%
—
6
61
10
139
0.72
0.42
2.0
2.7
—
—
—
0
0
0
18
0.00
0.40
0.0
3.2
—
0.59
—
0
18
13
97
1.34
0.39
1.0
1.2
—
—
—
0
0
7
105
0.66
0.39
1.1
1.1
—
—
—
0
0
16
124
1.29
0.38
1.7
2.0
—
—
—
0
0
5
36
1.39
0.38
4.2
2.9
—
—
—
0
0
33
280
1.18
0.38
4.2
2.8
7.52
7.65
mmol/l
0.11
33
272
21
170
1.24
0.37
3.9
2.9
57.62
60.00
%
0.29
21
170
5
79
0.63
0.35
1.0
1.3
1.94
0.99
promille
—
5
66
34
394
0.86
0.35
22.6
11.5
—
—
—
0
0
95
874
1.09
0.34
3.6
2.9
5.95
6.09
ph
0.88
73
635
68
616
1.11
0.33
2.5
2.6
29.28
21.17
au/ml
—
5
42
68
618
1.11
0.31
4.9
3.6
1.02
1.02
ratio
1.35
63
575
36
411
0.87
0.31
1.3
1.9
4.32
6.93
iu/ml
—
8
104
7
52
1.35
0.31
1.0
1.2
210.14
414.09
u/l
—
7
46
58
641
0.90
0.30
1.4
1.3
—
—
—
0
0
14
173
0.81
0.28
1.6
1.7
—
—
—
0
0
44
394
1.12
0.27
1.3
1.3
—
—
—
0
0
63
576
1.10
0.27
2.5
2.5
—
—
—
0
0
740
7521
0.96
0.26
7.3
4.0
15.41
15.07
pmol/l
3.26
693
6758
176
1680
1.05
0.25
1.3
1.3
20.49
36.55
iu/ml
3.79
50
508
159
1669
0.95
0.25
1.3
1.3
2.26
2.82
g/l
3.47
90
945
12
96
1.25
0.24
1.0
1.1
—
—
—
0
0
10
78
1.28
0.24
1.2
1.1
—
—
—
0
0
233
2414
0.96
0.23
5.1
4.5
245.98
483.12
ng/l
1.77
204
2078
32
358
0.89
0.22
3.1
3.4
0.89
0.82
nmol/l
0.39
24
291
110
1160
0.94
0.21
3.1
3.3
349.58
280.38
ng/l
0.59
103
1074
0
11
0.00
0.21
0.0
1.0
—
84.36
—
0
11
0
10
0.00
0.21
0.0
21.9
—
0.19
—
0
10
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
75
800
0.93
0.20
1.5
1.5
—
—
—
0
0
231
2383
0.96
0.19
1.7
1.8
1358.55
1162.39
nmol/l
1.95
173
1816
29
322
0.90
0.19
1.3
1.6
10124.35
16186.15
e6/l
0.82
23
228
15
128
1.17
0.18
1.0
1.1
—
—
—
0
0
7
59
1.19
0.18
1.7
1.8
18.43
14.99
umol/l
—
7
51
7
62
1.13
0.17
1.6
1.8
—
—
—
0
0
5
68
0.73
0.17
1.2
1.1
—
—
—
0
0
8
68
1.18
0.16
1.3
1.2
2.20
2.05
mmol/l
—
8
62
8
70
1.14
0.16
1.4
1.8
—
—
—
0
0
977
9698
1.03
0.16
29.1
16.7
33.53
27.12
mg/l
5.69
893
8028
6
77
0.78
0.15
1.2
1.1
—
—
—
0
0
11
129
0.85
0.14
1.2
1.1
—
—
—
0
0
5
47
1.06
0.09
1.0
1.3
—
—
—
0
0
5
60
0.83
0.08
1.0
1.1
40.60
36.09
mg/l
—
5
55
8
76
1.05
0.07
1.1
1.1
—
—
—
0
0
9
100
0.90
0.06
1.0
1.1
—
—
—
0
0
21
198
1.06
0.05
1.1
1.1
—
—
—
0
0
11
100
1.10
0.05
1.1
1.2
—
—
—
0
0
67
685
0.98
0.04
1.2
1.2
—
—
—
0
0
105
1033
1.02
0.04
2.1
2.2
110.99
165.48
ug/g
2.02
83
821
31
322
0.96
0.04
1.7
1.6
24.93
20.03
u/ml
—
6
58
10
91
1.10
0.04
1.1
1.1
—
—
—
0
0
26
249
1.05
0.04
1.2
1.2
—
—
—
0
0
40
388
1.03
0.04
1.3
1.2
—
—
—
0
0
459
4568
1.01
0.03
6.0
4.3
5.25
2.17
ug/l
1.29
412
4083
24
230
1.04
0.03
1.8
1.7
—
—
—
0
0
53
521
1.02
0.02
2.4
1.3
2.29
1.23
g/l
0.92
43
477
13
137
0.95
0.01
1.1
1.2
—
—
—
0
0
264
2630
1.00
0.01
1.8
1.8
445.87
23609587.95
pmol/l
1.92
222
2139
262
2613
1.00
0.00
3.4
3.0
0.84
0.76
ug/l
0.56
197
1798
11
106
1.04
0.00
1.5
1.3
—
—
—
0
0
9
99
0.91
0.00
1.0
1.1
—
—
—
0
0
8
80
1.00
-0.00
3.4
2.3
7.65
7.21
mmol/l
—
8
48
7
75
0.93
-0.00
1.3
1.5
—
—
—
0
0
7
77
0.91
-0.00
1.3
1.2
2.70
2.76
g/l
—
7
59
8
85
0.94
-0.00
3.0
2.5
—
—
—
0
0
7
77
0.91
-0.00
1.3
1.2
0.36
0.40
g/l
—
7
58
7
75
0.93
-0.00
1.0
1.0
—
2.34
—
0
36
7
76
0.92
-0.00
1.1
1.2
—
—
—
0
0
7
77
0.91
-0.00
1.3
1.2
7.22
7.24
g/l
—
7
59
6
61
0.98
-0.00
1.3
1.2
138.15
159.90
pmol/l
—
6
61
6
64
0.94
-0.00
3.2
3.0
—
—
—
0
0
6
61
0.98
-0.00
1.0
1.3
114.00
136.02
nmol/l
—
6
61
7
72
0.97
-0.00
2.3
2.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.5
—
361.75
—
0
8

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_RENAL_CELL_CARCINOMA – Renal cell carcinoma of kidney

GWS hits: 1

This endpoint is excluded from FinRegistry analyses (omitted endpoint).